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Abstract 
Caesarean section (CS) is a painful and common surgical procedure that many do 
not perceive as major surgery. The contemporary view is that CS is a 
biopsychosocial (BPS) experience and that pain perception is subject to unique 
individual beliefs and characteristics. Yet, little attention has been given to BPS 
approaches to acute pain. Moreover, outcomes such as perceived control and 
quality of pain have not been evaluated following CS as well as the potential for 
some women to develop chronic pain. Postoperative CS pain is treated in many 
settings with scheduled doses of controlled-release (CR) oxycodone and non-opioid 
analgesics. Clinical guidelines, however, recommend using immediate-release (IR) 
opioids to commence acute pain management as the formulation enables rapid 
follow-up and individualised management. The purpose of this research was to 
evaluate whether a NP intervention with oxycodone and supportive educational 
strategies would improve pain management outcomes the day after CS compared 
to standard treatment with CR oxycodone. Grounded in the BPS model of pain, the 
research also aimed to explore the experience of CS pain over three months. 
 
Methods 
The research was a two-group RCT (Registration: ACTRN 12613000076774) 
conducted in a metropolitan public hospital in Australia. Participants were booked 
for elective CS and were over 18 years of age. The randomisation sequence was 
computed and group allocation (1:1) was undertaken using sequentially numbered 
opaque sealed envelopes. Out of 298 eligible participants, 131 were randomised to 
either the intervention or control group. The NP was blinded to treatment allocation 
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until the morning following CS when the intervention commenced. The NP 
commenced analgesic therapy with oral IR oxycodone alongside supportive 
educational discussion with participants throughout the day. The control group 
received scheduled doses of CR oxycodone. All participants could request 
additional oxycodone or tramadol as required. The primary outcomes were repeated 
measures of pain intensity (0-100mm) over 24 hours from 8:00 hours. Secondary 
outcomes included patient global impression of change (PGIC), global assessment 
of the quality of pain management, quality of pain, pain interference, perception of 
control, opioid consumption and adverse effects. A follow-up study evaluated the 
experience of pain over three months. The research was supported with funding 
from the Margaret Winning Award managed by the Australian College of Nursing. 
 
Results 
The final sample size was 122 with 61 participants in each group. Pain scores were 
analysed by linear mixed models with spline regression. The final regression 
models for pain at rest and on sitting/moving found no statistical difference between 
the control and intervention groups over 24 hours. In the model for pain at rest, 
catastrophising and previous CS were associated with greater pain intensity (p< 
0.05). The effects of the intervention on PGIC were significant at 11:00 hours and 
those in the intervention group had greater odds of reporting ‘improved’ or ‘very 
much improved’ pain (p= 0.014, OR= 2.5, 95% CI 1.2, 5.3). Global assessment of 
the quality of pain at 20:00 hours was not statistically different between groups (χ²= 
1.51, df =1, p= 0.22). At the same time, participants in the intervention group 
recalled having less pain interference than those in the control group (p< 0.05). Less 
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oxycodone and tramadol were consumed by the intervention group and there were 
no differences in adverse effects in terms of drowsiness, nausea or itching. The NP 
intervention did not result in differences between groups in terms of control over 
pain management.  
 
The follow-up study (n= 85) found a 5.9% prevalence for pain greater than three 
out of 10 at three months. The median score for days in pain was four with only 
2.4% of participants reporting daily persistent pain. In the final multiple linear 
regression models, an increased Edinburgh Postnatal Depression Score (EPNDS) 
from baseline was associated with another day of pain (p< 0.001), more pain 
interference (p< 0.001) and greater total pain (p< 0.025) calculated from all scores 
on the Short Form Magill Pain Questionnaire- Version Two (SF-MPQ-2). In terms 
of grade of chronic pain, 5.9% of participants experienced Grade IV chronic pain 
or severe pain interference. 
 
Conclusion 
The research showed that the BPS model of pain is applicable to acute CS pain and 
that a NP approach can improve pain management measured by outcomes that were 
derived from an interrogation of the model. The NP intervention was characterised 
by an integrated approach that reduced pain interference without the need for more 
opioids when compared to those who received standard care. The results underscore 
that acute pain management is more complex than the prescription and 
administration of analgesics and that it also involves consideration of chronic pain 
developing in some women following CS. Many psychosocial and biological 
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factors were found to be associated with CS pain. Hence, this research proposes a 
refined BPS model for CS that can be applied in further research and service 
delivery in the area of acute pain management. 
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Chapter 1: Introduction 
This research developed from reflection on standard practices in acute pain 
management with a predominant focus on analgesics and pain intensity scores to 
guide patient care. This approach to pain management is often characterised by a 
one-size-fits all approach to improve pain management for a proportion of 
individuals and those who do not respond well can be left without adequate 
analgesia. This research challenges standardised management of CS pain the day 
after surgery with a NP approach to pain management that seeks to assess and 
manage postoperative pain with an individualised approach based on the BPS 
model of pain. 
 
Biomedical approaches to care have influenced the predominant approach to acute 
pain management over the last two decades. Examples are analgesic pain ladders 
and drug protocols that guide escalation in analgesic therapy alongside increases in 
pain intensity scores. Yet, these pharmacological approaches do not consider 
psychosocial aspects of pain management or how other strategies can be used to 
improve the use of analgesics and tailor them according to individual requirements 
or preferences. It is generally accepted that effective pain management is 
underpinned by the consideration of many biological, psychological and social 
factors that interact to determine an individual’s pain perception and response to 
pain. Observation of the CS experience in clinical practice supports a broader view 
of acute pain because it is also an emotional and social event for all concerned. This 
complexity was embedded in this thesis which aimed to apply the BPS model of 
pain to the acute pain setting by comparing two interventions for pain management 
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the day following CS, one based on the one-size-fits all approach and the other led 
by a NP. 
 
A brief look at history supports a view that CS has not been viewed the same as a 
normal delivery in terms of pain management and the psychosocial components of 
the experience. The lack of attention given to CS pain as a BPS experience may 
stem from the procedure being unsuccessful for many centuries in terms of maternal 
mortality. CS has been associated with Julius Caesar from Rome but it is highly 
unlikely he was delivered this way because Julius was the first-born of seven 
children and his mother, Aurelia, would not have survived a CS at a time when the 
mortality rate was probably 100% (Todman, 2007a; Van Dongen, 2009). Thus, 
maternal and infant death were common outcomes which may explain myths 
suggesting that historical figures such as Julius Caesar, Buddha and some Greek 
gods were delivered by CS because the social view would have associated survival 
with divine intervention (Van Dongen, 2009).  There may have been little need to 
consider postoperative pain management. Even in the seventeenth century, 
maternal death from infection occurred within 25 days after CS was first performed 
successfully (Van Dongen, 2009) and mortality rates during the first half of the 19th 
century were between 50 and 85% (Boley, 1935).  There were also philosophical 
arguments around these times that the brain, and therefore psychological factors, 
had no part to play in pain perception. 
 
The sensory-physiological view of pain could have prevented developments in 
understanding CS as a BPS experience as the interventional focus was to block the 
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pain stimulus with drug therapies that were seen as appropriate for all. It was only 
during the Second World War that these views were challenged and individual 
variation in the experience of pain was recognised (Beecher, 1946). Despite 
evidence of individual variation in response to war injuries (Beecher, 1946) and 
theories of pain proposing significant central processing of pain stimuli (Melzack 
& Wall, 1965), mind-body dualism as the dominant philosophy guiding acute pain 
management for CS persists. From this perspective, pain is considered directly 
proportional to the severity of the stimulus and the brain itself does not modify pain 
in any way.  To some extent, this view of pain has resulted in necessary innovations 
in pain management such as the ability to temporarily block nociception for surgery 
with local anaesthetic agents and general anaesthesia.  This approach, however, 
does not recognise the complexity of pain or how postoperative pain interventions 
can involve multiple strategies.  Thus, the Cartesian biomedical view is limited as 
a lens through which to study childbirth pain. 
 
The research reported upon here challenges the biomedical conceptualisation of 
acute pain by applying the BPS model of pain to the acute pain setting. Because it 
is difficult to predict the severity and impact of postoperative pain due to individual 
variability in reports of pain intensity, the BPS model of pain assumes that pain can 
be best explained as a combination of biological, psychological and social factors. 
While biological factors are important contributors to the experience of CS, this 
research explored all relevant factors such as beliefs about analgesic use, pain 
management in childbirth, catastrophising and depression. The BPS model 
informed the development of a NP intervention to improve postoperative pain 
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management the day after CS and to determine other relevant factors that may 
influence this experience. This research underscores the clinical significance of 
improving the management of CS pain by arguing that interventions guided by the 
biomedical model are deficient in addressing this problem. An alternative model to 
the biomedical approach is the BPS model of pain because it acknowledges that 
pain has multiple components and, thus, can be targeted with an intervention that 
integrates analgesic therapy with other strategies.  
 
1.1 Research Background  
1.1.1 The Burden of CS Pain and Management Approaches 
A high level of technical intervention is required to perform CS to ensure 
anaesthesia and minimal pain in the immediate postoperative period. In contrast to 
uncomplicated vaginal delivery, CS may be accompanied by significant 
postoperative pain and it is now understood that this pain causes undue distress and 
interference with the ability of women to mobilise and perform other roles such as 
breastfeeding (Schyns-van den Berg, Huisjes & Stolker, 2015). Studies have found 
that almost 50% of women report moderate to severe pain after the first 24 hours, 
often worse than other major surgical procedures (Eisenach et al., 2008; 
Gerbershagen, Aduckathil & van Wijck, 2013; Karlstrom, Engstrom-Olofsson, 
Nystedt, Sjoling & Hildingsson, 2010; Marcus et al., 2015). Some have argued that 
clinicians expect women to mobilise and perform parental duties regardless of pain 
intensity and that they may be treated differently by staff when compared to other 
similar surgeries (Marcus et al., 2015). Increasing evidence also suggests that 
poorly managed pain in the days following analgesia from intrathecal morphine 
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may interfere with mood, physical recovery and essential maternal roles such as the 
ability to care for a new-born infant (Eisenach et al., 2008; Karlstrom et al., 2010; 
Zanardo et al., 2010). Poor analgesia and the resulting pain interference may lead 
to psychological problems such as postpartum depression (Eisenach et al., 2008; 
Fenwick, Gamble & Mawson, 2003; Fisher, Astbury & Smith, 1997; Hiltunen, 
Raudaskoski, Ebeling & Moilanen, 2004; Keogh, Hughes, Ellery, Daniel, & 
Holdcroft, 2005). The complex interplay of many BPS factors and poor 
postoperative analgesia may also lead to chronic postsurgical pain (Lavand’homme, 
2013). Pain interventions after CS, therefore, require more than standardised 
analgesics and drug doses to account for individual variation in perception and 
responses to pain. Furthermore, a standardised oral analgesic plan without a NP 
approach to care is reminiscent of mind-body dualism where pain perception is 
viewed as a predictable result of the type of surgery. The BPS model of pain 
overcomes this problem by taking into account the individual characteristics of 
patients and their preferences. 
 
Biological methods of pain management have been reasonably successful for CS 
and the last decade has seen significant improvement due to the use of intrathecal 
morphine and multimodal oral analgesics to reduce pain in the first 24 postoperative 
hours. This regimen became a popular choice for anaesthetists due to evidence of 
its effectiveness and endorsement by clinical guidelines formulated by the National 
Institute of Clinical Excellence (NICE) in the United Kingdom (NICE, 2011). 
While this practice has improved pain relief during the first 12 hours following CS, 
evidence of effective interventions to reduce pain and its complications during the 
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subsequent few days and weeks is scarce.  There is a significant gap in the research 
literature on interventions to supplement the diminishing analgesia from intrathecal 
morphine the day following caesarean delivery.  
 
Despite clinical guidelines that recommend IR oral opioids to commence acute pain 
management (Analgesic Expert Group, 2012), CR oxycodone has become 
entrenched clinical practice for the management of postoperative pain in some 
Australian and New Zealand hospitals (Seaton & Reeves, 2009). However, 
commencing acute pain management with CR oxycodone may make individualised 
therapy difficult as the recommended first intervention is IR opioids to achieve 
rapid pain relief and dose titration (Analgesic Expert Group, 2012). Thus, for many 
women, a one-size-fits all approach without supportive care may result in poorly 
controlled pain the day after CS that negatively affects recovery and maternal-infant 
interaction (Declercq, Cunningham, Johnson & Sakala, 2008; Eisenach et al., 2008; 
Kealy, Small & Liamputtong, 2010). In the United Kingdom, IR opioids are the 
more common choice for CS pain and a survey found that no clinicians prescribed 
CR opioids following CS (Aluri & Wrench, 2014). Some have argued that CR 
opioids may be unsafe due to prolonged analgesia and risk of respiratory depression 
(Raeder & Breivik, 2015). No studies have compared a NP pain intervention with 
oxycodone to standard care with CR oxycodone that commences the day after CS 
to challenge the opinions of some clinicians who support the use of CR oxycodone 
to commence acute pain management. 
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1.1.2 Impetus for the Research 
The impetus for this study was based on the professional insights of the researcher 
in terms of clinical practice as a NP specialising in pain management. Interest in 
CS pain dates to 2002, when the researcher implemented an acute pain service in 
the same hospital as the research setting in this study. Prior to this service, there 
was no routine follow-up of women following CS in terms of pain management, 
unlike other major surgical procedures such as hysterectomy. Routine audits 
conducted by the researcher (the NP) within the maternity unit demonstrated that, 
while pain was mild over the first postoperative night for those who received 
intrathecal morphine, postoperative pain management was still a clinical problem 
the day after CS because of the need to mobilise in the context of the eroding 
analgesia from intrathecal morphine. At the time of first mobilisation, women were 
experiencing moderate to severe pain that inhibited their ability to perform essential 
functions that enable full recovery and unhindered maternal care of the baby. This 
made it clear that standardised approaches may not have been the best interventions 
to reduce pain on the first postoperative morning.  
 
As an NP, the researcher changed his own practice and prescribed IR oxycodone in 
place of the standard CR dose which was usually commenced at 8:00 hours the 
morning following surgery. This challenge to standard practice came with more 
confidence in acute pain management and analgesic prescribing and it has been 
argued that increased years as an NP is associated with greater confidence in 
prescribing medicines and adjusting the prescriptions of others (Cashin, Stasa, 
Dunn, Pont & Buckley, 2014). Like other experienced NPs in Australia, the NP 
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developed an approach to pain management based on Quality Use of Medicines 
principles and clinical guidelines such as the Therapeutic Guidelines (Buckley et 
al., 2015). For example, the therapeutic guidelines on acute pain management 
support using IR opioids for acute pain management as well as ongoing pain 
assessment to inform individualised management (Analgesic Expert Group, 2012). 
When the NP changed the analgesic plan to IR oxycodone and talked to women 
about their pain management, follow-up and further audit on the first postoperative 
morning after CS demonstrated reduced pain and less pain on mobilisation on 0-10 
numerical rating scales. This began an informal investigation into the topic and a 
review of the research literature. 
 
The NP in this research was influenced by an Australian study which found 
scheduled doses of IR oxycodone prevented severe pain for the first 24 hours after 
CS compared to the standard practice of injecting morphine into the intrathecal 
space prior to surgery (McDonnell, Paech, Browning & Nathan, 2010). This 
randomised controlled trial was important because intrathecal morphine is 
recognised as the ‘gold standard’ approach to pain management following CS 
(NICE, 2011). However, intrathecal morphine only lasts for approximately 18 
hours and the concentration in cerebrospinal fluid (CSF) declines after 12 hours 
(Hindle, 2008). Thus, supplementation of the decay in intrathecal morphine 
analgesia with oral immediate release oxycodone may improve pain management 
the day after CS and in the days that follow. This research expanded on the findings 
of McDonnell and others who suggested a need for further research on the 
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appropriate dose, form and regimen of oral oxycodone during the days that follow 
CS (McDonnell et al, 2010). 
  
1.1.3 Origins of CR Oxycodone for Postoperative Pain 
Various reasons could explain why CR oxycodone has become a popular choice for 
the management of postoperative pain. There has been a trend, for example, to 
replace other forms of analgesia for CS with oral opioids because of a perception 
that PCA pumps and intravenous lines may inhibit maternal mobilisation (Davis et 
al., 2006). Some have argued that oral oxycodone is most suitable for analgesia 
following CS because of convenience to staff and cost-effectiveness (McDonnell, 
Keating, Muchatuta, Pavy & Paech, 2009). Pain management nursing literature also 
supported the use of CR oxycodone for acute pain on the basis that CR oxycodone 
had a peak analgesic effect of 40 minutes with another peak effect seven hours after 
administration (Pasero & McCaffery, 2004). Similarly, others have suggested that 
CR oxycodone achieves a peak analgesic effect in one hour (Raeder & Breivik, 
2015) and this misunderstanding of the pharmacokinetics of CR oxycodone was 
also reflected in a recent study following CS (Niklasson, Arnelo, Ohman, Segerdahl 
& Blanck, 2015). It appears the belief in a biphasic absorption profile and a short 
time to maximum concentration for CR oxycodone still exists in the clinical 
community. This interpretation of the pharmacokinetics of CR oxycodone may 
explain the incorrect view that a single dose produces biphasic peak plasma 
concentrations which is now known to be a misinterpretation (Mundipharma, 2014; 
Appendix A). It was thought that this initial peak effect and prolonged analgesia 
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would enable a satisfactory transition from intravenous PCA to oral analgesia after 
surgery (Pasero & McCaffery, 2004).  
 
The earliest research supporting CR oxycodone for acute pain was a study by 
Reuben and others that compared CR to IR oxycodone following anterior cruciate 
ligament reconstruction (Reuben, Connelly & Maciolek, 1999). The results of the 
study demonstrated that CR oxycodone was more effective for postoperative pain 
than scheduled four hourly doses of IR oxycodone (Reuben et al., 1999). It is 
interesting to note that the editor of the journal, Anesthesia and Analgesia, retracted 
the publication 10 years later due to evidence of fabrication of data by the 
researchers (Shafer, 2009). In subsequent years and from 2000, CR oxycodone was 
evaluated as an alternative to invasive analgesic techniques for orthopaedic and 
abdominal surgery. One study claimed that CR oxycodone twice daily was more 
effective than PCA or epidural analgesia over 48 postoperative hours following 
total joint surgery (de Beer et al., 2005). However, another trial compared CR 
oxycodone to the IR formulation after total joint surgery and found scheduled doses 
of IR oxycodone to be more effective (Kerpsack & Fankhausen, 2005). Other trials 
demonstrated the effectiveness of CR oxycodone as a step-down from intravenous 
PCA following abdominal surgery (Fanelli et al., 2008; Ginsberg et al., 2003). 
Fanelli and others suggested that the preference for CR oxycodone was based on 
twice daily dosing and that it had been successful following orthopaedic surgery in 
the studies noted here (Fanelli et al., 2008).  
 
 
 11 
1.1.4 Pharmacokinetic Clarification 
The current research was partly driven by inconsistent information in the literature 
around the pharmacology and efficacy of CR oxycodone. Available evidence on 
the pharmacokinetics of CR oxycodone did not match the claims by some that the 
drug produces biphasic peak plasma concentrations. While previous product 
information on this formulation described this biphasic pharmacokinetic profile 
(Mundipharma, 2011), it was not supported by the early research of Mandema and 
others two decades ago (Mandema, Kaiko, Oshlack, Reder & Stanski, 1996). 
Mandema and others tested 24 participants for plasma oxycodone concentration 
after single doses of IR oxycodone solution (20mg) and CR oxycodone tablets 
(20mg) over 36 hours. There was a one-week washout period between the 
administration and testing for both formulations. Consistent with present 
knowledge on the pharmacokinetic profiles of both formulations, the researchers 
found that IR oxycodone had a mean time to maximum concentration of 1.3±0.63 
hours compared to 2.6±1.07 hours for CR oxycodone (Mandema et al., 1996). What 
is also important was that, at the same dose, the IR preparation achieved over twice 
the maximum plasma concentration than the CR formulation (Mandema et al., 
1996). The finding suggests that an equivalent dose of IR oxycodone in place of the 
CR dose would achieve superior analgesia and less pain interference if taken an 
hour prior to mobilisation. The article only supported the use of CR oxycodone for 
chronic pain because twice daily dosing may make it easier for patients than taking 
four doses of the IR tablet per day (Mandema et al., 1996). Seven years later, Davis 
and others also endorsed CR oxycodone for chronic pain or cancer pain based on 
the twice daily dose preference and bioequivalence with an equal daily dose of 
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divided doses of IR oxycodone (Davis et al., 2003). Importantly for acute pain 
management, the major difference between the two formulations was the difference 
in time to maximum concentration (Davis et al., 2003) which favours the use of IR 
oxycodone to commence acute pain management. The pharmacokinetic profile of 
CR oxycodone is represented in Figure 1. 
 
 
 
Figure 1. Mean plasma oxycodone concentration profiles after single doses of CR 
(black dots) and IR oxycodone at the same dose of 20mg (Mandema, Kaiko, 
Oshlack, Reder & Stanski, 1996).  
 
In April 2014, the manufacturer of CR oxycodone introduced a new formulation 
which met the Therapeutic Goods Administration's bioequivalence criteria 
compared to the original formulation (Mundipharma, 2014). The researcher 
requested information on the differences in pharmacokinetics between the old and 
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new formulations and previous perceptions by some that CR oxycodone had a 
biphasic analgesic effect. The response from the manufacturer suggested that there 
would be no clinical differences in terms of the analgesic effects and bioavailability 
of the old and new formulations of CR oxycodone (Mundipharma, 2014). The 
communication also implied that there may have been misinterpretations in the past 
suggesting that CR oxycodone demonstrated a biphasic absorption profile. This of 
course is not consistent with what is now known as an initial peak concentration 
followed by a steady decline (Mundipharma, 2014; see appendix A). Current 
product information also dismisses the view that administration of CR oxycodone 
for acute pain management would produce an initial rise in plasma concentration 
like IR oxycodone (Aspen, 2015; Mundipharma, 2015). 
 
It was clear that the pharmacokinetic study by Mandema and others (Mandema et 
al., 1996) contrasted with the view that CR oxycodone produced biphasic plasma 
concentration increases that may have been perceived as equivalent to 
administering IR oxycodone (Mundipharma, 2011). Current information about 
oxycodone has clarified that CR oxycodone reaches maximum plasma 
concentration in approximately three hours (Mundipharma, 2015) which may make 
it unsuitable as a supplementary opioid to reduce pain and pain interference when 
the analgesia from intrathecal morphine declines. In clinical practice, there is wide 
variation in how women respond to CS and pain management interventions and 
thus IR opioids may be titrated to the requirement of the individual. This is made 
possible due to its rapid onset and shorter duration than the CR preparation. The 
view of the researcher, therefore, was that pain management might be improved by 
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commencing therapy with IR oxycodone. This would help to enable greater control 
over pain management alongside the development of a supportive relationship 
between the woman and the health professional that fosters patient participation in 
how to use IR oxycodone effectively and through consideration of maternal beliefs 
about pain management.  
 
1.2 Purpose of the Research 
The overarching purpose of this research was to apply the BPS model of pain to the 
acute pain setting by demonstrating, over a three-month period, that its assumptions 
and components are relevant to the CS experience.  Embedded within this research 
framework was a two-group parallel RCT that was designed to determine the 
effectiveness of a NP pain intervention with oxycodone the day after caesarean 
delivery compared to CR oxycodone. A further follow-up study aimed to describe 
the pain experience for participants three months following CS. Independent and 
dependent variables were based on the BPS model of pain that informed the 
theoretical framework for this study. The research questions for this study were as 
follows: 
 
1. Does a NP intervention with oxycodone result in improved analgesia the day 
after CS when compared to standard management with CR oxycodone? and, 
2. What is the experience and nature of postsurgical pain over three months 
following CS? 
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1.3 Scope and Significance 
It was important to select a suitable model for this research because CS is one of 
the most common surgeries performed to the extent that there is international 
pressure to decrease the rate. Middle to high income earning countries such as 
Australia, New Zealand and some European countries have the highest rates of CS 
births rates up to 30% or more (Betran et al., 2016). One reason cited for the 
popularity of CS is the fear of litigation from negative outcomes related to vaginal 
birth (Churchill & Francome, 2009; Roberts, Algert, Ford, Todd & Morris, 2012).  
Some have suggested CS is not perceived as a major procedure that warrants 
sophisticated pain management resources (Churchill & Francome, 2009) and this 
may also lead to a perception that routine CS has become normalised in society. 
Nonetheless, there are many accounts of the CS experience that associate the 
procedure with moderate to severe postoperative pain, difficulty with the 
performance of maternal functions and socioeconomic difficulties (Litorp, Mgaya, 
Kidanto, Johnsdotter & Esser, 2015). Thus, while modern anaesthesia has reduced 
pain perception during CS surgery and during the immediate postoperative period, 
poor analgesia can be a feature of the maternal experience in the days and months 
that follow. It is clear that CS pain is a serious pain management issue and that 
standardised postoperative analgesic regimens may not be the answer for many 
women. 
 
This research is important because of the reported impact of pain following CS. In 
terms of chronic pain after surgery, it extended the period of evaluation to three 
months after surgery to describe the experience of women during this time. Thus, 
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the study went further than the first 24 hours after surgery and inquired about the 
pain experience into the community phase. This research was an original 
contribution because the treatment was a NP intervention that targeted pain the day 
after CS with oral oxycodone supported by educational strategies. The integrated 
aspects of the intervention challenges traditional views about pain interventions that 
focus on drug therapy or psychological interventions alone. The intervention was 
underpinned by the BPS model of pain that had evolved out of observational work 
on the success of interventions that applied other strategies such as education and 
reassurance (Turk et al., 2010). The NP intervention in this study integrated these 
methods in the delivery of a NP approach to pain management aimed at 
individualising the administration of oxycodone.  
 
1.4 Structure of the Thesis 
1.4.1 Chapter 1: Introduction 
This chapter reflected knowledge development that challenges the predominant 
view of acute pain as a biological concept by proposing the BPS model of pain as 
the overarching research framework. The model was presented as an alternative to 
the biomedical model that appears to underpin contemporary approaches to pain 
management following CS. It was also proposed that approaches to acute pain 
management are influenced by mind-body dualism, despite the appearance of 
evidence and theory after the Second World War of central processing of pain 
stimuli. 
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The chapter explained the impetus for this research in terms of the clinical 
experience of the principal investigator in his role as a NP. The NP observed 
inconsistent practices and outcomes for pain management following CS that gave 
rise to questions regarding the clinical management of acute pain. It was pointed 
out that the use of CR oxycodone may not be appropriate for acute pain 
management, yet it has become entrenched practice in some settings. The chapter 
concluded with a statement of the purpose of this research and research questions 
were presented. The NP intervention was described as an approach to pain 
management that incorporated IR oxycodone as part of a NP approach based on the 
BPS model of pain. The application of the BPS model of pain rested on the need 
for individualised management of oral oxycodone as supplemental opioid analgesia 
following the decline in intrathecal morphine the day after surgery. This chapter 
also highlighted the problem of persistent pain after CS and that the BPS model 
would be an appropriate model to guide this research. 
 
1.4.2 Chapter 2: Theoretical Framework 
The second chapter justifies the application of the BPS model of pain in this 
research. The discussion underscores the complexity of the CS pain experience and 
how biological, psychological and social factors contribute to pain perception. The 
chapter traces the evolution of pain theory and views of childbirth culminating in 
conceptual models of pain formed in the last 50-60 years. The discussion argues 
that developments after the Second World War paved the way for new 
understandings of pain that contrasted with previous views that pain was a sensory 
experience only. Contemporary models of pain accept that central processing of 
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pain stimuli in the central nervous system plays an important role in pain 
perception. The chapter then explains how these theories led to the evolution of the 
BPS model of pain as a framework for addressing and explaining chronic pain. Here 
it is argued that the model is also appropriate for acute pain management but that 
some refinement is required for its application to CS pain. While the broad 
theoretical assumptions of the model are appropriate for acute pain, the specific 
components of the model are critiqued in order to ensure a BPS model of acute pain 
that is relevant.  
 
The theoretical framework identifies the main factors that are associated with pain 
after CS such as previous experience, pain catastrophising, depression and 
sociocultural factors that influence maternal beliefs about pain and pain 
management. The chapter highlights the interaction of those factors that support the 
complexity of acute pain and how multidimensional strategies are appropriate to 
this research. The discussion moves on to consider the NP as an appropriate role 
that can manage pain with a BPS approach so that treatment can be person centred. 
The chapter finally explores the domains of NP practice according to Australian 
national standards and how the domains reflect elements of the BPS model of pain 
management. 
 
1.4.3 Chapter 3: Literature Review 
The purpose of the literature review is to explore the evidence around the scope and 
impact of pain following CS and the relevant factors that have been associated with 
pain outcomes.  Guided by the BPS model of pain as outlined in Chapter Two, the 
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review describes the experience of women in terms of pain intensity and how pain 
interferes with mobility, infant care and other necessary functions the day after 
surgery. Cohort studies are analysed and provide supportive evidence for poor 
analgesia for many women. As well as the impact of pain on physical function, the 
review also underscores the significant psychological distress associated with the 
CS experience. The review also explores research on the key factors associated with 
CS pain including pain catastrophising, depression, previous CS experiences and 
maternal perception of control over pain management. The review concludes that 
such factors are relevant to this research because many of them form the 
components of the BPS model of pain.  
 
A key section of the literature review involves the evidence around the effectiveness 
of pain interventions following CS. An analysis of relevant clinical trials points to 
significant gaps in the literature pertaining to pain management the day after 
surgery. Various pain interventions are explored and the review argues that many 
previous studies reflect a biomedical approach to acute pain management. Many 
approaches to pain following CS have attempted a one-size-fits all therapeutic 
regimen that does not account for individual variations. It is argued that IR 
oxycodone would be a more appropriate formulation of oxycodone to commence 
pain management. Again, the review points out the lack of evidence for the most 
effective formulation of oxycodone the day after CS and how supportive strategies 
led by a NP could enhance analgesia. Finally, the review analyses evidence relating 
to chronic pain after CS and suggests that follow-up prospective studies can 
determine the burden of chronic pain after caesarean delivery. 
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1.4.4 Research Design and Methods 
Chapter Four explains the design of this research as a randomised controlled trial 
that compared a NP intervention to standard care following CS. The introductory 
section conveys that the trial was registered with the Australian and New Zealand 
Registry of Clinical Trials as well as confirming ethics and site approval for the 
research. The extension of the research to the community phase after discharge from 
hospital is described as a follow-up study relating to chronic pain after CS. 
Description of the research design follows the CONSORT guidelines and includes 
a discussion on the research setting, inclusion criteria, sample size calculation, 
recruitment of participants, randomisation and blinding. A description of research 
instrumentation follows with identification of the primary and secondary outcomes. 
Research procedures are explained in terms of the care provided to all participants 
including preadmission care, anaesthetic interventions and analgesic regimens 
common to both groups. The intervention and standard care provided to the control 
group participants is described. Finally, analysis of data is explained for all types 
of variables. In particular, an explanation is provided for the mixed effects model 
to analyse the primary outcome of pain intensity at rest and on sitting/movement 
and how this method controlled for multiple variables that may have affected the 
primary outcome.  
 
1.4.5 Chapter 5: Results 
The results are presented in Chapter Five in line with the CONSORT guidelines for 
the reporting of clinical trials. A CONSORT flowchart describes the flow of 
participants in the postoperative phase from recruitment through to analysis of trial 
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data. The results are presented in order of baseline data for 122 participants (61 in 
each group), primary outcome, secondary outcomes and then the follow-up study. 
The final regression models for pain intensity on 0-100mm VASs are presented as 
tables and mean pain scores at all time points are depicted in graphical form. All 
results are summarised at the end of this chapter. 
 
1.4.6 Chapter 6: Analysis and Discussion 
Chapter Six constitutes an analysis of results and their relationship to the research 
questions. The results are further grounded in existing research literature and how 
the findings reflect the assumptions and theoretical components of the BPS model 
of pain. The discussion underscores that CS is a BPS experience by showing how 
it is affected by many BPS factors along a continuum. The follow-up study is 
analysed as a cohort comprised of all participants and this discussion also highlights 
that biological and psychosocial factors drive the development of chronic pain 
following CS.  
 
Research outcomes and changes associated with the NP intervention are critically 
analysed and a point is made that the outcomes were not a direct result of drug 
therapy, but occurred due to the approach to pain management managed by the NP 
within a BPS approach. The analysis critiques the validity of the 0-100mm VAS as 
a stand-alone outcome when evaluating pain interventions and suggests that the 
BPS model can be used to guide research design to include multiple factors. The 
perceived limitations of this study are then discussed.  Finally, and in drawing on 
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the theoretical assumptions and the findings of the study, the chapter proposes and 
presents a revised BPS model for acute pain which may be used in further studies. 
 
1.4.7 Chapter 7: Conclusion 
Chapter Seven concludes the thesis and begins by revisiting the lead-up to the 
research with a reflection on clinical practice and the literature on CS pain that 
paved the way for the design of the study. The conclusion underscores the broad 
aspects of inquiry and the statistical methods employed to provide the most robust 
results possible. The discussion then moves to summarise the main findings of the 
research followed by a synthesises of the main points of the study in the context of 
the BPS model of pain. Finally, the analysis of findings and implications for clinical 
practice are discussed in line with the original purpose of the research. It is pointed 
out that the implications of the research are not only relevant to clinical practice but 
to service innovation within a nursing model of care and the extension of the BPS 
model of pain into the acute pain arena. 
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Chapter Two: Theoretical Framework 
2.1 Introduction 
Many factors influence pain perception including human social interaction, the 
social environment, the psychological makeup of individuals and biological factors 
(Leo & Quinton, 2010). In other words, pain is much more complex than a simple 
sensation and drug treatment, as is often the view of clinicians influenced by the 
biomedical model (Douglas, 2014; Keefe, 2009; Leo & Quinton, 2010). The 
International Association for the Study of Pain (IASP) does not accept a narrow 
biomedical approach to pain and suggests that pain is a sensory and emotional 
experience that relates to actual or potential tissue damage (IASP, 2016). 
Conceptualisations of pain over centuries, however, have situated sensation as the 
primary and initial concept in pain theory where pain is a static entity that changes 
only with the extent of the physical sensation (Keefe, 2009; Leo & Quinton, 2010). 
Prior to the emergence of the BPS model of pain, it appeared that suffering and pain 
behaviours were perceived to be the result of tissue damage and were unrelated to 
pain perception or social disturbance due to pain.  
 
There is abundant evidence that pain is an individual experience that is influenced 
by interrelated and multidimensional biological, psychological and social factors 
(Keefe, 2009; Leo & Quinton, 2010). From its origins in the discipline of 
psychology in the late 1990s, the BPS model of pain has enabled the development 
of individualised models to guide pain interventions and research (Turk et al., 
2010). Hence, this chapter argued for a NP approach to acute pain management 
based on the BPS model of pain. The problem was that the BPS model of pain had 
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not been developed for the acute pain setting because the model focuses on 
psychological and social aspects of chronic pain (Turk et al., 2010).  
 
This chapter explored the components of the BPS model of pain and synthesised 
the major assumptions and components that support a BPS model for acute pain 
following CS. The adapted BPS model in this research overcomes deficiencies 
identified in the BPS model of pain such as the lack of detail regarding biological 
aspects of pain perception and therapeutic treatment. The application of the model 
to this acute pain situation enabled an integrated research design and methodology 
that considered biological, psychological and social factors that influence acute 
pain management. In order to develop the theoretical framework, a broad method 
of inquiry was used to explore the major elements of the childbirth experience and 
in particular, CS. The inquiry process drew on historical, professional and research 
literature that addressed the complexity of childbirth pain.  
 
The argument for using the BPS model in this research began with the historical 
and social development of thought surrounding childbirth pain and how the BPS 
model evolved from a BPS approach to health and illness late in the 20th century. 
The adaptation of the BPS model in this research presents a balanced view of acute 
childbirth pain and rejects interpretations by some health professionals who accept 
only biological or psychosocial aspects of this approach to pain management 
(Blythe, MacFarlane & Nicholas, 2007; Leap & Andersen, 2008). In contrast, the 
role of the NP is presented as an approach to pain management that rejects views 
of pain management based on interpretations of the BPS model that favour 
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particular components over others. Through an exploration of the domains of NP 
practice embedded in Australian national standards for NP practice, the features of 
NP practice have been situated within the components of the BPS model of pain 
which fosters a supportive approach to care. 
 
As a future direction for acute pain research (Keefe, 2009) this chapter interpreted 
the BPS model of pain as the most appropriate framework that identifies and 
describes the major biological, psychological and social factors influencing pain 
following CS by drawing on theory and evidence surrounding childbirth pain. The 
model was an appropriate choice because the research literature and the 
longitudinal assumptions about pain in the model also supported the extension of 
this research into the chronic phase of CS pain, bearing in mind that the BPS model 
is traditionally a model for chronic pain (Turk et al., 2010). Derived from the 
relevant factors that are associated with the CS pain experience, the BPS model for 
acute pain was used to support the research questions: (1) Does a NP intervention 
with oxycodone result in improved analgesia the day after CS when compared to 
standard management with CR oxycodone? and (2) what is the experience and 
nature of postsurgical pain over three months following CS? 
 
The major components of the BPS model relevant to this research were situated on 
the premise that there is a complex interplay between biological, psychological and 
social factors along a continuum (Turk et al., 2010). This means that the CS 
experience commences prior to admission to hospital and the theoretical 
components of the model highlight previous CS surgery, depression, pain 
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catastrophising and perceived control as major factors associated with CS pain and 
maternal outcomes. Interventions for pain management are fundamental to the BPS 
model of pain (Turk et al., 2010). Thus, the NP role was an ideal vehicle for a pain 
intervention that sought to reduce pain, enable greater control over pain 
management and reduce pain interference following CS. The intervention was 
based on components of the BPS model of pain such as analgesic therapy, 
educational strategies and supporting maternal control of pain. Because the BPS 
model assumes that the pain experience is complex, psychosocial components of 
pain assessment were applied to the acute pain setting and so measures included 
pain interference, perceived control and the role of depression along the continuum. 
As noted, the BPS model in this acute pain context also supported the inclusion of 
chronic pain in the model as it appears that, for some women, pain can persist 
beyond the expected healing time following surgery.  
 
2.2 Historical Background to the BPS Model of Pain 
Debate over the nature and treatment of pain has a long history and contains many 
complex arguments surrounding the validity of beliefs about the nature and 
treatment of pain. The predominant social view in the West has been that women 
endure terrible childbirth pain and there are many accounts over centuries that 
suggest that distressing pain has been acceptable to women and society (Simms, 
1924). One of the possible reasons for this is that women may have had little choice 
other than to experience agony. This may have been due to religious opposition to 
the use of analgesics or a scarcity of resources available for most women (Dick-
Read, 1944; Paull, 1988). For many centuries, there was no technology to support 
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humane CS and so this event would have been even more distressing to women and 
observers (Boley, 1935). Women may have had to rely on other interventions to 
attenuate pain such as social support from others, an ability to cope with pain and 
by the use of breathing and relaxation strategies.  
 
2.2.1 Ancient Approaches to Childbirth 
There is evidence that women in ancient societies may have treated childbirth pain 
with multidimensional interventions that were more aligned with a BPS approach. 
In Ancient Egypt, women and their supports invoked the power of Goddesses to 
assist with the pain of labour (Chamberlain, 2004; Fouly, McCool & Kouci, 2012). 
Furthermore, maternal body position and topical oils were known to ease the pain 
of labour (Fouly et al., 2012).  Alcohol may also have been offered to women during 
ancient Egyptian births and herbal remedies were also administered to women in 
other ancient societies such as China and Rome (Fouly et al., 2012; Furth, 1987; 
Todman, 2007b). Others have described the use of distraction techniques for 
childbirth pain such as groups of other women shrieking in sympathy for the woman 
in labour (Chamberlain, 2004). This suggests that a BPS approach to childbirth 
existed in some form prior to the 20th Century. It appears as though there was a 
progressive shift away from these traditional approaches to a rational scientific 
model of care practiced by Greek medics (Todman, 2007b). While some women 
and their supports in ancient cultures may have embraced a variety of strategies to 
manage childbirth, the entrenchment of mind-body dualism in Western culture spelt 
the end of these approaches. 
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2.2.2 Mind-Body Dualism 
The concept of mind-body dualism and the dominance of beliefs surrounding 
biological solutions for pain emerged from ancient Greece and became cemented 
in modern Western philosophy from the 17th century onwards (Flor & Turk, 2011; 
Turk, 1996). The idea that the mind has a passive role in pain perception was 
influenced by the work of Renee Descartes who wrote that the mind and body were 
separate entities and that pain was transmitted by biological structures from the skin 
to the brain where it is acknowledged as pain (Brendelow & Williams, 1995). Thus, 
it was thought that pain transmission ends with only the acknowledgement of 
sensation by the brain and that the intensity of the sensation was directly 
proportional to the amount of physical stimulation (Duncan, 2000; Turk, 2001). In 
contrast to traditional childbirth practices, the last 400 years has been marked by 
attempts to manage pain with biological innovations such as chloroform which 
became socially acceptable after it was administered to Queen Victoria in the 19th 
century (Paull, 1988; Pitcock & Clark, 1992). While these interventions helped to 
reduce pain for many women, the emphasis on biological intervention still 
dominates Western approaches to pain management. Yet, because pain 
management is considered more dynamic and complex than conceptualised in 
sensory-physiological models and there is acknowledgement that psychosocial and 
biological factors influence pain perception (Flor & Turk, 2011), the biomedical 
approach to childbirth pain does not appear an appropriate model of care. 
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2.2.3 World War II and the Natural Childbirth Movement  
Despite the dominance of the biomedical model, alternative views about the nature 
of acute pain emerged during the Second World War. A natural childbirth 
movement was given support by arguments, such as that by Grantly Dick-Read, 
that pain could be reduced without the aid of chloroform (Pitcock & Clark, 1992). 
Dick-Read, a London Obstetrician, also referred to childbirth as a potentially 
uplifting experience where severe pain could be decreased or eliminated by a 
reduction of fear and the promotion of maternal control (Dick-Read, 1944).  The 
views of Dick-Read reflected the appearance of psychological and social factors as 
central issues surrounding childbirth pain (Moscucci, 2002). Another major shift 
from the biomedical view on pain occurred when Henry Beecher (a United States 
medical officer) observed severe battlefield injuries during the Second World War 
and that a proportion of these injuries were not associated with intense pain. 
Beecher found that 75% of men badly wounded in battle (n=215) reported little 
pain for many hours and did not request morphine. He thus concluded that strong 
emotions were also associated with pain perception (Beecher, 1946). Beecher later 
explained that the processing and interpretation of pain by an individual was equally 
important to the biological cause of the pain (Beecher, 1956). The assumptions 
about pain made by Beecher countered the predominant philosophy of mind-body 
dualism (Beecher, 1956). During the war, the views of Beecher and Dick-Read 
paved the way for a shift in the conceptualisation of pain from a sensory-
physiological model (Flor & Turk, 2011) to one that binds together a range of 
assumptions about the nature of pain and pain interventions. Moreover, the 
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evidence from this period suggested that acute pain was a unique individual 
experience. 
 
2.2.4 Gate Control Theory 
Like Beecher, Melzack and Wall challenged the sensory-physiological concept of 
pain which proposed a direct proportional relationship between the degree of a pain 
stimulus and the perception of pain (Melzack & Wall, 1965). These authors 
proposed the Gate Control Theory (GCT) which refuted previous assumptions 
about a direct link between the periphery and the brain by suggesting that intense 
stimulation at the periphery could be modified at the dorsal horn of the spinal cord 
(Melzack & Wall, 1965). The GCT suggested there were specialised cells in the 
dorsal horn (the substantia gelatinosa) that could be influenced by physical 
therapies applied at the periphery to modify pain transmission at the dorsal horn 
(Melzack & Wall, 1965). This formed the basis of therapies such as trans-electrical 
nerve stimulation and massage which were accepted nursing interventions years 
prior to the conceptualisation of the BPS model by Engel (Siegele, 1974). The 
theory also proposed that the dorsal horn could be influenced by descending inputs 
from higher brain structures such as the thalamus, limbic system, and cortex 
(Melzack & Wall, 1965). Thus, the GCT was instrumental in forging a view of 
acute pain that suggested psychosocial factors were not only responses to pain but 
could be manipulated to reduce acute pain (Keefe, 2009). The theory proposed a 
view that pain was a multidimensional experience and, therefore, could be managed 
by multidimensional strategies (Flor & Turk, 2011). 
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Prior to the BPS model of pain, there is evidence that nurses had already applied 
these principles in clinical practice by implementing therapies such as distraction, 
relaxation and educational interventions for acute and chronic pain (Siegele, 1974). 
Some have argued that the GCT had already convinced nurses that pain was a 
complex experience that could be attenuated by alleviating anxiety, providing 
support to patients and teaching them how to better cope with pain (Siegele, 1974). 
Nonetheless, the GCT was important to pain theory development as it replaced 
mind-body dualism as the dominant force in pain science and was the first theory 
to propose central control of pain processes (Melzack, 1996). The implication for 
this research was that a comprehensive approach is appropriate for acute pain 
management because biological, psychological and social interventions can be used 
effectively for acute pain as they were prior to the BPS model but without being 
fully conceptualised (Melzack & Wall, 1965; Siegele, 1974). Furthermore, GCT is 
regarded as the first attempt at conceptualising a BPS model of pain that was not 
solely based on chronic pain (Turk & Monarch, 2002). 
  
2.2.5 George Engel and the BPS Model 
In 1977, the BPS model was conceptualised within the broader context of health 
and illness, rather than simply as a model of pain. George Engel (a psychiatrist) 
suggested illness was best described in terms of biological, psychological and social 
factors that shape the individual’s experience, a position that opposed dualistic 
views about health and illness (Engel, 1977). This conceptual work stemmed from 
Engel’s experience as a psychiatrist and his argument that the biomedical model 
sits uncomfortably with most psychiatrists because it does not explain presentations 
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that are primarily psychosocial (Engel, 1977). Hence, by proposing a broad 
conceptual model of health and illness, Engel sought to displace mind-body dualism 
(Duncan, 2000). Conceptualisation of pain was not a constituent part of Engel’s 
BPS model but it marked a new era where Wilbert Fordyce (a psychologist) then 
wrote that behavioural aspects of pain were more important than pain sensation 
(Fordyce, 1976; Turk, 2001). Fordyce proposed that pain behaviours were a 
consequence of pain but could be influenced by social learning processes (Flor & 
Turk, 2011). The works of Fordyce and Engel prompted the development of new 
conceptual models of pain (Loeser, 1982). Hence, from the GCT onwards pain was 
considered a complex experience determined by many biological and psychosocial 
factors.  
 
2.2.6 Conceptual Models of Pain 
Although theories such as GCT were acceptable for application in acute pain 
settings (Siegele, 1974), most conceptual models of pain were developed in relation 
to chronic pain. In the 1980s, John Loeser (a neurosurgeon) expanded upon the 
work of Fordyce and proposed a multifaceted model of pain comprising four 
components (Loeser, 1982). The components were referred to as nociception 
(activation of peripheral nerves), pain (perception of a noxious stimulus), suffering 
(a negative response such as depression, isolation & anxiety) and pain behaviour 
(an observable response indicating that nociception, pain or suffering has occurred) 
(Loeser, 1982). Loeser also suggested that social interactions between patients and 
clinicians had the potential to affect the pain experience and that patients could 
modulate the pain experience either consciously or subconsciously (Loeser, 1989, 
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1982). This model of pain was another important step as an alternative to Cartesian 
mind-body dualism because how a person responded to pain was again linked to 
their psychological appraisal of the pain (Loeser, 1982). What was missing from 
Loeser’s model is how interventions can manipulate thoughts and beliefs in patients 
that may lead to rehabilitative behaviours and coping skills. Furthermore, the 
individuality of the pain experience was not yet fully conceptualised. In this 
research, therefore, a suitable model for acute pain intervention was not realised in 
Loesers’ concepts of pain model.  
 
A BPS approach to pain intervention was gaining momentum in the chronic pain 
setting when Dennis Turk (a psychologist) and others described psychological 
therapies to treat pain (Kerns, Turk & Holzman, 1983; Turk, Meichenbaum & 
Genest, 1983). Turk and others also drew on the wartime work of Henry Beecher 
because the central focus of their approach was that a patient’s thoughts and 
behaviour could reduce pain perception (Kerns et al., 1983; Turk et al., 1983). This 
approach challenged the linear feature of previous models by suggesting that 
learning to cope with pain could reduce suffering, rather than the patient response 
being a unidirectional result of pain and suffering. Turk and others suggested a 
multidimensional approach to pain management that involved education about the 
nature of pain, enhancing pain coping skills, reinforcing rehabilitative pain 
behaviours and increasing perceived control (Kerns et al., 1983). This interactive 
approach would enable clinicians to achieve therapeutic and collaborative 
relationships with patients to explore their beliefs about pain (Turk et al., 1983). 
Clinicians could then engage patients in a process of re-conceptualisation of beliefs 
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that both parties interpreted as unhelpful such as avoidance of normal activities 
(Turk et al., 1983). These new ideas demonstrated the clinical potential for 
multidimensional pain interventions because these approaches to pain management 
were being applied in clinical practice and evidence for the effectiveness of 
integrated strategies was accumulating (Turk et al., 1983). Turk and others also 
suggested a relationship between the social environment and an individual’s pain 
responses in terms of how one copes with pain and the influential response of others 
around the person (Turk et al., 1983). In childbirth pain, this would be exemplified 
by the social expectations about pain management that are placed upon women by 
family, friends and society. It is clear from the conceptualisation of pain in the 
1980s that a BPS model of pain was imminent as social and psychological aspects 
of pain were being accepted in clinical practice and described more clearly in the 
developing pain literature.  
 
2.2.7 The Neuromatrix Theory 
The neuromatrix theory supports the consideration of biological and psychosocial 
factors for the assessment and management of acute pain (Keefe, 2009). While 
broader conceptual models acknowledged that biological and psychosocial factors 
influenced pain perception in the brain, Melzack expanded upon these assumptions 
by describing a neuromatrix theory of pain that theorised on how higher brain 
centres process and respond to these complex factors. It has been argued that 
advances in neuroscience, embedded in the neuromatrix theory, support a BPS 
conceptualisation of pain (Keefe, 2009; Leo & Quinton, 2010). The neuromatrix 
theory does this by describing pain perception in the brain as an active physiological 
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process whereby brain networks work together to filter, select and modulate 
biological, psychological and social inputs (Melzack, 2003; Turk & Monarch, 
2002). The neuromatrix referred to widespread networks of neurons between the 
cortex and the thalamus as well as the cortex and the limbic system with their spatial 
distribution and synaptic links genetically determined to form a neurosignature 
(Melzack, 2001). The neuromatrix theory describes three major inputs that affect 
pain perception and these include sensory input from the periphery, cognitive-
evaluative factors and motivational-affective factors (Keefe, 2009). The 
neuromatrix theory explained how a person in pain receives these multiple sensory 
inputs that forge pain perception and examples include previous experience, 
learning, personality, immunity, hypothalamus-pituitary-adrenal axis, limbic 
system activity and aspects of pain that can be expressed as sub-modules of the 
neuromatrix (Melzack, 2003). Output from the neuromatrix itself includes pain 
perception, action programs (behaviour) and stress regulation processes such as 
cortisol secretion and the release of endogenous opioids (Keefe, 2009; Melzack, 
2001). The repetitive processing of these factors results in the synthesis of a neural 
perception of pain or a neurosignature that is specific for an individual (Keefe, 
2009; Melzack, 2003). At the time, the neuromatrix theory completed the 
integration of theory and evidence on the nature of pain (Gatchel and Maddrey, 
2004). It also supported the assumptions of broader conceptual models of pain that 
had moved further away from specificity theories of pain that remained under the 
influence of mind-body dualism (Melzack, 1999). In terms of this research, the 
application of the BPS model of pain to CS is supported by historical, conceptual 
and theoretical shifts away from biomedical approaches to acute and chronic pain. 
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It is important to note, however, that biological approaches have evidence-based 
credibility in the acute pain setting and that a BPS model of pain accepts the 
credibility of multiple understandings of pain and pain intervention, with integrated 
interventions for pain being the acceptable position (Leo & Quinton, 2010).  
 
2.3 The BPS Model of Pain 
The BPS model proposed by Turk in the 1990s suggested that pain is a subjective 
experience and that individuals experience pain in unique ways (Turk, Wilson & 
Swanson, 2010; Turk, 1996). Turk conceptualised pain as influenced by biological, 
psychological and social factors (Turk, 1996). From the BPS perspective, the 
dynamic interaction between these factors shape the personal experience of pain 
and there is no discrete linear relationship between any of the components (Gatchel 
& Maddrey, 2004). Hence, while previous conceptual models of pain suggested that 
psychosocial factors such as suffering and pain behaviour were linear effects that 
resulted from biological processes (Loeser, 1982), Turk’s view is that all factors in 
the BPS model are inseparable and may shape the pain experience at different times 
and in unique ways (Gatchel, 2010; Turk et al., 2010; Turk et al., 1983).  
 
2.3.1 Assumptions 
The key assumption that underpins the BPS model of pain is that it does not give 
exclusive support for the importance of either biological, psychological or social 
aspects of pain and frames a view that all factors contribute to the pain experience 
(Turk et al., 2010).  Although these major aspects of the model are not mutually 
exclusive, the weight of influence they have on an individual’s experience of pain 
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may change according to situation and time (Turk et al., 2010). Hence, the model 
also assumes that the pain experience can be viewed from a longitudinal perspective 
rather than a cross-sectional view of the pain experience (Turk et al., 2010).  
 
Another key assumption of the BPS model of pain is that of reciprocal determinism 
(Turk et al., 2010). In other words, psychological factors may influence 
physiological and social processes, while social factors may reciprocate with the 
others and contribute to pain perception (Turk et al., 2010; Turk & Monarch, 2002). 
Psychological factors, for example, affect hormone production, brain processes and 
autonomic nervous system function, while drugs can also influence mood and the 
individual’s appraisal of the pain situation (Turk et al., 2010).  This espouses the 
dynamic characteristics of the BPS model of pain and supported the use of the 
model in this research because CS pain is a complex experience. These points will 
be addressed further in this chapter and in the literature review. 
 
2.3.2 Fundamental Components 
The BPS model of pain acknowledges that analgesics and other medical therapies 
make a significant contribution to pain relief for many patients but that these 
therapies have more benefit during the acute phase of pain (Flor & Turk, 2011; Turk 
et al., 2010). The BPS model does not view drug therapy as a discrete treatment and 
so how a person uses analgesics and responds to the situation can have implications 
for their physical rehabilitation (Turk et al., 2010). Physical responses to acute and 
chronic pain include an individual’s degree of activity and other physical functions 
while experiencing pain.  
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While pharmacological therapies have a place in pain management, the BPS model 
of pain explains numerous psychological components that influence acute and 
chronic pain (Keefe, 2009; Turk et al., 2010). Pain catastrophising, for example, is 
characterised by having extremely negative thoughts about one’s plight (Flor & 
Turk, 2011) and these thoughts are associated with more subjective pain intensity, 
greater analgesic use and less perceived ability to control pain (Turk et al., 2010).  
Depression is also a major component of the BPS model of pain because it is 
common in patients with chronic pain and made worse by lack of perceived control 
and cognitive errors regarding the impact of pain (Flor & Turk, 2011; Turk et al., 
2010). Self-efficacy is closely related to control and it is defined as a conviction 
that one can overcome a painful situation by using resources seen as successful in 
past experiences or the experiences of others (Flor & Turk, 2011). If individuals 
perceive the ability to control pain and carry out a planned course of action, they 
are likely to achieve their therapeutic goals (Turk et al., 2010). Hence, interventions 
that enhance coping strategies and patient participation in pain management may 
lead to better pain relief and responses to pain. 
 
Coping refers to self-regulation of pain and involves purposeful individual actions 
directed at reducing pain and adjusting to the situation (Flor & Turk, 2011). The 
BPS model of pain explains how effective coping can influence pain perception and 
a person’s ability to function appropriately so that they can achieve health goals 
(Flor & Turk, 2011; Turk et al., 2010).  Examples of coping strategies are greater 
control over analgesic use, accessing information and problem solving to adapt to 
pain (Flor & Turk, 2011; Turk et al., 2010). Coping strategies can be enhanced by 
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educational strategies that also complement analgesic use in some pain situations 
(Flor & Turk, 2011). Poor coping may lead to more pain and has been associated 
with catastrophising (Flor & Turk, 2011). 
 
The BPS approach to pain also considers sociocultural components of pain such as 
beliefs and expectations about pain and how these factors can influence pain 
perception (Flor & Turk, 2011; Turk et al., 2010).  Turk and others suggest that this 
encompasses what individuals believe to be appropriate for pain management and 
how they should cope with pain such as the use of analgesics, rest and rehabilitative 
activity (Turk et al., 2010). An important part of what an individual believes 
includes their own perception of the ability to function despite having some pain 
(Flor & Turk, 2011). Disruptive cognitive beliefs about pain such as anticipation of 
severe pain can be associated with increased muscle tension and a preoccupation 
with physical symptoms rather than positive attempts to overcome the situation 
(Turk et al., 2010). 
 
The BPS model of pain is not complete without applying these fundamental 
concepts to therapeutic action and the model underscores the importance of using 
techniques to increase a sense of control by targeting catastrophising, depression, 
negative beliefs about pain, coping strategies and how to manage the sensory 
experience (Turk et al., 2010). Educational strategies can also be used to encourage 
patients to adopt more adaptive beliefs, thoughts and responses to pain and it is 
recommended that individuals should be active agents in change by participating in 
pain assessment and management (Flor & Turk, 2011; Kaptain, Bregnballe & 
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Dreyer, 2016). The BPS model of pain encourages integrated interventions such as 
educational approaches that enable greater control and participation in decision-
making about pain management (Leo & Quinton, 2010). 
 
2.3.3 The BPS Model and Acute Pain Management 
Although the BPS model of pain was directed at chronic pain states (Turk et al., 
2010), the model and approach has been suggested as appropriate for application to 
acute pain and childbirth management (Edozien, 2015; Keefe, 2009; McNeil & 
Jomeen, 2010; Mosely & Butler, 2015). For many pain states, the acute phase 
requires a weighted biological approach to attenuate the pain condition but there is 
also a need to consider the fear and anxiety that is generated in patients (Keefe, 
2009; Leo & Quinton, 2010). While it has been suggested that psychosocial factors 
are less important in this acute phase (Leo & Quinton, 2010), this research refutes 
this notion by showing that factors such as catastrophising and fear of pain may be 
potent factors associated with acute pain (Keefe, 2009). Pain-related fear, 
catastrophising, self-efficacy, personal control over pain management and coping 
strategies have been associated with acute pain (Escott, Slade & Spiby, 2009; 
Keefe, 2009).  
 
Acute pain has a social context (Keefe, 2009). This chapter has argued that 
throughout history there has been a range of social and cultural views on childbirth 
pain.  Furthermore, a woman’s social environment has a profound effect on what is 
believed to be appropriate childbirth pain relief and behaviour (Bastian et al., 2014; 
Lowe, 2002; Schmid, 2005; Talbot, 2012). The general perception of a supportive 
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environment for many women can be powerful in terms of positive emotions and 
pain reduction (McNeill & Jomeen, 2010). The current research incorporated these 
views on pain in applying the BPS model to the NP intervention. The assumption 
was that in the acute pain setting, the use of pain medications may be made more 
effective by integrating supportive strategies (Keefe, 2009). Thus, social interaction 
between participants and health professionals surround many aspects of acute pain 
management. This acknowledgement was used to improve the design of the NP 
intervention for postoperative CS management. 
 
From what appear to be concepts drawn from the BPS model of pain, Escott and 
others proposed strategies for maternal education and the use of other cognitive 
interventions targeting catastrophic thoughts about labour pain and enhancing 
maternal control and coping skills for pain management (Escott et al., 2009). One 
of the key assumptions of this approach was that women have individual pain 
histories, backgrounds and requirements for information and control (Escott et al., 
2009). This is a further reason why a BPS approach to care was appropriate to this 
research because both acute and chronic pain are influenced by many factors 
including psychosocial variables. 
 
An abundance of opinion and scientific evidence suggests that the childbirth 
experience is influenced by many biological, social, cultural and psychological 
factors that are unique for every woman (McNeill & Jomeen, 2010). A BPS 
approach to acute pain management is not poor science (Edozien, 2015) because it 
discourages dualistic thinking about acute pain that restricts the development of 
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interventions and knowledge in this area. The lessons learnt about acute pain from 
the Second World War (Beecher, 1956, 1946) and from the popularity of non-
pharmacological interventions for childbirth pain (Lamaze, 1970) support the use 
of a BPS model for acute pain that includes biological, psychological and social 
components. Hence, the research reported upon here sought to demonstrate that 
women who undergo CS are influenced by factors that mirror the BPS model of 
pain.  The BPS model was also appropriate in addressing the research questions 
regarding the effectiveness of a NP approach to pain management after CS and the 
experience of chronic pain. 
 
2.3.4 Barriers to a BPS Model for Acute Pain Management 
There are many barriers to a BPS approach to acute pain management and this thesis 
demonstrates that dichotomous views persist around the value of technical 
intervention over comprehensive approaches for acute pain management. 
Associated with this dichotomy is an approach to pain management that attempts 
to single out a specific cause for a change in pain.  Thus, while it appears that 
multiple interventions are more appropriate to treat pain (Turk et al., 2010), some 
view this as problematic because it does not enable the dissection of a 
multidimensional intervention into its components to explain which aspect of the 
intervention resulted in pain reduction. Nonetheless, current evidence supports CS 
pain as a BPS experience that deserves an approach to analgesic therapy that 
considers psychological and social aspects of care in terms of the design and 
evaluation of pain interventions (Edozien, 2015; McNeil & Jomeen, 2010; Mosely 
& Butler, 2015). Yet, the biomedical model continues to exert great influence on 
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clinical practice and research in the area of childbirth pain (Edozien, 2015; 
Maclaren & Kain, 2007).  
 
Researchers in acute pain may not consider the BPS model appropriate because the 
underlying assumptions reject the kind of linear cause-and-effect thinking that 
characterize biomedical interventions. Also, the model equally supports analgesic 
therapy and non-drug interventions to reduce pain (Turk et al., 1983). Acute pain 
management has been reliant on biological approaches and this may explain why 
the BPS model has not been fully accepted. This is exemplified in anaesthesiology 
professional publications which downplay the role of non-pharmacological 
interventions for acute pain saying they are adjunctive therapies to analgesics 
(Schug et al., 2015). Recent work, for example, referred to hypnosis as ineffective 
for childbirth pain in comparison to epidural techniques that are portrayed as 
superior to other methods (Schug et al., 2015). Despite some acceptance of the role 
of psychosocial factors in acute pain, the Australian and New Zealand College of 
Anaesthetists assert that all non-pharmacological methods of pain relief should be 
viewed as complementary to biomedical interventions (ANZCA, 2013).  Thus, the 
BPS model of pain challenges this view as evidence points to psychosocial factors 
as key influences on pain perception and the individual experience of pain (Bruehl 
et al., 2013).  
 
The recent proliferation of procedure-focused interventional pain medicine 
demonstrates this shift away from a person-centred approach to a modality-centred 
one that is driven by economic reward (Roth, Geisser & Williams, 2012). The 
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danger in this approach is that it is reminiscent of a Cartesian viewpoint that if 
nociception can be blocked by a biological intervention (and this is often 
temporary) the pain problem will be cured as the patient plays only a passive role. 
Roth and others (2012) suggested that another negative consequence of a system 
that supports the biomedical model is that patients will assume a passive role and 
not attempt other more effective psychosocial interventions, a belief that may 
extrapolate to the views of society. 
 
In contrast to the above and within the midwifery profession some argue that pain 
management is mistakenly viewed as administering analgesics and other invasive 
interventions to women and neglecting other options for managing pain (Malacrida 
& Boulton, 2012). It has been suggested that it is not drugs women need for vaginal 
birth but the social support of other women and clinicians (Van der Gucht & Lewis, 
2013). There are some midwifery scholars who extended this argument to propose 
that a degree of pain may be rewarding, giving meaning and purpose to the 
childbirth experience (Bastian et al., 2014). Others have recently argued that 
pharmacological pain relief is a conspiracy by men to control and oppress women 
and that midwives who offer analgesics to women are agents of this oppression, 
rendering women weak and unable to cope (Leap and Andersen, 2008). Views such 
these may appear extreme in a society that values technological intervention for 
pain. They also may lead to poorly managed childbirth pain for some women (D' 
Cruz & Lee, 2014). If the BPS model is to be applied, clinicians need to consider 
all components of the model and options for pain intervention as credible. This 
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means that all options for pain management be considered within an integrated 
approach. 
 
The components of the BPS model offer a broader view of acute pain than previous 
models and it can be used for the development of theory, new multidimensional 
pain interventions and research questions on pain (Blythe et al., 2007). Some have 
argued that the scope of the model has led to a lack of clarity regarding the design 
of research interventions that need to be described in detail so effective treatments 
can be applied in the real world (Blythe et al., 2007). The lack of clarity and 
definition may drive ongoing tension between those supporting technological 
intervention and others who say that only natural methods should be used for 
childbirth (Schmid, 2005). The BPS model described by Turk and others does not 
include a detailed discussion on biological interventions and how they interrelate 
with other factors in pain management (Turk et al., 2010). This may also explain 
the slow uptake of the model in the acute pain context. 
 
2.4 Conceptualising BPS factors in the CS Pain Experience 
The following sections support the use of the BPS model in this research by linking 
the components of the model with conceptual evidence around the CS experience. 
It may be deduced from this discussion that the BPS model of pain was selected for 
this research based on factors that affect the CS pain experience as evident in the 
research literature and that these factors are embedded in the BPS model of pain. 
This is why this research applied the BPS model of pain to the acute pain setting. 
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2.4.1 Previous CS 
Persistent pain from a previous CS may go unnoticed in some women who present 
to hospital for another delivery if a comprehensive BPS pain assessment is not 
undertaken. This may be an important influence on the CS experience and for two 
reasons. First, women may have persistent pain due to a previous CS that may have 
resulted in features consistent with neuropathic pain often associated with chronic 
pain after surgery (Grosu & de kock, 2011; Landau, Bollag & Ortner, 2013; Loos, 
Scheltinga, Mulders & Roumen, 2008). Second, the intense stress of previous 
childbirth experiences may induce a state of fear and catastrophising about pain 
(Escott et al., 2009). Thus, where women have experienced severe postoperative 
pain and persistent pain from previous surgery, they may learn to expect severe pain 
and pain interference for a subsequent CS (Turk et al., 2010). This may result in 
fear of childbirth pain prior to future deliveries and have a negative impact on 
central processing of pain (Melzack, 2003).  
 
2.4.2 Pain Catastrophising 
Women have established beliefs about expected pain and the use of analgesics for 
CS well before the event that might generate intense fear in some (Keogh et al., 
2005). This fear may be justified where there has been previous experience of poor 
analgesia and difficult interactions with clinical staff regarding pain management. 
A previous bad experience may induce a process of respondent learning whereby 
an individual will expect severe pain and will not be able to function normally if a 
similar episode occurs again (Turk et al., 2010). This could lead to pain 
catastrophising which is characterised by rumination (worry and inability to inhibit 
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thoughts about pain), magnification (expectations and worrying about a negative 
outcome), and helplessness (perception of an inability to cope with pain (Sullivan, 
2009; Sullivan, Bishop & Pivik, 1995). Impending CS places considerable stress 
on women and has been linked to the formation of catastrophic thoughts about pain 
and the development of depression (Hobson, Slade, Wrench & Power, 2005; Keogh 
et al., 2005; Saunders et al., 2006). Hence, the way a person thinks about pain 
influences the pain experience and these thoughts may lead to more pain following 
CS (Dannenbring, Stevens & House, 1997; Escott et al., 2009; Gatchel & Kishino, 
2011; Lumley et al., 2011; Saisto et al., 2001).  
 
In the context of postoperative pain, pain catastrophising is a potent predictor of 
pain and may predict chronic pain (Khan et al., 2011). As a major psychological 
factor that influences pain perception (Flor & Turk, 2011), pain catastrophising is 
associated with intensified pain and sits alongside depression as a risk factor for 
experiencing greater acute and chronic pain (Yarnitsky, Granot & Granovsky, 
2014). For these reasons, catastrophising is a major component of the BPS model 
of pain (Turk et al., 2010). 
 
2.4.3 Depression 
In this research and in the BPS model of pain, depression is regarded as a key factor 
that influences pain perception and behaviour (Leo & Quinton, 2010; Turk et al., 
2010). In Australia, women are screened for depression in the prenatal phase 
(Hayes, 2010) and yet little is known of any attention given to the implications of 
this screening process in terms of pain management. Within this BPS approach to 
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research, women with depression were viewed as higher risk for increased 
postoperative pain and chronic pain following discharge from hospital because 
depression can amplify pain perception in acute and chronic pain (Khan, et al., 
2011). Hence, the BPS model of pain was an appropriate research framework that 
considers these factors as well as biological influences on pain. 
 
2.4.4 Sociocultural factors and beliefs about pain 
Sociocultural factors also influence maternal beliefs about managing pain (Bastian 
et al., 2014; Lowe, 2002; Schmid, 2005; Talbot, 2012). What individual women 
believe to be appropriate pain interventions and strategies to cope with pain may 
have consequences for postoperative pain management. For example, some women 
may reject analgesics and this is often related to fear of opioid analgesics harming 
a baby (Schyns-van den Berg et al., 2015). The BPS model of pain suggests that 
operant conditioning processes can sometimes have an unhelpful effect if others 
such as family members reward patients for adopting a sick role that causes 
avoidance of activities necessary for mobilisation and infant care (Turk et al., 2010; 
Turk, 2003). Through observation and the influence of others, operant conditioning 
may also cause an expectation that pain be completely obliterated by technological 
intervention (Lowe, 2002; Talbot, 2012). Other beliefs can be reinforced such as 
the acceptance of severe pain that heightens a sense of womanhood (Bastian et al., 
2014; Schmid, 2005). While for some women this may be effective, how a woman 
decides to cope with CS pain is an individual decision and clinicians need to work 
with existing attitudes and beliefs to build a pain management plan that supports 
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women to have control over pain which is another key feature of the BPS approach 
(Turk et al., 2010).  
 
2.4.5 Perceived Control 
Perception of control in childbirth has been described as personal control over the 
situation and is important for women to adjust to childbirth (Stevens, 2011).  
Control in childbirth has also been described as an ambiguous concept because it 
can relate to a range of factors including pain management, the environment and 
who may be present during delivery (Meyer, 2013). Compared to vaginal delivery, 
women about to undergo CS may feel that they have lost control over the situation 
because decision-making power about childbirth pain has been shifted to those 
performing technological interventions (Fenwick et al., 2003; Fisher et al., 1997; 
McAra-Couper, Jones & Smythe, 2010). Some clinicians and researchers have 
neglected to consider perceived control in studies on CS pain because of a 
perception that women are not likely to be able to make decisions regarding pain 
relief and that they would not be able to feel in control at all (McCrea & Wright, 
1999).  
 
It is common for a familiar support person to be the primary source of maternal 
support, but impending technological intervention may change this relationship as 
other clinicians assume pain management roles. Common to most theories about 
control in childbirth is the support of a trusted clinician who enables a woman to 
exercise control and who provides reliable information (Meyer, 2013). If a woman 
can be supported by a familiar clinician, some of the problems created by 
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catastrophising and disempowerment may be addressed to result in a satisfying and 
less painful CS (Hobson et al., 2005; Kitzinger, 2012; McNeil & Jomeen, 2010). 
This is because a heightened sense of control may modulate pain perception and 
reduce the emotional aspects of the appraisal of pain (Turk et al., 2010; Wiech et 
al., 2006). Changes in brain activity on functional magnetic imaging have 
demonstrated that perceived control affects physiological function in higher brain 
structures that are involved in pain perception (Wiech et al., 2006). The BPS model 
of pain links these biological and psychosocial concepts in the complexity of pain 
perception even prior to a surgical event such as CS. These complex relationships 
are rarely explored in research on acute pain and the BPS model supports a need 
for such factors to be considered such as previous CS, catastrophic thoughts, 
depression, sociocultural factors and perceived control over pain. Thus, the 
complexity of the CS experience can be conceptualised and described within the 
bounds of the BPS model of pain and this is supported by what has been described 
in the literature on childbirth pain and CS. 
 
2.5 The BPS model and Targets for Pain Intervention 
Opinions about the clinical relevance of biological interventions versus 
psychosocial strategies for childbirth pain are not representative of the major 
assumptions of the BPS model (Turk et al., 2010) or what is now known about the 
physiological processes involved in pain perception (Melzack, 2003). An 
exploration of the physiological processes and relationships involved in pain 
perception reinforces the BPS model as a persuasive theoretical framework for this 
research because the interrelationships between all components of the BPS model 
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are now recognised as key influences on pain physiology (Edozien, 2015; Leo & 
Quinton, 2010; McNeil & Jomeen, 2010; Melzack, 2003; Mosely & Butler, 2015). 
Pain perception is influenced directly when specific brain regions receive and 
process all peripheral and central inputs resulting from an inflammatory event that 
transduces electrical impulses at the periphery (Argoff, 2011; Vadivelu, Whitney 
& Sinatra, 2009). It is now known that higher brain structures form the link between 
psychosocial factors and biological processes involved in pain perception because 
direct observation of brain structures by functional magnetic resonance imaging has 
demonstrated that physiological processes in the brain are altered by psychosocial 
factors (Jensen et al., 2015; Navratilova & Porreca, 2014). These changes occur 
because the electrical impulse is propagated through the dorsal horn, thalamus, 
periaqueductal grey, parabrachial areas and amygdala. This results in the 
cognisance of pain by the sensory cortex (Jensen, 2010; Simmons et al., 2014; 
Voscopoulos & Lem, 2010). Specific areas of the brain activated by acute pain 
include the thalamus, amygdala, prefrontal cortex, primary and secondary 
somatosensory cortex (insula) and the anterior cingulate cortex (Jensen, 2010; 
Navratilova & Porreca, 2014; Simmons et al., 2014). In particular, the amygdala 
has demonstrated structural and functional changes associated with anxiety and 
depression (Simmons et al., 2014). The cortical-limbic circuit (including the 
anterior cingulate cortex, amygdala and insula) is involved in the emotional aspects 
of pain perception plus anticipation and expectation of pain relief (Jensen, 2010; 
Navratilova & Porreca, 2014; Simmons et al., 2014). 
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The links between these structures and pain perception may explain how 
psychosocial factors such as depression, catastrophising and perceived control can 
influence pain intensity and behavioural responses to pain (Turk et al., 2010). Thus, 
the BPS model and pain physiology provide a conceptual and theoretical synthesis 
of the complexities of pain that justifiably can be applied to research on CS. This 
also means that approaches to pain intervention may target these processes by 
integrating drug and non-drug strategies. The assumptions of the BPS model of pain 
suggest that an individualised approach may integrate strategies that target 
biological, psychological and social processes of the CS experience (Turk et al., 
2010). Furthermore, the conceptual scope of the BPS model of pain incorporates 
many components of the CS experience and recognises that some components will 
have greater influence at different times (Turk et al., 2010). Hence, interventions 
for pain may be delivered at different points in time using multiple strategies. This 
is a fundamental position of the model because stand-alone interventions have been 
less effective in reducing pain across many pain contexts (Turk et al., 2010). 
 
2.5.1 Anaesthetic Intervention for CS 
The neuromatrix theory supports the BPS model of pain in emphasising central 
processing in the brain.  It may therefore be difficult to conceptualise a BPS 
approach to pain management in the operating suite where the primary target for 
eliminating pain and sensory perception for CS surgery is to block the transmission 
of pain at the dorsal horn of the spinal cord which processes inputs from the 
peripheral surgical event (Hindle, 2008; NICE, 2011). Indeed, intrathecal local 
anaesthetic block is considered the most effective and safest choice for CS surgery 
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based on a large amount of empirical evidence (Girgin et al., 2008; Hindle, 2008; 
Hughes, 2008; NICE, 2011). The high concentration of local anaesthetic used to 
produce a total sensory and motor block for women appears to circumnavigate the 
individualised view of pain management at this point in time because it is successful 
in providing anaesthesia. However, when total peripheral block diminishes, pain 
perception becomes a complex issue when higher brain structures become 
cognisant of pain stimuli (Jensen, 2010; Navratilova & Porreca, 2014; Simmons et 
al., 2014). Neglect of the influence of psychosocial factors prior to this point is also 
a narrow view because the BPS model assumes that the pain experience is 
longitudinal and that many factors prior to anaesthesia influence pain perception. 
Nonetheless, in order to target physiological pain processes to reduce postoperative 
pain, various analgesics are necessary following CS to prevent moderate to severe 
pain.  
 
In relation to pharmacological analgesia, clinical guidelines on the management of 
CS support multimodal pain management that includes intrathecal morphine, non-
steroidal anti-inflammatory drugs and paracetamol (NICE, 2011). Following 
injection of morphine, high CSF concentrations are produced and activation of 
opioid receptors results in a reduction of intracellular calcium, reducing the release 
of excitatory neurotransmitters such as glutamate (Hindle, 2008). Postsynaptic 
binding also produces a descending pathway response in the dorsal horn, helping 
to reduce pain perception (Hindle, 2008). The prolonged action of intrathecal 
morphine is due to the drug being less lipophilic than fentanyl which moves rapidly 
from CSF and has a shorter duration of action (Cousins & Mather, 1984; Hindle, 
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2008). Morphine also exhibits a low affinity for spinal cord white matter and this 
accounts partly for its slow penetration and sustained high concentration in CSF 
(Hindle, 2008). Multimodal approaches with oral analgesics target multiple 
processes leading to pain perception and they may be administered orally without 
the need for invasive intravenous lines. Because most oral analgesics have shorter 
half-lives than intrathecal morphine, some are administered around-the-clock to 
ensure effective plasma concentrations (Pasero & McCaffery, 2011; Rang, 2016). 
Despite this multimodal approach, once the pain stimulus reaches higher brain 
structures the individual appraises pain at that particular time and responds in a 
personal way based on their own biology and psychosocial makeup (Turk et al., 
2010).  
 
Individualising therapy with non-opioid analgesics such as paracetamol and non-
steroidal anti-inflammatory agents has limited scope because these drugs have 
maximum daily doses (Analgesic Expert Group, 2012). However, systemic opioid 
analgesics such as oxycodone may be titrated to the requirements of the individual 
as doses may be adjusted without fear of liver or renal toxicity (Analgesic Expert 
Group, 2012). Thus, oral oxycodone may be the most effective agent to include in 
an integrated approach to pain management when opioid analgesia produced by 
intrathecal morphine has diminished the day after CS. A woman’s awareness of 
pain and its ramifications may result in the need for additional opioid analgesia and 
this creates an opportunity for the NP to improve pain management with an 
integrated intervention. The BPS model of pain reinforces multiple strategies to 
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enhance pain management and outcomes through drug therapy and educational 
strategies (Flor & Turk, 2011; Leo & Quinton, 2010).  
 
2.5.2 Challenges to pain management with oral oxycodone 
The implementation of a tailored intervention with oral oxycodone presented a 
challenge to the NP because individuals display wide variance in requirements for 
opioid analgesia. This is due to biological differences such as receptor 
polymorphism and how the liver metabolises analgesics (Sadhasivam & 
Chidambaran, 2012). From a biological perspective, oral opioids undergo first-pass 
metabolism in the gut and liver before a concentration of drug is delivered to 
plasma. There are also genetic differences in the way humans metabolise opioids 
and this affects an individual’s response to pain management (Albin & Buskila, 
2012). The variations in human responses to pain and analgesics may also result in 
unpredictable responses that may be more readily evaluated with short-acting 
opioids (Baber et al., 2015; Candiotti et al., 2013; Rang, 2016). A recommendation, 
therefore, would be to commence oral opioid therapy with IR oxycodone so that the 
patient’s response to the medication may be assessed in a shorter timeframe to allow 
for dose adjustment. However, commencement of CR opioids the day following CS 
has become popular practice (Dieterich et al., 2012; Seaton & Reeves, 2009; Zhong 
et al., 2014) despite clinical guidelines that do not recommend using CR opioids for 
the initial management of acute postoperative pain (Analgesic Expert Group, 2012). 
Moreover, these clinical guidelines indicate that CR oral opioids are difficult to 
titrate and it is difficult for an individualised response to be ascertained (Analgesic 
Expert Group, 2012). In addition, unpredictable adverse drug reactions may be 
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more difficult to address due to the increased duration of action (Analgesic Expert 
Group, 2012). Added to this complexity are the individual beliefs women may have 
about pain management with oxycodone after CS and their needs and preferences 
as to what may seem appropriate. The BPS model of pain fostered a NP approach 
that considered these factors in the overall treatment plan (Leo & Quinton, 2010; 
Turk et al., 2010). 
 
2.5.3 The NP role and a BPS approach to pain management 
A specialised NP can apply the necessary support and knowledge to prescribe and 
improve pain management for women following CS with an integrated BPS 
approach. The NP role in Australia is regulated to signify the right to prescribe 
medicines autonomously within a defined scope of practice (Cashin et al., 2015). 
This distinguishes the role from other registered nurses (Cashin, Stasa, Dunn, Pont 
& Buckley, 2014) and so NPs can provide effective pain management through 
individualised opioid prescription. Although many other nurses and midwives in 
Australia can prescribe analgesics, the process is guided by a strict formulary that 
does not allow for prescription or titration of oral opioid doses (Australian Health 
Practitioner Regulation Agency, 2016). Together with the ability to carry out 
complex health assessment at an advanced clinical level (Cashin et al., 2014; Leo 
& Quinton, 2010), the NP role is suitable for improving pain management after CS 
using a range of BPS strategies and evaluation methods. 
  
The NP role in pain management has specialised functions in terms of managing 
complex analgesic therapy and adjusting therapeutic treatments according to the 
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needs of individuals (Schoenwald, 2011). As part of this role, a BPS approach to 
pain management also involves talking to patients and enabling them to talk about 
their beliefs and experience of pain (Albin & Buskila, 2013). Thus, NPs who 
discuss pain management with women may influence decision-making in relation 
to the use of analgesics. It has been argued that this supportive relationship is a key 
factor that can influence the ability of women to cope with pain (Van der Gucht & 
Lewis, 2015). In addition, follow-up treatment and adjustment of therapy according 
to the response and preferences of individual women characterises NP practice 
which sits within a BPS approach to management (Buckley et al., 2015; Nursing & 
Midwifery Board of Australia, 2014).  
 
The NP role fits well with a BPS approach to intervention because the underlying 
assumptions of the model can be found within the domains of NP practice in 
Australia. The first standard states that NPs undertake health assessment that is 
based on physical data as well as psychological and social determinants of health 
(Nursing & Midwifery Board of Australia, 2014). In terms of the BPS model of 
pain, this standard reflects an assumption that biological, psychological and social 
factors contribute to the experience of pain (Leo & Quinton, 2010; Turk et al., 
2010). The National Standards go on further to converge with a BPS approach as 
the assessment of the patient by an NP should constitute a synthesis of knowledge 
from the biological and behavioural sciences (Nursing & Midwifery Board of 
Australia, 2014). The next standard of NP practice involves the translation of a care 
plan for patients based on the synthesis of data collected in the assessment phase. 
This standard is also related to a BPS approach because the NP explores options for 
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management in collaboration with the patient and develops an individualised care 
plan that is communicated to other members of the team (Nursing & Midwifery 
Board of Australia, 2014). Again, individualised pain management is an underlying 
assumption of the BPS model of pain (Turk et al., 2010). The third standard also 
emulates a BPS approach as the NP supports, educates and counsels the patient 
throughout the implementation of the therapeutic plan (Nursing & Midwifery Board 
of Australia, 2014). Finally, evaluation of the patient involves follow-up on the 
outcomes of interventions that may result in modifications to the original plan based 
on individual response to treatment (Nursing & Midwifery Board of Australia, 
2014). The BPS model of pain assumes that care of the patient is along a continuum 
and should be based on multiple time-points (Turk et al., 2010). These approaches 
may be repeated at various times in the patient’s episode of care and the basis for 
the intervention in this study reflected the national standards that concur with the 
BPS model of pain as an appropriate framework in this research. 
 
2.5.4 Integrated Pain Intervention 
The BPS model of pain, as explained by Turk and others, is a framework that 
encourages an integrated approach to pain assessment and management (Turk et 
al., 2010). The model is not just an assessment framework for pain but a platform 
for the design of multimodal interventions to manage pain (Turk et al., 2010). In 
pain research, BPS approaches can be problematic because the specific composition 
of interventions are often not described in sufficient detail so that they may be 
applied by others (Jensen, 2011). This is an important point because beneficial 
outcomes from the intervention can only occur if a clinician knows how to perform 
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the intervention. Turk and others suggest important elements of integrated 
interventions to be education, discussing beliefs about pain and suggesting 
strategies to increase perceived control over pain management (Turk et al., 2010). 
Studies in other settings have described integrated pain interventions consisting of 
analgesic drugs and other strategies. For example, researchers in Turkey described 
an effective pain management intervention with patients who underwent breast 
surgery where nurses discussed with patients the options for pain management and 
the pharmacology of the drugs available (Sayin & Aksoy, 2012). A Chinese study 
also described an educational intervention where a nurse explained how analgesics 
could reduce pain interference and how to communicate more effectively with 
health care professionals about pain (Wong, Chan & Chair, 2010). Another study 
involving cancer patients described a pain management intervention targeting 
knowledge and beliefs about pain management and analgesics (Yates et al., 2004). 
This Australian study involved a pain management intervention to increase 
communication on pain management with clinicians, improve knowledge and 
attitudes about pain management and develop individualised pain management 
plans. The above interventions have attempted to integrate various strategies to 
address an individual’s requirement for analgesics and to reduce pain. In a broad 
sense, the BPS model encompasses this approach using drug and non-drug 
strategies (Bruehl et al., 2013). The NP intervention for CS pain drew on these 
principles by integrating analgesic therapy with other strategies based on the BPS 
model. 
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2.5.5 Components of NP Pain Management 
Exploration of the BPS model of pain and the domains of NP practice led to an 
argument in this research over what constitutes a NP approach to pain management. 
It appears that the features of this approach reflect various conceptual approaches 
that aim to address the complexity of pain and the unique characteristics of 
individuals. To improve pain management, it is clear that the development of a 
supportive relationship is a common thread that underpins these conceptual views 
(Kaptain et al., 2016). In a sense, this really means getting to know the patient so 
that their needs and preferences can be identified (Jungyoun, 2015). Supportive 
relationships in childbirth can reduce catastrophising and consumption of 
analgesics by addressing issues relating to the meaning of pain for the patient, 
expectations and interpretation of the impact of pain (Leo & Quinton, 2010; Lowe, 
2002; McNeil & Jomeen, 2010; Olayemi, Morhason-Bello, Acledokun & 
Ojengbede, 2009). Alongside individualised analgesic therapy in this research, NP 
pain management seeks to understand these complex issues and how they may 
affect pain perception and response to CS pain (Jungyoun, 2015; Kitzinger, 2012; 
Lowe, 2002; Van der Gucht & Lewis, 2015).  
 
Embedded in a BPS approach, the NP strategy also seeks to identify perceived 
barriers and facilitators of analgesia so that these issues can be discussed with 
participants (Turk et al., 1983; Yates et al., 2004). In the BPS model of pain, 
cognitive misconceptions about analgesics and the current health situation may 
become barriers to adequate analgesia and maternal beliefs about pain management 
for childbirth will depend on the patient’s appraisal of the situation (Douglas, 2014; 
 61 
Turk & Monarch, 2002). As an example, poor analgesia may result from a rejection 
of opioid analgesics due to fear of harm to a neonate (Schyns-van den Berg, et al., 
2015). It may also result from rejection of other strategies aimed at reducing 
catastrophising and depressive thoughts (Turk, 1983). Some women may also reject 
analgesics and tolerate severe pain in order to appear competent and in control 
(Eriksson, Jansson & Hambers, 2005). Strategies to try and understand individual 
beliefs about pain and analgesic therapy are embedded in the assumptions of the 
BPS model of pain and the NP approach to management.  
 
Shared decision-making supported with appropriate education is a further aspect of 
this approach to pain management that aims to enable more control over pain 
management (Jungyoun, 2015; Turk et al., 2010). An important component to pain 
education is the pharmacology of analgesics and how this can be used to reduce 
pain interference (Sayin & Aksoy, 2012; Wong et al., 2010). Following analgesic 
therapy, the NP approach involves further pain assessment which also involves 
looking at the person’s overall function and well-being (Jungyoun, 2015; Yates et 
al., 2004). This approach is particularly important where there are more challenges 
for women to face the day after CS, especially in relation to the interference of pain 
on mobilisation and infant care. Thus, the NP approach to oral opioid therapy could 
reduce the impact of pain on women through the supportive educational and follow-
up actions of the NP who can consider many factors that contribute to the pain 
experience along multiple time-points. This is in contrast to many standard care 
situations where a clinical review is undertaken at one point in time. 
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2.5.6 Goals of pain management the day after CS 
The contemporary view on childbirth is that women mobilise as early as possible 
to care for a neonate (Davis et al., 2006; Schyns-van den Berg et al., 2015). 
However, moderate to severe pain may impact on these activities and make it 
difficult for women on many levels which include respiratory effort, coughing, 
walking, breastfeeding and healthy mood (Chin, Vincent & Wilkie, 2014; Eisenach 
et al., 2008; Karlstrom et al., 2010). Pain interference for many women may lead to 
social withdrawal, increased self-absorption and depression (Joshi & Ogunnaike, 
2005). Therefore, a major goal of the NP pain intervention was to reduce pain 
interference so that women can meet their objectives. This is a new way of thinking 
about acute pain management because, in the past, the impact of pain has been 
neglected in the acute pain setting (Gordon et al., 2010; Varni et al., 2010; Wilson, 
2014). The NP approach to pain intervention can enable greater control of analgesic 
administration, minimise pain intensity and reduce pain interference with various 
functions important for maternal recovery (Keefe, 2009; Turk et al., 2010; 
Wellington & Chia, 2009). This could be achieved by explaining to women how IR 
oxycodone could be taken prior to anticipated periods of more pain such as 
attending to infant care and mobilising. Enabling control over pain management 
can contribute to positive mood states and improve pain management (Hobson et 
al., 2005). 
 
2.6 Chronic Postsurgical Pain after CS 
Chronic pain following CS is an emerging public health issue, given the increasing 
numbers of women who deliver by CS and the effects of CPSP on maternal health, 
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physically, psychologically and socially (Recker & Perry, 2011). Hence, the BPS 
model of pain was a most appropriate contextual lens for this research because it 
was originally developed for chronic pain (Turk et al., 2010). CPSP is defined as 
pain that persists greater than two months after surgery and the pain has to be related 
to the surgery (Bruce & Quinlan, 2011; Landau et al., 2013; Macrae, 2008). The 
characteristics of CPSP may be nociceptive or neuropathic in nature. However, 
unlike most nonsurgical chronic pain, CPSP does not necessarily have to display 
any of the characteristics of neuropathic pain such as paraesthesia, hyperalgesia or 
allodynia (IASP, 2010). The incidence of CPSP following CS is approximately 
10%, with severe disability occurring in about 4% of women (IASP, 2011). Given 
the biological trauma that results from major surgery and the emotional impact, full 
recovery is not possible for all and chronic pain may lead to disability 
(Lavand'homme, 2013).  It makes sense, therefore, to include CPSP and associated 
risk factors in trials evaluating pain interventions (Joshi & Ogunnaike, 2005). The 
BPS model of pain supports this because chronic pain is a complex issue affected 
by interrelated biological, psychological and social components that can only be 
identified by comprehensive pain assessment (Kerns & Ebert, 2010). The perceived 
burden of pain following CS was another reason for the use of the BPS model as a 
framework for this research. 
 
2.6.1 Physiology of CPSP 
The biological processes that occur with CPSP may change the structure and 
function of the central nervous system and so chronic pain after surgery is not just 
a psychosocial phenomenon. Biological forces that may contribute to CPSP 
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commence as an exponential amplification of postoperative pain causing alterations 
to the cerebral cortex and the loss of descending capacity to modify pain perception 
(Grosu & de Kock, 2011; Gupta, Gandhi & Viscusi, 2011; Kehlet, Jensen & Woolf, 
2006; Voscopoulos & Lema, 2010). Specifically, the barrage of action potentials 
from strong and persistent pain increase ion channel trafficking and the release of 
excitatory neurotransmitters (Kehlet et al., 2006). Spontaneous action potentials 
may develop and altered gene expression may render these changes long-term and 
irreversible (Kehlet et al., 2006). The N-Methyl-D-Aspartate (NMDA) receptor in 
the dorsal horn plays a role in long-term neuroplasticity as well as microglia cells 
that assist in increasing electrical impulses to the brain (Grosu & de Kock, 2011). 
Activation of the NMDA receptor allows entry of calcium ions into cells that lead 
to the release of Substance-P and glutamate which bind to receptors on second-
order neurons located in the dorsal horn. This in turn results in enhanced signal 
processing and additional calcium ion influx that contributes to central sensitisation 
and the loss of inhibitory interneurons (Sufka & Price, 2002). Glial cells secrete 
cytokines that stimulate neuroplasticity and enhance pain by supporting more 
connections with second-order neurons within the central nervous system 
(Voscopoulos & Lema, 2010). The physical re-modelling of the neuronal 
architecture, or neuroplasticity, signifies the biological transition to chronic pain 
(Navratilova & Porreca, 2014; Voscopoulos & Lema, 2010). Much attention has 
been paid to these biological factors involved in the development of CPSP. 
Protective surgical techniques that reduce the risk of nerve injury and the use of 
adjunctive analgesics such as gabapentin have been suggested as perioperative 
factors that may prevent CPSP (Grosu & de Kock, 2011). Again, this approach is 
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based on the biomedical model of CPSP and fails to integrate other strategies to 
provide optimal analgesia the day after CS and on discharge into the community.  
 
2.6.2 Transition to CPSP and the BPS Model of Pain 
Chronic pain has been categorised by time, where the transition from acute pain to 
chronic pain may lie somewhere between three and six months after injury (Flor & 
Turk, 2011). Rather than understanding chronic pain as physiological processes and 
time of onset, a conceptual BPS approach has been proposed to explain the 
transition from acute to chronic pain. The acute phase marks the pain stimulus that 
produces fear, anxiety and worrying about pain (Gatchel & Maddrey, 2004). In the 
second stage, the physiological processes described above are accompanied by the 
development or exacerbation of psychological problems such as depression. As 
pain persists, the psychosocial aspects of the experience become more dominant 
and patients may become preoccupied with pain (Leo & Quinton, 2010). If 
moderate to severe pain persists at home, it further impairs physical recovery, 
emotional well-being and adaptation to new social roles. Poor analgesia in this 
phase can lead to more depression which may also contribute to the development 
of pain-related disability (Joshi & Ogunnaike, 2005). Postnatal depression (PND) 
can emerge within three weeks after delivery with symptoms of sadness, despair, 
anxiety, fatigue, fear, alienation and feelings of inadequacy (Roseth, Binder & 
Mast, 2011; Rowe, Fisher & Loh, 2008). Most cases of PND improve within the 
first three months but persistent cases may need to be treated with a mixture of 
psychosocial interventions and serotonin re-uptake inhibitors (Horowitz & 
Goodman, 2005). Depression and pain have been associated with poor maternal 
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recovery following CS and may contribute to pain persisting beyond normal healing 
time (Kainu, Sarvela, Tippana, Halmesmaki & Kortilla, 2010; Masselin-Dubois et 
al., 2013; Nikolajsen, Sorensen, Jensen & Kehlet, 2004; Schytt & Waldenstrom, 
2007; Sng, Sia, Quek & Lim, 2009). Pain may continue to interfere with social 
relationships, activities of daily living, sleep and general happiness (Niklasson, 
Ohman, Segerdahl & Blanck, 2015). In combination with lack of social support and 
poor adaptation to new maternal roles, these factors risk development of persistent 
pain after CS and long term disability may result (Turk & Okifugi, 2002). The stress 
of coping with pain may lead to the chronic pain phase where the individual 
becomes focused on the pain that dominates all aspects of life (Gatchel & Maddrey, 
2004). In turn, physical deconditioning may occur and lead to more disability and 
depression (Gatchel & Maddrey, 2004). This conceptual approach to chronic pain 
explains the importance of the BPS model in approaching chronic pain following 
CS as it takes into account the driving forces of depression and social dysfunction. 
People in the chronic phase of pain become depressed about what the pain means 
for them and this may worsen pain perception and increase physical symptoms of 
pain (Gatchel, 2010). 
 
2.6.3 Risk factors for CPSP 
A BPS perspective on CPSP may lead one to question the need for biological 
interventions such as opioid analgesics. This is because the risk factors for the 
development of CPSP are largely psychosocial in nature (Masselin-Dubois et al., 
2013). Some argue the main risk factors for the development of CPSP are pain 
catastrophising, pre-existing pain, poorly managed acute pain and depression 
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(Schug & Pogatzki-Zahn, 2016). However, a large longitudinal study of surgeries 
other than CS in the Netherlands (n= 908) found pain catastrophising did not predict 
CPSP one year after surgery (Hoofwik et al., 2015).  Other studies have found that 
neuropathic pain may result from Pfannenstiel surgical approaches (Landau et al., 
2013; Loos et al., 2008; Ortner et al., 2013; Richez et al., 2015). In other surgical 
contexts, pain related to previous surgery in the same location has been associated 
with the development of CPSP (Hoofwik et al., 2015). Recent experimental 
evidence suggests that increased BMI may also contribute to CPSP and some have 
argued that prospective research may be able to explore this association as maternal 
obesity is known to support a pro-inflammatory state (Iannitti, Graham & Dolan, 
2012; Lavand'homme, 2013). The various risk factors for CPSP clearly point to the 
BPS model as a framework to guide research on this aspect of pain following CS 
(Lavand'homme, 2013). The main goals for preventing the transition from the acute 
phase to the chronic phase of pain involve the increase of personal control, adequate 
analgesia, prevention of depression and reduced pain interference (Gatchel, 2010). 
Key factors relevant to the community phase following CS include the severity and 
prevalence of CPSP after discharge from hospital, days women experience pain 
after discharge from hospital, pain interference with maternal functions and roles, 
quality of pain (e.g. neuropathic, nociceptive, affective), and the impact or 
relationship between pain and depression. As noted, CS is a complex experience 
and the BPS model of pain embraces this complexity by recognising that biological, 
psychological and social factors interact along a continuum (Turk et al., 2010). 
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2.7 Conclusion 
One of the main aims of the current research was to apply the BPS model of pain 
in the acute pain setting in the context of pain management the day after CS. While 
the BPS model of pain was developed for chronic pain, an exploration of childbirth 
pain and CS has shown that many of the components of the BPS model of pain are 
also relevant to acute post-caesarean pain management. Specific examples include 
the association between postoperative pain and catastrophising, depression and 
perceived control over pain management. These factors are important contributors 
to the pain experience as are the effects of analgesic interventions. Paying equal 
attention to all these factors provides a more complete understanding of acute pain.  
 
There are potential disadvantages in using the BPS model of pain as a framework 
for acute pain management. The model presented by Turk and others accepts the 
value of biological approaches for pain management and yet there is no detailed 
analysis of these fundamental processes (Turk et al., 2010). The tendency to 
downplay biological factors in pain could be related to the view that drug therapy 
is less important in the chronic phase of pain where psychosocial factors become 
predominant (Flor & Turk, 2011). Others have attempted to shape a BPS model of 
acute pain but have also focused on the psychosocial aspects of acute pain 
management (Keefe, 2009). There are therefore contrasting conceptualisations of 
acute pain where a biological focus is applied by some and others give psychosocial 
factors more weight in terms of importance to the acute pain experience (Keefe, 
2009). The current research challenged such views and applied a more complete 
understanding of acute pain as framed by the BPS model of pain. 
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A comprehensive conceptualisation of acute pain incorporates biological, 
psychological and social factors. There are advantages to this approach because all 
dimensions of the model are equally important in explaining acute pain and how a 
multidimensional intervention can reduce postoperative pain and its impact (Turk 
et al., 2010). Unidimensional approaches and sensory physiological 
conceptualisations of pain represent an outdated view of acute pain management 
(Flor & Turk, 2011; Siegele, 1974). Acute pain and childbirth pain in particular are 
complex BPS experiences (Edozien, 2015; McNeill & Jomeen, 2010).  The BPS 
model facilitates a broad approach to the evaluation of the pain intervention rather 
than a focus only on reports of numerical pain intensity. Multidimensional factors 
were considered in this research such as pain interference which is viewed as a 
quality indicator of acute pain management and addresses some of the physical and 
psychosocial impact of acute pain (Gordon et al., 2010). In addition to pain 
interference, the role of depression in acute pain management after CS, not 
previously explored, was addressed in the research. This is despite the fact that 
postnatal depression is a significant health issue for many women (Hayes, 2010) 
and the link between depression and chronic pain supports an exploration of chronic 
pain following CS (Lavand'homme, 2013). The assumptions of the BPS model of 
pain are also compatible with a longitudinal approach to the evaluation of pain 
interventions into the chronic phase and perhaps also with a consideration of BPS 
factors prior to CS as these may influence postoperative and chronic pain. 
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Derived from what is known about pain physiology and the central processing of 
pain, there are multiple targets for acute pain intervention such as analgesic therapy 
and other strategies to support acute pain management. While analgesics are the 
obvious choice for acute postoperative pain, there are potential problems related to 
the unique makeup of individuals and how opioid management is affected by 
physiological and genetic differences between individuals (Flor & Turk, 2011; 
Sadhasivam & Chidambaran, 2012).  While it is possible to improve pain 
management with oxycodone, this requires a skilled clinician who is able to assess 
a patient’s response to therapy and adjust the treatment plan accordingly.  
 
In Australia, the NP is well situated to implement a BPS strategy that integrates 
analgesic therapy with supportive educational interventions to improve pain 
management. The NP approach to pain management falls within the scope of 
practice of many NPs because the management of oral opioids can be carried out 
autonomously (Schoenwald, 2011) which distinguishes the role from that of 
midwives (Australian Health Practitioner Regulation Agency, 2016; Cashin et al., 
2014). Furthermore, the domains of NP practice can be assimilated with the BPS 
model of pain as the NP role draws on elements from the biological and 
psychosocial sciences (Nursing & Midwifery Board of Australia, 2014). NP 
practice is also characterised by a strong emphasis on patient education and 
counselling so that health care can be tailor-made to the individual needs of patients 
(Nursing & Midwifery Board of Australia, 2014). In formulating this approach to 
acute pain management, the NP role can facilitate a supportive continuing 
relationship with women so that issues such as catastrophising, control and beliefs 
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about pain management are addressed (Jungyoun, 2015; Leo & Quinton, 2010; 
McNeil & Jomeen, 2010). The BPS model of pain is a framework that supports this 
approach because pain management and assessment occurs along a continuum 
rather than at one particular point in time (Turk et al., 2010).  
 
The components of the BPS model of pain are applicable to the acute pain setting 
(Keefe, 2009; Turk et al., 2010). While dichotomous views persist surrounding 
acute pain management (Leap & Anderson, 2008; Schug, Palmer, Scott, Halliwell 
& Trinca, 2015), this research assumed a balanced approach to the BPS model of 
pain and its application for acute pain management. The review of the literature in 
the following chapter justifies the approach by associating the major assumptions 
and components of the model with the evidence of the experience of CS.  
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Chapter 3: Literature Review 
3.1 Introduction 
Pain management following CS is understood to be a complex BPS experience 
(Edozien, 2015; Lowe, 2002; McNeil & Jomeen, 2010) and thus a broad range of 
factors were considered in this literature review. The theoretical assumptions and 
components of the BPS model informed the scope of inquiry by identifying the 
major concepts and their relationships with CS. The intention of this review was to 
critique the evidence that relates these concepts in order to identify gaps in the 
research knowledge and inform the design of the study. A focus of this review was 
poor analgesia that appears to mark the CS experience the day after surgery and in 
the weeks and months that follow. Thus, the review also addressed how CS pain 
impacts on women biologically, psychologically and socially through the phases of 
CS from preadmission to the community phase when women may develop CPSP 
(Lavand’homme, 2013). For this reason, the review explored factors that influence 
pain prior to CS, how pain impacts on women while in hospital and then following 
discharge from hospital.  
 
Many studies have evaluated pain management interventions to reduce pain in the 
initial postoperative period following CS. As noted in Chapter One, these 
interventions are usually short-lived and an intervention such as intrathecal 
morphine has an analgesic effect that declines after 12 hours (Hindle, 2008). Thus, 
intrathecal morphine may contribute little to maternal pain relief and function the 
day after CS, a time when women are expected to mobilise and look after a baby. 
Acute pain services are usually in place to review women in terms of the 
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effectiveness of this intervention the morning after CS, yet there is no evidence 
around supplemental analgesic therapy for women or other clinical support 
required. Oral oxycodone is a popular choice the day after CS (Seaton & Reeves, 
2009), but the days ahead have received little clinical or research attention in terms 
of oral analgesic supplementation or the needs of women in terms of educational, 
psychological and social support. The purpose of this chapter is to: (1) describe the 
scope and impact of pain on women following CS, (2) discuss relevant research 
describing BPS factors that influence pain outcomes following CS, (3) discuss 
relevant evidence on pain management interventions for CS, and (4) explore the 
experience of CPSP following CS.  The review will conclude with an outline of 
gaps in the literature that supported the rationale for this study and the NP 
intervention. 
 
3.2 Search Methods 
Multiple databases and sites were used to search for relevant literature on factors 
influencing pain following CS, the pain experience of women following CS, pain 
management interventions for CS and CPSP. The databases searched included 
Medline, PubMed, PsycINFO, Cochrane, Cumulative Index of Nursing and Allied 
Health, Queensland University of Technology Library Database, Joanna Briggs 
Institute, Google Scholar and Embase. Citations retrieved from those databases 
were reviewed for relevance to this research and only appropriate studies were 
accepted for further review. Relevance was based on the conceptual evidence 
identified from an interrogation of the BPS model of pain and the literature on 
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factors associated with childbirth pain. All relevant citations were searched for 
ancestral articles from all years that were deemed relevant to this research.  
 
3.3 Scope of Pain following CS 
This section highlights the clinical problem of CS pain as it affects women in the 
postoperative phase and in the months following. As noted, CS is a common 
procedure that deserves more attention in terms of innovative interventions to 
improve maternal outcomes along a continuum rather than at a single point in time. 
The need for improved management that extends past the analgesic duration of 
intrathecal morphine is exemplified by a recent prospective cohort study of more 
than 70,000 patients in Germany that found women who underwent CS ranked 
ninth for pain intensity on the first day after surgery among 179 different surgical 
procedures (Gerbershagen et al., 2013). Women in this study reported a median 
pain score after CS of 6.1 on a 0-10 verbal rating scale, more than reported for 
abdominal hysterectomy which was ranked 27th for pain intensity (Gerberschagen 
et al., 2013). One of the clinical problems that may drive poor analgesia for women 
is that staff may treat women who have undergone CS differently to other women 
who have had similar surgery. For example, a recent prospective cohort study (n= 
2406) sought to evaluate the quality of CS pain management and factors that may 
contribute to poor analgesia compared to hysterectomy and other gynaecological 
surgeries (Marcus et al., 2015). After adjusting for preoperative pain and age, 
participants who underwent CS reported greater pain intensity and interference 
compared to abdominal or vaginal hysterectomies and yet received significantly 
less opioids with 63% of women not given any opioid analgesics after leaving the 
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post-anaesthesia care unit (Marcus et al., 2015). This suggests significant barriers 
to effective pain management where clinical staff treat women differently if they 
deliver by CS. In most cases, midwives have total control over the administration 
of analgesics, making it difficult for women to request additional opioid analgesics. 
Evidence of poor analgesia after CS and misconceptions regarding pain perception 
also underscores the clinical relevance of improving postoperative pain 
management by raising clinical awareness of the potential for severe pain that may 
negatively affect maternal outcomes. Thus, supportive approaches may empower 
women to communicate more effectively with midwives and other health 
professionals about their requirements for analgesia. 
 
3.4 Impact of Pain following CS 
Although pain intensity may decrease significantly for most women by the second 
postoperative day (Karlstrom, Engstrom-Olofsson, Norbergh, Sjoling & 
Hildingsson, 2007), it is clear that the impact of pain on women is a major clinical 
problem that hinders recovery from surgery and the ability of women to carry out 
desired maternal functions (Eisenach et al., 2008). Many studies have reported pain 
interference with breastfeeding (Chalmers et al., 2010; Zanardo et al., 2010) and 
this may be experienced the day after CS when intrathecal opioids become less 
effective. A Swedish study (n= 121) found that this was the case for many women 
who reported pain interference with infant care and breastfeeding when intrathecal 
opioid analgesia diminished the day after surgery (Karlstrom et al., 2010). A small 
descriptive quantitative study (n=30) showed that pain may also impact on other 
aspects of maternal function such as sleeping, getting in and out of bed, sitting, 
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standing, and enjoyment of life (Chin, Vincent & Wilkie, 2014). Only one study 
has evaluated pain interference in response to pain interventions for CS 
(McDonnell, 2009). The results were published in a thesis dissertation only and not 
in the subsequent journal publication (McDonnell et al., 2010). Out of the sample 
of participants (n= 111) who completed the modified BPI, almost half scored 
greater than three (0-10 VAS) for pain interference with activity, walking and 
coughing during the first 24 postoperative hours (McDonnell, 2009).   
 
The BPS model of pain describes a strong link between pain and depression (Turk 
et al., 2010) and the evidence also shows that this needs to be considered in research 
on CS pain (Eisenach et al. 2008). This can be supported by a cohort study (n=287) 
which found every point increase in acute postoperative pain (NRS 0-10) was 
associated with an 8.3% increase in score on the Edinburgh Postnatal Depression 
Scale (EPNDS) eight weeks after surgery (Eisenach et al., 2008). Other studies have 
not been so conclusive about this association and a study in Finland (n = 185) found 
that women who underwent CS had less risk for the development of postpartum 
depression reported on the EPNDS than those who experienced significant pain 
from vaginal deliveries (Hiltunen et al., 2004). Hence, the association between poor 
analgesia and depression following CS is unclear and further studies are required 
to explore this relationship. The link between chronic pain and depression has been 
explored towards the end of this chapter. Table 1 summarises key studies that have 
contributed to knowledge regarding the scope and impact of pain following CS.  
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Table 1 
Scope and impact of postoperative pain after CS 
Lead Author 
Year 
Study Design 
Sample 
Size 
Outcomes 
Marcus 
2015 
Prospective 
Cohort 
2406 
Greater pain intensity on 0-10 
NRS than hysterectomy. 
Chin 
2014 
Descriptive 
Study 
30 
Pain interference with sleep, 
getting out of bed, sitting up and 
enjoyment of life. 
Gerberschagen 
2013 
Prospective 
Cohort 
70,764 
CS ranked 9th for pain intensity 
compared to 179 other surgery 
types based on NRS 0-10. 
Karlstrom 
2010 
Experimental 
Study 
121 
20% of women in the sample 
reported difficulty with 
breastfeeding due to pain. 
Zanardo 
2010 
Prospective 
Cohort 
398 
CS was associated with lower 
breastfeeding rates. 
Chalmers 
2010 
Retrospective 
Cohort 
8542 
CS was associated with lower 
breastfeeding rates. 
McDonnell 
2009 
RCT 111 
Approximately 50% reported 
greater than 3 out of 10 pain 
interference with activity, walking 
and coughing. 
Eisenach 
2008 
Retrospective 
Cohort 
287 
Increased postoperative pain was 
associated with higher scores for 
depression. 
Hiltunen 
2004 
Prospective 
Cohort 
162 
CS had the same risk of 
developing depression than 
vaginal delivery, but poor 
analgesia for vaginal delivery was 
associated with depression. 
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Many of the studies examined in this review underscore the clinical relevance of 
developing interventions to improve pain outcomes for women. This is because 
pain may be severe for many women (Gerberschagen et al., 2013; Marcus et al., 
2015) and impact on all aspects of life, including walking, breathing relationships 
and care of the neonate. Thus, the impact of pain on women has biological, 
psychological and social aspects (Chin et al., 2014; Eisenach et al., 2008; Karlstrom 
et al., 2010). The evidence on the severity and impact of CS pain contrasts with the 
sensory-physiological model of pain by demonstrating that the attitudes of clinical 
staff may influence the standard of analgesia after CS. Hence, a different approach 
to pain management may be required to address this problem by approaching it 
from a BPS perspective. 
 
3.5 Key BPS Factors influencing CS Pain 
The research literature review thus far has depicted CS as a complex experience 
related to a range of biological, psychological and social factors affecting women 
in the days and months following surgery. The consequences of CS pain also sit 
within a BPS framework which supports a broad approach to research outcomes 
and potential factors that are associated with the experience. The next section 
explores the evidence around the main factors that have been associated with the 
CS experience as conceptualised by the research literature and the BPS model of 
pain.  This section looked at the evidence surrounding these factors rather than the 
conceptual arguments that were discussed in the previous chapter. 
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3.5.1 Previous CS 
The evidence so far points to the fact that pain can be severe for many women 
following CS. Thus, memories of these experiences for women are likely to cause 
a degree of fear and anxiety in relation to subsequent deliveries and so this research 
considers the number of previous CS deliveries as baseline information because 
previous CS surgery may have negative effects on women in a subsequent delivery 
and also risk the development of CPSP (IASP, 2011). It has also been found that 
women who have experienced CS are likely to decline a subsequent CS due to fear 
of intense postoperative pain (Enabudoso, Ezeanochie & Olagbuji, 2011). This fear 
may be made worse by the biological effects of Pfannenstiel incision that has been 
associated with CS scar hyperalgesia following surgery (Loos et al., 2008; Ortner 
et al., 2013). The negative effects of previous experience and scar hyperalgesia were 
evaluated in research where women reported greater than one point out of ten (VAS 
0-10) increased pain (p<0.004) after a subsequent CS when compared to 
participants without scar hyperalgesia and this may predispose women to being 
more sensitive to further pain situations (Ortner et al., 2013). Biological and 
psychosocial factors may enhance sensitivity to pain and lead women to experience 
more CS pain (Orbach-Zinger et al., 2015). Thus, the research suggests that 
biological and psychological factors formed by a previous CS experience may 
result in poor analgesia in subsequent surgeries. 
 
3.5.2 Pain Catastrophising 
Studies that have evaluated interventions for CS have not accounted for the 
association between pain catastrophising and postoperative pain outcomes despite 
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catastrophising being a strong predictor of pain in various surgical models 
(Masselin-Dubois et al., 2013). There may be a strong association between fear of 
pain and pain catastrophising that can result in increased CS pain (Dehghan, Sharpe 
& Khatibi, 2014). An observational study (n= 300) found that high levels of fear 
and catastrophising were associated with women feeling they wanted to avoid 
childbirth (Dehghan et al., 2014). This intense fear and catastrophic thought pattern 
may cause women to anticipate greater postoperative pain (Flink, Mroczek, 
Sullivan, & Linton, 2009). This anticipation of more pain has been associated with 
higher postoperative pain scores. In one study, women with high catastrophising 
scores also reported a high degree of postpartum pain and interference compared to 
other women (Flink et al., 2009). While participants in these studies were a mixture 
of vaginal and caesarean deliveries, a smaller CS study (n= 47) also found a 
correlation between catastrophising and increased postoperative pain (Strulov et al., 
2007), although the results in this study may not be reliable due to the small sample 
size. Nonetheless and because pain catastrophising appears to be a powerful 
influence, studies can measure this factor prior to an intervention and later 
determine how pain catastrophising influences pain perception and maternal 
recovery during the months following surgery (Masselin-Dubois et al., 2013).  
 
 3.5.3 Depression 
From the perspective of the BPS model of pain, depression is another prominent 
factor that influences pain perception and function in acute and chronic pain states 
(Turk et al., 2010). Depression in pregnancy may influence pain following CS 
because it is also linked to increased fear of pain and anxiety associated with 
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childbirth (Anderssen, Sundrom-Poromau, Wulff, Astrom & Bixo, 2004). Even 
though a recent study (n= 139) found high rates of prenatal depression in women 
preparing for CS, many studies have not accounted for depression as a factor that 
may influence pain outcomes (Clout & Brown, 2015). The emotional aspects of 
pregnancy may increase the perceived intensity of postoperative pain and a study 
across three Chinese hospitals (n= 764) found prenatal depression was associated 
with 2-3 points greater postoperative pain (0-10 VAS) for participants with 
depression at 24, 48 and 72 hours after caesarean delivery (Lou & Kong, 2012). 
The relationship between depression and pain after surgery is complex and it is 
unclear whether pain contributes to depression or depression results in more pain 
(Gaudet, Wen & Walker, 2013). However, trials evaluating pain interventions for 
CS may also include prevalence and measures of prenatal depression in participants 
because, while the nature and direction of the association is unclear, depression is 
a major psychological factor that is associated with pain, suffering and pain 
behaviour within the context of the BPS model of pain (Turk et al., 2010). 
 
3.5.4 Perceived Control 
There is a need to explore perceived control in pain research and determine the 
preferences of women for control over their pain management and how to 
individualise control for women. The importance of addressing maternal control is 
supported by a recurring theme in the literature that suggests women feel a loss of 
control over the childbirth situation and that this also involves control over pain 
management (Fenwick et al., 2003; Fisher et al., 1997; McCrea & Wright, 1999).  
However, one small study (n=65) in the United Kingdom has measured perceived 
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control and postoperative pain management following CS and the results suggested 
that maternal perception of control did not predict postoperative pain (Keogh et al., 
2005). Thus, there is little evidence for the benefit of greater perceived control in 
improving pain management following CS surgery, despite evidence for a positive 
effect in studies in other areas such as acute dental pain (Gedney & Logan, 2007). 
This may be because some people perceive control to relate to a broad range of 
factors and not just pain management (Meyer, 2013; Vallerand, Crawley, Pieper & 
Templin, 2015). Nonetheless, perceived control was associated with maternal 
satisfaction with pain relief in labour in a correlational study (n= 100) that measured 
perceived control over pain management on 0-10cm VASs (McCrea & Wright, 
1999). This was a small study and the results, therefore, are not able to be applied 
to the general population of women who undergo childbirth, let alone CS as these 
women were excluded from the study (McCrea & Wright, 1999). 
 
Adding to this complexity and lack of evidence is that not all women desire high 
levels of control over pain management. Research compared two groups of women 
from Belgium and the Netherlands by measuring their levels of perceived control 
and use of pharmacological therapies for childbirth pain (Christiaens, Verhaeghe & 
Bracke, 2010). The results demonstrated that greater consumption of analgesics for 
childbirth pain was associated with lower levels of perceived control but that 
women from Belgium also did not perceive control as important as Dutch women 
(Christiaens et al., 2010). This suggests that there are sociocultural differences in 
the desire for control over childbirth pain management. The findings give further 
support to a BPS approach to pain management as the needs of women are different 
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following CS (Keogh et al., 2005). The literature also suggests that women may 
benefit from an individualised degree of control over a broad range of factors. Table 
2 summarises key BPS factors that have been associated with CS. 
 
Table 2 
BPS factors associated with CS pain 
Lead Author 
Year 
Study Design 
Sample 
Size 
Outcomes 
Orbach-
Zinger 
2015 
Experimental 229 
Women reported increased 
postoperative pain if they 
demonstrated pain sensitivity to the 
intrathecal injection. 
Dehghan 
2014 
Observational 
study 
300 
Women reported they wanted to 
avoid childbirth due to intense fear 
of pain and catastrophic thoughts 
about pain. 
Ortner 
2013 
Prospective 
Cohort 
163 
Scar hyperalgesia from a previous 
CS was associated with increased 
postoperative pain. 
Lou 
2012 
Prospective 
Cohort 
764 
Prenatal depression was associated 
with higher pain scores following 
CS on a 0-10 VAS. 
Enabudoso 
2011 
Observational 
study 
139 
Previous CS was associated with 
women being more likely to decline 
a subsequent CS due to fear of 
intense postoperative pain. 
Christianens 
2010 
Prospective 
Cohort 
327 
Greater consumption of analgesics 
was associated with lower levels of 
perceived control. 
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Flink 
2009 
Prospective 
Cohort 
82 
Women reporting catastrophic 
thoughts about pain reported 
increased anticipated pain as well as 
increased postoperative pain. 
Loos 
2008 
Retrospective 
Cohort 
690 
Previous Pfannenstiel incision was 
associated with scar hyperalgesia 
and chronic pain. 
Strulov 
2007 
Observational 
study 
47 
Correlation between catastrophising 
and increased postoperative pain. 
Keogh 
2005 
Observational 
study 
65 
Maternal perception of control did 
not predict postoperative pain 
intensity. 
Anderssen 
2004 
Prospective 
Cohort 
1495 
Depression in pregnancy was 
associated with increased fear of 
pain and anxiety relating to 
childbirth. 
 
Several studies in this review have found that pain catastrophising, previous CS, 
depression and perception of control are associated with CS pain and so these 
factors need to be considered in research that evaluates pain interventions following 
CS. Fear of pain and maternal catastrophising appear to result in anticipation of a 
negative pain experience (Dehghan et al., 2014; Enabudoso et al., 2011) and higher 
reports of postoperative pain (Flink et al., 2009; Strulov et al., 2007). Depression 
has been linked to increased fear of pain and anxiety associated with childbirth 
(Anderssen et al., 2004) and the BPS model of pain supports the reciprocal 
relationships between these factors (Turk et al., 2010). From this review, depression 
alone can result in greater postoperative CS pain (Lou & Kong, 2012). There is also 
a relationship between depression, catastrophising and perceived control (Turk et 
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al., 2010) but this review has found inconsistent and poor evidence on how control 
over pain management may enhance analgesia after CS (Christianens et al., 2010; 
Keogh et al., 2005). When looking at all these factors, however, it is clear that 
previous delivery by CS may be associated with poor analgesia in subsequent 
deliveries and that this may also be due to biological causes (Loos et al., 2008; 
Orbach-Zinger et al., 2015; Ortner et al., 2013). 
 
3.6 The Biomedical Approach to CS Pain Management 
Studies on CS pain interventions have generally addressed the issue from a 
biomedical approach that seeks to attenuate pain with pharmacological agents and 
invasive procedures such as intrathecal opioids (Booth, Harris, Eisenach & Pan, 
2016), peripheral local anaesthetic techniques (Kainu et al., 2012; Larsen et al., 
2015; Mishriky, George & Habib, 2012), and adjunctive analgesics like 
gabapentinoid drugs or ketamine (Heesen et al., 2015; Short, Downey, Bernstein, 
Shah & Carvalho, 2012). The majority of interventions have been commenced in 
the operating suite by anaesthetists hoping to reduce pain for the first 24 
postoperative hours. The days following CS have received little attention in terms 
of the effectiveness of pain interventions and a recent Cochrane review is an 
example of the biomedical focus on CS pain research (Mkontwana & Novikova, 
2015). The review found no evidence for the effectiveness of any oral analgesic 
agent compared to another class of analgesic or placebo (Mkontwana & Novikova, 
2015). Yet, none of the included studies compared formulations of analgesics such 
as oxycodone and how they integrate with other aspects of pain management such 
as educational support or the degree of patient participation in pain management. 
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The paucity of evidence surrounding BPS approaches to pain management after CS 
represents a significant gap in the research literature. This is because the theoretical 
underpinnings of most studies obscure the complexity of childbirth pain that could 
be addressed with a NP approach to pain management based on a BPS model of 
pain.  
 
When intravenous PCA became popular in the 1980s, the concept of control over 
pain was viewed as control over analgesic doses (Rayburn, Geranis, Ramadei, 
Woods & Patil, 1988).  This technique had been used for other major surgeries prior 
to widespread use for caesarean pain management (Davis et al., 2006; Rayburn et 
al., 1988). It has been argued that there may have been a delay in providing PCA to 
women because CS pain was underrated (Gerberschagen et al., 2013; Marcus et al., 
2015). Despite this, the effectiveness of PCA for postoperative pain has been well 
established in multiple surgical contexts and offers patients a high degree of control 
over their pain management. Such control, however, is only in terms of immediate 
access to analgesia and the circumventing of barriers that hinder communication 
between patients and health professionals (Macintyre & Schug, 2014). The use of 
PCA devices for CS have also been criticised as some have argued that pumps and 
intravenous lines impede maternal mobility (Davis et al., 2006; Dieterich et al., 
2012). Thus, innovative strategies are required that can enable control over pain 
management without invasive technologies. Some have argued that the relationship 
between the clinician and patient is fundamental to develop a situation where 
patients can attain a degree of control that is therapeutic in terms of pain 
management (Kaptain et al., 2016). 
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For many women following CS, intrathecal opioids have replaced the need for PCA 
devices particularly if longer acting opioids such as morphine are injected into the 
intrathecal space (NICE, 2011). Intrathecal analgesia is the recommended method 
for CS analgesia and the addition of morphine extends the duration of analgesia, 
potentially up to 18 hours after surgery (Hindle, 2008; NICE, 2011). The 
effectiveness of intrathecal morphine was demonstrated in a Swedish study (n=121) 
that compared two cohorts of women who had undergone CS (Karlstrom et al., 
2010).  Participants in the first cohort were administered intrathecal bupivacaine 
only (1.8-2.6 ml) and the other cohort received intrathecal bupivacaine (1.8-2.6ml) 
with the addition of 120 micrograms of morphine and five micrograms of fentanyl 
(Karlstrom et al., 2010). All participants received equal doses of oral paracetamol 
(one gram four times daily) and diclofenac (50mg three times daily). Opioid 
injections of ketobemidone were available to both groups of women for 
breakthrough pain. Participant responses were analysed using binary logistic 
regression for two responses in pain intensity, either 0-3 out of 10 (0-10 VAS) or 
pain scores of 4 through to 10. Participants who received intrathecal morphine and 
fentanyl experienced less postoperative pain the day after CS and were less likely 
to experience pain intensity greater than three out of 10 on a 0-10 VAS (RR= 0.6, 
95% CI 0.4-0.8, p=0.001) than those who received intrathecal bupivacaine only 
(Karlstrom et al., 2010). While there is general consensus regarding the 
effectiveness of intrathecal morphine for the first 18 hours after CS (NICE, 2011), 
there have been no studies on the effects of opioid supplementation when analgesia 
from intrathecal opioids diminishes from 12-18 hours following administration 
 89 
(Hindle, 2008). A potential clinical problem is the hesitation of some staff to 
prescribe or administer oral opioids for breakthrough pain due to fear of respiratory 
depression while the concentration of morphine in CSF is active at the same time 
(Macintyre & Schug, 2014). Despite this issue, intrathecal morphine does not 
provide complete opioid analgesia for many women and supplemental opioids are 
required. 
 
Long-acting intrathecal opioids can be effective for many women in the immediate 
postoperative period but the intervention has little benefit past the point of initial 
mobilisation the day after CS when the clinical preference is to eliminate the need 
for invasive administration tubing and accessories (Davis et al., 2006; Schyns-van 
den Berg et al., 2015). There is clearly a need for effective interventions for pain 
management beyond the first postoperative phase after CS that do not rely on 
invasive techniques that may inhibit maternal function and contribute to feelings of 
disempowerment (Fisher et al., 1997). The move away from invasive interventions 
has brought new issues regarding maternal control of analgesics in the context of a 
clinical preference to prescribe oral opioids after CS (Davis et al., 2006; Schyns-
van den Berg et al., 2015). While the removal of technology and invasive lines can 
enable some ambulatory freedom, effective analgesia needs to be sustained beyond 
this point using oral oxycodone and supportive strategies. 
 
3.7 The BPS Model and Pain Management following CS 
A new approach to acute pain management may improve outcomes after CS by 
drawing on interventional aspects of the BPS model of pain such as understanding 
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maternal beliefs about the degree of intervention appropriate for pain and the use 
of oral oxycodone (McNeill & Jomeen, 2010; Turk et al., 2010). This type of pain 
management is more than a prescription of oxycodone and integrates other 
components including a supportive relationship, pain management education, 
promotion of maternal control and regular follow-up to evaluate individual 
response to therapy (Jensen et al., 2015; Mander & Murphy-Lawless, 2013; 
McNeill & Jomeen, 2010; Mosely & Butler, 2015; Turk et al., 2010; Turk & 
Okifugi, 2002). Despite the potential benefits, the literature is scarce on exploring 
integrated interventions for acute pain.  Most research has involved methods to 
administer oral analgesics or broader conceptual approaches to pain management. 
 
3.7.1 Self-administration of analgesics 
Some researchers have attempted to improve CS pain management by supporting 
them to administer their own oral analgesics. While some studies have shown that 
self-administration is safe and effective for pain management, the results have 
demonstrated little benefit over standard practices. For example, a recent RCT (n= 
77) compared women who received nurse-administered parenteral morphine with 
others who self-administered all analgesics including oral morphine tablets (Bonnal 
et al., 2016).  Postoperative pain scores at rest and movement were similar for both 
groups, although the study highlighted that this method may be an acceptable 
intervention according to many women (Bonnal et al., 2016).  Participants in the 
intervention group also consumed more opioid analgesics than those who did not 
self-medicate (Bonnal et al., 2016), which may indicate that self-administration 
better met individual requirements for analgesics or that barriers preventing 
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midwife administration were removed. Similarly, a UK study (n= 95) demonstrated 
comparable postoperative pain outcomes with self-administration of analgesics 
when compared to analgesia controlled by midwives (Snell & Hicks, 2006). In 
contrast to the study by Bonnal and others, self-medicating women consumed less 
analgesic medication (Snell & Hicks, 2006). The self-medicated group of women 
also reported satisfaction with this method and a desire to use this method again 
(Snell & Hicks, 2006). However, participants had already expressed a desire to self-
medicate as part of the recruitment process and so these results cannot be 
generalised to the population of CS patients (Snell & Hicks, 2006). A further 
Canadian study (n= 145) found no differences between groups of women who 
underwent CS where one group self-administered their own medications including 
oral paracetamol, codeine plus paracetamol tablets and oral naproxen (East, Dube 
& Pereault, 2007). However, women who self-administered reported that they 
experienced more control over their pain management and greater satisfaction with 
the experience (East et al., 2007). Evidence surrounding self-administration of 
analgesics for CS pain are presented in Table 3.  
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Table 3  
Self-administration of analgesics following CS 
Lead 
Author 
Year 
Study 
Design 
Sample 
Size 
Intervention Outcomes 
Bonnal 
2016 
RCT 77 
Self-
administration 
of analgesics. 
Pain scores were similar 
for both groups and the 
intervention resulted in 
more opioid 
consumption. 
East 
2007 
RCT 145 
Self-
administration 
of analgesics. 
No differences in pain 
intensity between groups. 
Snell 
2006 
Experimental 95 
Self-
administration 
of all 
analgesics. 
No differences in pain 
intensity between groups 
but the self-
administration group 
consumed less 
paracetamol plus codeine 
tablets. 
 
These studies have shown that self-administration of analgesics meets the needs of 
some women but the results have demonstrated little benefit over nurse or midwife 
controlled analgesia in terms of pain intensity or opioid reduction. The small sample 
sizes for two of these studies and complex research methods make it difficult to 
draw conclusions regarding self-administration of analgesics. Like many other 
interventions for CS pain, no attention is given to other supportive educational 
strategies that may improve the use of analgesics appropriate for individual women. 
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3.7.2 Integrated educational approaches 
There is some research that has integrated oral analgesic therapy with educational 
strategies to improve postoperative pain and some have described pain 
interventions that have targeted beliefs about pain management and how to use 
analgesics effectively. The overall results of these studies suggest that a supportive 
approach to pain management with education has benefit across many surgical 
models and pain contexts. However, an experimental study (n= 60) found no 
differences in pain intensity or opioid consumption over three days compared to a 
group of participants who were encouraged to take control over their pain 
management to reduce pain interference following orthopaedic surgery (Sjoling, 
Nordahl, Olofsson & Asplund, 2003). Furthermore, a postoperative intervention 
that integrated the use of analgesics and relaxation techniques also showed no 
benefit compared to standard care for participants (n= 234) who underwent inguinal 
hernia repair (Glindvad & Jorgensen, 2007). Both of these studies provided 
inconclusive evidence as they did not describe the analgesic components of the 
intervention that may have contributed to the results. 
 
Other studies have shown some benefit for supportive educational approaches to 
pain management with analgesics. A RCT (n= 70) found that a preoperative 
discussion regarding pain management, control of pain management and prevention 
of pain interference reduced pain and opioid consumption in patients who 
underwent thoracotomy (Kol, Ecevit & Erdogan, 2014). Another study (n= 125) 
integrated educational discussion about options for pain management, relaxation 
and control over analgesia and the intervention resulted in reduced pain intensity 
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on a 0-100mm VAS over several days after surgery for a fractured lower limb 
(Wong et al., 2010). The intervention in this study was described as a cognitive-
behavioural approach and participants receiving the intervention consumed more 
postoperative analgesics than the control group (Wong et al., 2010). The researchers 
did not report on the classes and doses of analgesics consumed in this study (Wong 
et al., 2010). Another study involving preoperative education on analgesic use 
following breast cancer surgery (n= 84) resulted in less pain on a 0-10 VAS over 
six postoperative hours and better mobility compared to standard treatment but the 
analgesic components were also not reported (Sayin & Askoy, 2012). In the context 
of cancer pain, development of a supportive pain management plan based on the 
knowledge and attitudes of patients about analgesic use resulted in a greater 
willingness of patients to communicate about their pain management and express 
concerns to healthcare professionals (Yates et al., 2004). Participants who received 
the pain management intervention reported greater perceived control after one week 
than the control group (Yates et al., 2004). The study also did not report on the types 
of analgesics used by participants or amounts that were consumed. Table 4 
summarises research that has included these various strategies alongside analgesic 
therapy. 
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Table 4 
Studies evaluating pain education and other supportive strategies 
Lead 
Author 
Year 
Study 
Design 
Sample 
Size 
Intervention Outcomes 
Kol 
2014 
RCT 70 
Discussion: pain 
management, control 
of pain management 
and prevention of 
pain interference. 
Reduced pain and 
opioid consumption 
in patients who 
underwent 
thoracotomy. 
Sayin 
2012 
Experimental 84 
Education on 
analgesics. 
Less pain over six 
postoperative hours 
and better mobility 
after breast cancer 
surgery. 
Wong 
2015 
Quasi-
experimental 
125 
Discussion: options 
for pain 
management, 
relaxation and 
control over 
analgesia. 
Less pain but more 
consumption of 
analgesics over 
several days 
following fractured 
limb surgery. 
Glindvad 
2007 
RCT 234 
Discussion: use of 
analgesics and 
relaxation 
techniques. 
No difference 
between groups who 
underwent inguinal 
hernia repair. 
Yates 
2004 
RCT 189 
Supportive education 
based on the 
knowledge and 
attitudes of patients 
about analgesic use. 
 
Greater willingness to 
communicate about 
pain and greater 
perceived control. 
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Sjoling 
2003 
Experimental 60 
Discussion: using 
analgesics to reduce 
pain interference 
following 
orthopaedic surgery. 
No differences in pain 
intensity or opioid 
consumption over 
three days. 
 
The overall results of these studies suggest that a supportive approach with pain 
education may enhance pain management by using analgesics more effectively. 
Key features include building rapport with patients, discussing their beliefs and 
concerns about pain management and sharing information on analgesics and how 
they can be used to reduce pain and pain interference. A criticism of these studies 
is that the researchers did not describe the analgesics used in the interventions. The 
doses and formulations were also not addressed in these studies and this suggests 
that their views of pain management may be skewed to the psychosocial end of the 
dichotomous spectrum of pain conceptualisation. More research is needed to take 
all factors into consideration when designing interventions for acute pain 
management. 
 
3.7.3 Participation in Pain Management 
Some researchers have argued that acute pain management can be improved by 
patient participation in their care. This involves, not only enabling control over pain 
management, but the creation of a supportive relationship that enhances shared 
decision-making about pain management (Zoega et al., 2014). A relationship of 
trust and quality communication between the nurse and patient are seen as key 
factors that aid in the provision of individualised management (Kaptain et al., 
2016).  A recent qualitative study evaluated the experience of women in a post-
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anaesthesia care unit who had undergone spine surgery (Kaptain et al., 2016).  
Based on semi-structured interviews, the central themes to patient participation in 
acute pain management involved communication and acquisition of knowledge 
around a therapeutic patient-nurse relationship (Kaptain et al., 2016).  Participants 
reported that the frequency of nurse contact was also a factor that made them feel 
secure and confident to express their pain experience or request pain relief (Kaptain 
et al., 2016). The results here cannot represent the general population or women 
who undergo CS. The features of the nurse-patient interaction described, however, 
suggest that drugs are not the only answer to finding a better solution for acute pain.    
 
Similar to perceived control, not all patients express a desire for a high degree of 
participation in pain management.  A recent descriptive study (n= 308) found that 
participants who perceived they experienced the degree of participation they 
desired reported lower pain scores and spent less time in severe pain than those who 
lacked or did not express a desire to participate (Zoega et al., 2014). The sample of 
participants consisted of surgical and medical patients and the results, therefore, 
may not be relevant to CS pain. Others have evaluated the quality of postoperative 
pain management in patients following cardiac surgery and related participation to 
the degree of control patients wanted to have (McTier, Botti & Duke, 2014). The 
exploratory descriptive study (n= 130) found that only 63.8% of participants 
expressed a desire to share decision-making with clinical staff regarding pain 
management (McTier et al., 2014). Other participants, however, may not consent 
to this approach as they preferred to allow clinical staff to decide on the pain 
management plan (McTier et al., 2014). Indeed, 23% of participants in the previous 
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research stated they did not want to participate in their own pain management 
(Zoega et al., 2014). The results above suggest that not all patients desire complete 
control over pain management and that this aspect of pain management can be 
individualised alongside administration of oral analgesics. A potential disadvantage 
of participation as a research concept is that, similar to perception of control in 
childbirth, it relates to many factors including control over pain management 
(Meyer, 2013; Zoega et al., 2014). Nonetheless, the research above converges with 
the BPS model of pain because it shows that acute pain management occurs within 
a social context that also involves patients and health professionals (Keefe, 2009). 
 
3.7.4 Oral oxycodone for CS 
Oral oxycodone is the most common opioid analgesic used after CS and is 
standardised care in many settings after intrathecal morphine or other interventions 
have lost effect (Davis, et al., 2006; Dieterich et al., 2012; McDonnell et al., 2010; 
Seaton & Reeves, 2009; Zhong et al., 2014). Oxycodone has the potential to cause 
respiratory depression in breast-fed babies (Lam et al., 2012; Timm, 2013) but it is 
accepted by many that this is mitigated by the low volumes of breast milk produced 
and ingested in the first few days after delivery (Seaton, Reeves & Mclean, 2009). 
As noted previously, the oral route is preferred to supplement analgesia after 
intrathecal morphine as it eliminates the need for intravenous lines that may 
interfere with maternal mobilisation and the ability to care for a new baby (Davis 
et al., 2006; Schyns-van den Berg et al., 2015).  
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Unlike CR oxycodone, the IR formulation can support women to plan times of 
mobilisation and other activities after surgery in line with the predicted shorter time 
to maximum concentration (Aspen, 2015; Mundipharma, 2015). Because IR 
oxycodone has a shorter duration of action (Aspen, 2015), women can request it 
intermittently every 3-4 hours to hasten analgesia and reduce pain interference 
depending on the level of activity required. Research on fast-track CS surgery 
showed that IR oxycodone was a contributor to effective pain management and 
early discharge from hospital (Wrench, Allison, Galimberti, Radley & Wilson, 
2015). Thus, the evidence suggests it may be the appropriate formulation of 
oxycodone to commence acute pain management and to reduce pain and pain 
interference.  
 
Only two studies have evaluated IR oxycodone to provide opioid analgesia 
following CS. One study was conducted in the USA (Davis et al., 2006) and the 
most recent study was undertaken in Australia (McDonnell et al., 2010). The 
purpose of the trial by Davis and others was to test scheduled doses of IR oxycodone 
as an alternative to PCA which was perceived as a restriction on women with pumps 
and intravenous poles (Davis, et al., 2006). The study compared IR oxycodone (as 
a combination tablet with paracetamol) with intravenous PCA following CS and 
the results of the study demonstrated that IR oxycodone could replace intravenous 
PCA in the immediate postoperative phase following CS (Davis, et al., 2006). This 
RCT (n= 93) reported less pain for the oral oxycodone group, six hours and 24 
hours following CS with a mean difference of 1.2 out of 10 (p= 0.004) on a 
numerical rating scale at 24 hours (Davis, et al., 2006). A major criticism of this 
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study would be that the PCA group did not receive any paracetamol for 12 hours 
following the protocol commencement and were stepped down to the combination 
oxycodone and paracetamol tablet after 12 hours on PCA (Davis, et al., 2006). Both 
groups, therefore, did not receive the same amounts of paracetamol. Like many 
other studies, this RCT was grounded in biomedical assumptions in that the study 
did not control for any psychosocial variables or previous CS experience (Davis, et 
al., 2006). Maternal requirements for rescue analgesics were also not described but 
the results suggest that IR oxycodone might be the appropriate choice compared to 
scheduled doses of CR oxycodone. There was no attention given to other strategies 
to improve management with oxycodone such as educational discussion with 
participants. 
 
McDonnell and others conducted an RCT in Australia which drew on the 
intervention and results reported by Davis and others (McDonnell et al., 2010). 
Instead of comparing IR oxycodone to PCA, the study compared scheduled IR 
oxycodone doses to intrathecal analgesia with morphine over 24 hours following 
CS. While the intervention group received 20mg of CR oxycodone immediately 
following surgery, the primary opioid analgesic up until 24 hours was scheduled 
doses of 10mg of IR oxycodone administered every six hours. There were no 
baseline differences between participants in terms of other drugs or interventions 
administered prior to the intervention or control treatment and all participants 
received intrathecal local anaesthetic plus fentanyl (15mcg), intravenous parecoxib 
(40mg) during anaesthesia, oral paracetamol (1g) and oral diclofenac (50mg) in 
scheduled doses. Pain intensity scores were reported at zero, six, 12 and 24 hours 
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and they decreased in linear fashion up until 24 hours. The results showed no 
significant differences in pain intensity scores between both groups at all time-
points (McDonnell et al., 2010). Also, the study found no statistically significant 
difference between groups in terms of extra doses of oxycodone or tramadol 
required for analgesia and the reported interquartile range for breakthrough 
oxycodone use was between 10 and 44 mg for both groups (McDonnell et al., 2010). 
Nonetheless, the implications of this trial were that IR oxycodone was an effective 
analgesic for CS pain and that there was a wide range of individual requirements 
for IR oxycodone as a breakthrough analgesic (McDonnell et al., 2010). This 
suggests that women need more control over what they actually need for 
postoperative analgesia. However, while the results of this trial support the use of 
IR oxycodone following CS, they only apply to pain intensity during the first 24 
hours after surgery and not pain quality. In the original thesis that preceded this 
publication, pain interference was measured by the modified BPI but there was no 
difference between the intervention or control groups (McDonnell, 2009).   Also, 
the study did not consider the influence of key factors such as catastrophising, 
perception of control or depression on study outcomes. Despite these 
disadvantages, the RCT by McDonnell and others was an important study in the 
development of this research because it was used to inform the sample size and 
design of the standard treatments administered to both groups which were similar 
to standard anaesthetic practice in the research setting. 
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3.8 Chronic pain following CS 
Pain may persist beyond the expected healing time following CS and the complex 
experience of CS may lead to the development of CPSP which may be described in 
terms of pain intensity, pain quality and degree of interference with a broad range 
of maternal functions (Grosu & de Kock, 2011; Lavand'homme, 2013). According 
to the International Association for the Study of Pain, the prevalence of CPSP after 
CS lies between six and 55% (IASP, 2011). This wide range of reports for the 
prevalence of CPSP after CS indicates that there may be inconsistencies in the 
research literature about what denotes significant chronic pain after surgery. A 
national survey in the United States (n= 1573) found 85.5% of women reported pain 
two months after CS (Declercq et al., 2008), much higher than the figure reported 
by the International Association for the Study of Pain (IASP, 2011). In contrast, a 
French study (n=69) found only 10-15% of participants were still experiencing pain 
two months following surgery (Bonnal et al., 2016). None of these studies reported 
the actual number of days that women experienced pain or the quality of pain. Only 
one study attempted to quantify pain interference three months after CS and found 
significant pain interference for those women who reported pain at three months 
with almost one third of participants reporting moderate to severe interference with 
sleeping, enjoyment of life and mood (Niklasson, Ohman et al., 2015). 
 
The clinical picture of CPSP after CS is complex and studies also need to measure 
the number of days that pain was experienced, pain intensity over time, quality of 
pain and how pain interferes with maternal health and quality of life. Some studies 
have reported more than the point prevalence of chronic pain following CS by also 
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describing the number of days that women experienced pain during a specified time 
period. In Finland, a small study (n=42) found 19% of women experienced daily 
pain over two months (Kainu, Sarvela, Tippana, Halmesmaki & Korttila, 2010). 
Another small Australian study (n = 62) found that 24.2% of women experienced 
daily pain for two months after CS (Liu, Raju, Boesel, Cyna & Tan, 2013). Again, 
the small sample sizes make these results difficult to interpret and some larger 
sample sizes have reported less daily pain during the days following CS. An 
example is a Singaporean study (n=857) that reported only five participants 
experienced daily pain over three months (Sng et al., 2009). A questionnaire sent 
to women in Denmark (n= 220) also found a smaller burden of daily pain after CS 
because only 5.9% of women reported pain every day for the three-month period 
(Nikolajsen et al., 2004). However, a large USA study found that 40% of 
participants (n= 391) experienced pain daily for eight weeks following CS 
(Eisenach et al., 2008). These results suggest that more research, larger sample sizes 
and more complex research methodologies are required to determine the impact of 
pain on women over several months. Furthermore, no studies have explored the 
quality of pain in the community phase after CS as the presence of neuropathic pain 
after CS may contribute to chronic pain for some women (Loos et al., 2008). Table 
5 summarises studies that have described the scope and impact of CPSP after CS. 
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Table 5 
Prevalence and days of chronic pain experienced following CS 
Lead Author 
Year 
Study Design 
Sample 
Size 
Outcomes 
Bonnal 
2016 
Follow-up 
RCT 
69 
5-10% reported mild pain at 8 weeks 
(point prevalence). 
Niklasson 
2015 
Follow-up 
RCT 
93 
56% reported CS scar pain at three 
months (point prevalence). 
Liu 
2013 
Prevalence 
Study 
62 
24.2% of women said they 
experienced pain daily for two 
months. 
Kainu 
2010 
Retrospective 
Cohort 
229 
18% of women reported pain at 12 
months after CS (point prevalence). 
19% recalled experiencing pain daily 
for 2 months after CS. 
Sng 
2009 
Retrospective 
Cohort 
857 
0.5% of women said they 
experienced pain daily for three 
months. 
Declercq 
2008 
Retrospective 
Cohort 
1573 
79% of women reported having pain 
at two months (point prevalence). 
 
Eisenach 
2008 
Retrospective 
Cohort 
391 
40% of women reported having pain 
daily for 8 weeks following CS. 
Nikolajsen 
2004 
Retrospective 
Cohort 
220 
5.9% said they experienced daily 
pain for three months. 
 
There is no specific causal factor that may result in the development of CPSP and 
many BPS factors are involved (IASP, 2011). Nonetheless, some research has 
linked chronic post-caesarean pain to poor analgesia in the acute postoperative 
phase. An important finding of the study by Nikolajsen and others was that 66.7% 
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of women who reported persistent pain had a higher recall of postoperative pain 
following CS (Nikolajsen et al., 2004). Sng and others also found an association 
between chronic pain and increased postoperative pain (OR=1.3, 95% CI 1.2-1.5, 
P<0.001) following CS (Sng et al., 2009). Niklasson and others found that greater 
postoperative pain increased the risk of persistent pain six months following CS 
(Niklasson, Ohman et al., 2015). Furthermore, a Finnish study (n=229) also 
demonstrated a strong association between CPSP and the impact of pain on deep 
breathing and coughing the day after CS (Kainu et al., 2010). These findings 
suggest that there may be a link between pain interference in the postoperative 
period and the development of CPSP which strengthens an argument for measuring 
pain interference after CS. These findings support the need for more attention to be 
given to CS pain management in the postoperative phase and after discharge from 
hospital and to develop research that explores the relationship between CPSP and 
postoperative pain. The BPS model of pain would view this relationship in terms 
of broader issues other than scores for pain intensity and multiple relationships 
could be explored if one views CS pain and CPSP as BPS experiences which are 
shaped by multiple factors. 
 
Some have argued that the main factors involved in the development of CPSP are 
psychosocial in nature (Masselin-Dubois et al., 2013). Pain and depression are often 
associated with CPSP and a large cohort study found that severe postoperative pain 
was associated with high scores obtained from the EPNDS eight weeks following 
CS (Eisenach et al., 2008). A further study (n=353) also found that childbirth pain 
and lack of control over pain management was associated with the development of 
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PND (Mohammed, Gamble & Creedy, 2011). Other cohort studies have reported 
associations between childbirth pain and the development of PND (Chang et al., 
2016; Gaudet et al., 2013). These studies underscore the importance of measuring 
depression and pain outcomes in women before and after CS to further explore the 
relationships between PND, CPSP and postoperative pain. 
 
3.9 Conclusion 
The research literature supports the notion that poor postoperative analgesia after 
CS may be associated with many BPS factors including pain catastrophising (Flink 
et al., 2009; Strulov et al., 2007) and depression (Lou & Kong, 2012). It was also 
suggested that poor pain outcomes from a previous CS may also lead to increased 
fear of pain (Enabudoso et al., 2011) and CS scar hyperalgesia (Loos et al., 2008; 
Ortner et al., 2013), placing women at risk of more pain following a subsequent 
delivery. Furthermore, reduced maternal control over pain management may be 
associated with more postoperative pain but the evidence suggests the benefits of 
more control may only be associated with decreased opioid analgesic consumption 
(Christianens et al., 2010). No studies comparing interventions for CS pain have 
included these psychosocial factors or how pain may interfere with maternal 
function during the days and months following CS. This is despite observational 
studies that found CS pain is associated with breastfeeding difficulties (Zanardo et 
al., 2010), reduced maternal mobility (Chin et al., 2014), poor emotional health 
(Eisenach et al., 2008) and chronic pain (Nikolajsen et al., 2004; Sng et al., 2009). 
Moreover, no comparative studies have sought to associate CPSP after CS with the 
development of depression or changes in the quality of pain. For this research, the 
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literature supports the view that many BPS factors may influence pain outcomes 
following CS.  
 
A fundamental position of the BPS model of pain is that the model may be used to 
design pain interventions that integrate various strategies to enhance analgesia 
(Turk et al., 2010). Biological interventions have been extensively evaluated for CS 
pain but most have focused on the first 24-hour postoperative period (Booth et al., 
2016; Heesen et al., 2015; Larsen et al., 2015). While interventions such as 
intrathecal local anaesthetic with morphine included are necessary and effective for 
most women (NICE, 2011), the degree of analgesia diminishes after 12 hours 
(Hindle, 2008) resulting in the need for supplementation with oral opioids. There is 
little evidence regarding the most appropriate strategies to improve pain 
management with oral opioids the day after CS. 
 
The BPS model of pain informed an exploration of how a NP approach to 
management may improve analgesia following CS. This approach to pain 
management establishes a supportive relationship, uses pain education strategies, 
enables a greater degree of control and commences opioid therapy with IR 
oxycodone to hasten analgesia and early mobilisation (Analgesic Expert Group, 
2012; Jensen et al., 2015; Mander & Murphy-Lawless, 2013; McNeill & Jomeen, 
2010; Mosely & Butler, 2015; Turk et al., 2010; Turk & Okifugi, 2002). No studies 
have integrated any of these strategies to enhance pain management following CS. 
Researchers have attempted to improve pain management by supporting women to 
self-medicate but the results have not demonstrated benefit over midwife 
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administration (Bonnal et al., 2016; East et al., 2007; Snell & Hicks, 2009). No 
studies have compared IR oxycodone to CR oxycodone after CS that appears to be 
common practice in some facilities (Dieterich et al., 2012; Seaton & Reeves, 2009; 
Zhong et al., 2014). Only two studies have evaluated the effectiveness of IR 
oxycodone following CS but the comparisons were made to PCA and intrathecal 
morphine (Davis et al., 2006; McDonnell et al., 2010). No studies have challenged 
the practice of CR oxycodone for step-down analgesia following intrathecal 
morphine.  
 
This literature review has also provided justification for a follow-up study of CPSP 
after CS. A follow-up study was necessary because poor postoperative analgesia 
has been associated with CPSP (Niklasson, Ohman et al., 2015; Nikolajsen et al., 
2004; Sng et al., 2009). The review showed that there are inconsistencies in the way 
CPSP is described and the burden it places on women. Prospective evaluation 
appears to be a more reliable method for evaluating the prevalence and burden 
(Bonnal et al., 2016; Lavand’homme, 2013; Niklasson, Ohman et al., 2015). Across 
various surgical models, CPSP may be largely due to psychosocial factors 
(Masselin-Dubois et al., 2013) and so a BPS approach is required to explore the CS 
experience after discharge from hospital.  
 
Pain the day after CS remains a serious clinical problem (Gerberschagen et al., 
2013; Marcus et al., 2015). Attempts to improve pain management following CS 
have focused on the immediate postoperative phase and many invasive 
interventions are either too cumbersome to sustain analgesia past the first 
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postoperative morning or, like intrathecal morphine, analgesic effects have 
diminished. Another deficiency in many studies on CS pain interventions is the lack 
of attention given to psychological and social factors, reminiscent of a biomedical 
approach to research. In contrast, this research was based on a BPS approach and, 
therefore, it considered all components of the BPS model of pain in the research 
design. This research will have important implications for the evaluation of pain in 
the acute pain setting because it brings the BPS model out of the domain of chronic 
pain. As the overarching framework for this study, the assumptions of the BPS 
model of pain have driven a broad method of inquiry into the CS pain experience. 
Thus, the review has uncovered key factors that have not been considered when 
comparing interventions for CS pain.
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Chapter 4: Research Design and Methodology 
4.1 Introduction 
The RCT reported upon here compared two treatment approaches to pain in the 
context of diminished opioid analgesia from intrathecal morphine the day after CS. 
The trial was registered with the Australian and New Zealand Registry of Clinical 
Trials (Registration: ACTRN12613000076774) and ethical approval to conduct the 
study was obtained from the hospital and university human research ethics 
committees (Appendix C). Site approval for the project (SSA/13/QWMS/19) was 
granted by the Executive Officer of the hospital and access to the medical records 
of participants was granted by the Data Custodian. The hospital where the research 
was undertaken sponsored the trial with resources such as printing, recruitment, 
standard anaesthetic intervention, time for the NP intervention and collection of 
data. Extra funding was provided by the Australian College of Nursing to employ 
research assistants (RAs) to calculate opioid analgesic doses and to conduct 
telephone interviews in the exploratory follow-up study. 
 
The two-group parallel RCT compared a NP intervention to a standard prescription 
of CR oxycodone the day after CS. A follow-up study aimed to explore the 
experience of pain and how pain impacts on maternal health three months after CS. 
Thus, two research questions formed the platform for the methodology: 
 
1. Does a NP intervention result in improved analgesia the day after CS when 
compared to standard management with CR oxycodone?  
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2. What is the experience and nature of postsurgical pain over three months 
following CS? 
 
4.2 Research Setting 
The health service district encompasses a large geographical area in South East 
Queensland and lies West of Brisbane. Over one quarter (26.8%) of the population 
of approximately 316,000 persons were born outside of Australia and 13.0% can 
speak a language other than English (Australian Bureau of Statistics, 2016). 
Aboriginal and Torres Strait Islander peoples comprise only 3.6% of the district 
population (Australian Bureau of Statistics, 2016). Almost half of all persons over 
the age of 15 (49.3%) have an education qualification higher than a high school 
certificate (Australian Bureau of Statistics, 2016). The fertility rate for women in 
the district is 2.3 births compared to 1.8 for the Australian population (Australian 
Bureau of Statistics, 2016). Births in this district from 2014 to 2015 accounted for 
6.7% of births in the State (Queensland Health, 2015b). In Queensland, the CS rate 
is over 30% of all births (Queensland Health, 2015b). 
 
The clinical setting for this research was a metropolitan public hospital in 
Queensland, Australia. Outpatient facilities exist for the prenatal care of women by 
midwives and medical staff. The maternity service also has a 12-bed birth suite and 
34 bed postnatal unit where participants are admitted prior to surgery. The hospital 
is a major referral centre for surgery and is equipped with an intensive care unit. 
Acute pain service staff consisting of specialist nurses, a NP and medical staff 
review all women after CS on the first postoperative morning. The NP who 
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administered the intervention in this study did not participate as a member of the 
acute pain service for the routine review after 8:00 hours the morning following 
CS. 
 
4.3 Participants 
4.3.1 Inclusion Criteria 
Eligible women were required to be at least 18 years of age and scheduled for 
elective CS. Only English speaking women were considered for inclusion because 
of the requirement to complete questionnaires that were only printed in English. 
Also, the follow-up study required a telephone interview with RAs who could speak 
English only. 
 
4.3.2 Exclusion Criteria 
Exclusion criteria included contraindications to spinal analgesia and a history of 
any type of chronic pain, opioid tolerance or substance abuse. Potential participants 
were also excluded if they stated adverse reactions to any drugs or interventions 
planned for use in the trial such as intrathecal morphine and oral analgesics. A final 
exclusion criterion was where a woman had a current herpes simplex viral infection 
as concomitant administration of intrathecal morphine may result in spread of the 
infection. 
 
4.3.3 Sample Size Calculation 
A sample size was calculated using G*Power version 3 based on the ability of an 
independent samples t-test to detect a mean difference of 10 mm on a 0-100mm 
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VAS between two groups. The standard deviation used in the calculation was 18 
mm reported in previous RCTs on the use of oral oxycodone after CS (Davis et al., 
2006; McDonnell et al., 2010). A confidence level of 95% (p < .05) and power of 
80% were used. The calculation gave a sample size of 104, that is, two equal groups 
of 52 women. The sample size was increased by 15% to address the possibility that 
non-parametric statistics might have to be used because of non-normality of the 
dependent variable. A further increase of 10% was calculated to allow for attrition, 
giving an overall sample size of 130 participants.  
 
4.3.4 Recruitment 
The sample was recruited from a prospective list of 298 elective CSs booked from 
July 2013 to December 2014. As principal investigator, the NP identified potential 
participants in the booking record of scheduled CSs. Following an initial telephone 
call, women who indicated a willingness to participate were mailed trial 
information and consent forms. After signing a consent form, participants 
completed self-report baseline measures. The NP collected all forms and stored 
them securely with the master participant list in a locked office during the study.   
 
4.4 Randomisation 
An independent researcher who was not involved in the trial created the 
randomisation sequence using a table of random numbers processed on a computer. 
This randomisation sequence was accessible to a RA who was not involved in the 
trial. The RA, the only person who had access to this sequence, prepared the 
envelopes with the group allocation concealed inside and sequence number written 
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on the front. This concealment of group allocation was based on the SNOSE 
(sequentially numbered opaque sealed envelopes) technique. Each sequentially 
numbered envelope contained the treatment group allocation and instructions that 
remained concealed until given to the medical practitioner assigned to provide 
anaesthesia on the day of surgery. The sequential number corresponded to the 
research participant number on the master list (allocation ratio 1:1). 
 
4.5 Blinding 
Blinding in this study was a difficult task given the design of the intervention that 
integrated drug and non-drug strategies for pain management and there were no 
funds available at the time for the creation of sham tablets of oxycodone. However, 
various aspects of the study involved blinding of participants, the NP and RAs. The 
SNOSE process blinded anaesthetists and other perioperative staff until the 
envelopes were opened prior to surgery. SNOSE also blinded the NP to treatment 
allocation until the intervention commenced the day after surgery. Although some 
participants may have known about their treatment plan in the operating theatre, 
their beliefs about analgesics and pain management may not have been influenced 
prior to this time due to lack of knowledge about allocation. That is, without 
knowledge of the allocation, other clinicians and support persons could not have 
influenced participants at least until admission to the operating suite. For the 
follow-up study three months after CS, RAs who conducted the telephone 
interviews were blinded to treatment allocation and only the sequence number was 
placed on the completed questionnaires. 
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4.6 Baseline Data 
Prenatal phase data included age, ethnicity, level of education, parity, gestation in 
weeks, previous CSs, body mass index and history of depressive illness. Pre-
intervention consumption of oxycodone and tramadol within six hours of the 
commencement of the intervention was recorded as was the dose and time of 
administration of intrathecal morphine. The surgical approach was also recorded in 
the baseline data because the type of approach can affect pain intensity following 
CS (Hofmeyr, Novikova, Mathai & Shah, 2009; Kisielinski et al., 2004; Loos et al., 
2008; NICE, 2011).  
 
4.6.1 Pain Catastrophising Scale 
The Pain Catastrophising Scale (Sullivan et al., 1995) was used to screen for 
catastrophic thoughts prior to admission to hospital. The pain catastrophising scale 
(PCS) is a thirteen-item scale and participants recorded a categorical score about 
statements linked to thoughts or feelings when experiencing pain or past painful 
experiences (Sullivan et al., 1995). Each statement was rated on 5-point sub-scales 
from 0-4 and total scores were calculated for the 13 statements as well as the three 
dimensions of catastrophising that included: rumination (worry and inability to 
inhibit thoughts about pain), magnification (expectations and worrying about a 
negative outcome), and helplessness (perception of inability to cope with pain) 
(Sullivan, 2009; Sullivan et al., 1995). During the development of the PCS, validity 
and reliability testing was undertaken and the results demonstrated that pain 
catastrophising was correlated with depression (r= 0.26), anxiety (r= 0.32) and fear 
of pain (r= 0.80) (Sullivan et al., 1995).  The scale also exhibited a high degree of 
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temporal stability (r= 0.70) over a period of 10 weeks and was correlated with pain 
intensity from ice water immersion (r= 0.33) (Sullivan et al., 1995). A total PCS 
score greater than 16-17 out of a total of 52 may be predictive of more postoperative 
pain (Olsson, Grooten, Nilsson-Wikman, Harms-Ringdahl, & Lundberg, 2012; 
Riddle, Wade, Jiranek & Long, 2010). Olsson and others used the PCS to determine 
the incidence of postpartum pain and disability after childbirth (Olsson et al., 2012). 
 
4.6.2 Edinburgh Postnatal Depression Scale 
The presence of prenatal maternal depression was also measured prior to 
hospitalisation by a total score from the EPNDS (Cox, Holden & Sagovski, 1987). 
The total score was collected from the medical record. The EPNDS is a widely used 
screening tool for anxiety and depression (Cox et al., 1987; Rowe et al., 2008; 
Swalm, Brooks, Doherty, Nathan & Jaques, 2010) and contains ten items that are 
scored in a range of 0-3 with higher scores signifying emotional distress and one 
item indicating if the participant has suicidal thoughts. A total score over greater 
than 13 requires intervention and the likelihood of clinical depression is high (Cox 
et al., 1987). The validity and reliability of the scale has been established in 
worldwide populations and is endorsed in Australia as a national guideline for 
screening women for depression (Hayes, 2010). The validity and reliability of the 
tool was demonstrated by comparing it with other depression scales during and after 
pregnancy (Ji et al., 2011). It has not been used as a baseline measure or a 
postoperative outcome following CS. A systematic review of validation studies 
found that scores greater than eight were needed to predict depressive symptoms 
(Gibson, McKenzie-McHarg, Shakespeare, Price & Gray, 2009). 
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4.7 Primary Outcome 
The visual analogue scale (VAS) was used to evaluate pain intensity where the 
participant marked a 100 mm line with the anchors ‘no pain’ and ‘the worst pain 
imaginable.’ The validity and reliability of the VAS in clinical research has been 
well established (Breivik et al., 2008; Kahl & Cleeland, 2005; Moore, Edwards, 
Barden & McQuay, 2003). The advantage lies in the ability to detect differences on 
a ratio scale and in being more sensitive than the categorical and numerical rating 
scales due to the higher number of responses available (Jensen & Karoly 2011; Kahl 
& Cleeland, 2005). In this study, VAS pain scores were assessed at rest and on 
sitting or movement. For the first four hours, pain on sitting was described as pain 
on moving to a sitting position the first morning following CS. The study was 
powered to test for differences between the two groups in terms of pain intensity 
over time (repeated measures). Prior to photocopying questionnaires for 
dissemination to participants, the length of each 0-100mm VAS was verified with 
a metric ruler. 
 
4.8 Secondary Outcomes 
4.8.1 Patient Global Impression of Change 
Measurement of pain using a categorical rating of change in pain due to an 
intervention may be equally important as the evaluation of raw pain intensity scores 
on VASs (Farrar, Polomano, Berlin & Strom, 2010). The PGIC scale was 
completed over the first four hours starting one hour after the first scheduled dose 
of oxycodone administered the day after CS. The PGIC is a seven-item categorical 
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scale designed to evaluate pain relief over time (O'Connor & Dworkin, 2011). 
Categories range from ‘very much worse’ pain to ‘very much improved’. The PGIC 
scale is recommended for use in clinical pain trials (O'Connor & Dworkin, 2011). 
This scale has been validated by comparison with 0-100mm VAS and pain intensity 
difference (PID) scores demonstrating consistency with changes in these scales 
(Farrar et al., 2010). Some experts have criticised the use of 0-100mm VAS scores 
for evaluating pain intensity because participant responses can be highly variable 
(Farrar et al., 2010). Some studies have shown that a reduction in VAS pain scores 
was associated with participants rating pain as ‘much improved’ or ‘very much 
improved’ on the PGIC scale (Mehta, Bucior, Bujanover, Shah & Gulati, 2016). 
One study noted that 22% of participants reported ‘much improved’ or ‘very much 
improved’ pain relief while not achieving greater than 30% reduction in pain 
intensity (Mehta et al., 2016). A validation study on patients with fibromyalgia 
(Geisser et al., 2010) demonstrated that improved pain intensity on a 0-10 VAS was 
correlated with improved ratings on the PGIC scale (r= 0.63). Another study on 
persistent back pain stated a lower correlation between these factors (r= 0.49) but 
the results also suggested that improved global impression is predictive of pain 
reductions greater than 20mm on a 0-100mm VAS (Elfving, Lund, Luning-
Bergsten & Bostrom, 2016). In the acute pain setting, the PGIC scale was used to 
measure differences in analgesia comparing oral IR and CR tramadol (Park et al., 
2015). Global measures of pain relief are now assuming greater importance in 
clinical pain trials (Dworkin, Turk, McDermott et al., 2009). They are 
recommended for evaluating pain interventions for postoperative pain and can be 
more responsive to treatment effects than pain intensity scores (Jensen, Martin & 
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Cheung, 2005). No studies have used this scale to measure the effects of an 
intervention for CS pain. 
 
4.8.2 Patient Global Assessment of Pain Management 
As a new outcome measure of treatment effect following CS, global categorical 
ratings of the quality of pain management were recorded by participants at 20:00 
hours on the first postoperative night. Global assessment of pain management is a 
one-item categorical scale that provides an overall rating of the quality of pain 
management interventions. The categorical rating consists of poor, fair, good, very 
good or excellent (Rothman, Vallow, Damaraju & Hewitt, 2009). It evaluates 
perceptions of the value of one intervention over another and, as a single question, 
may capture dimensions of pain that cannot be extracted from pain intensity scores 
alone (Rothman et al., 2009). Patient global assessment (PGA) of pain management 
has been validated as a research tool for postoperative pain. Several studies have 
supported content and construct validity for the PGA question in postoperative pain 
research (Farrar et al., 2010; Grond et al., 2007; Rothman et al., 2009). A review of 
150 trials demonstrated that the PGA scale had strong correlation with at least 50% 
total pain relief derived from hourly measurements of pain intensity (Collins, 
Edwards, Moore, Smith & McQuay, 2001). In one validation study on 
postoperative pain, participants reported different interpretations of the meaning of 
the scale in terms of whether it referred to pain intensity, ease of the method of pain 
relief or control over administration (Rothman et al., 2009). The study did report 
that good to excellent ratings were associated with 2.1 to 3.9 reductions in pain 
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intensity on 0-10 VASs (Rothman et al., 2009).  The validation study did not report 
statistical data to support these figures. 
 
4.8.3 Pain Interference 
The Modified Brief Pain Inventory (BPI) Short Form (Akyol, Karayurt & 
Salmonds, 2009) evolved from the original BPI (Cleeland & Ryan, 1994) and was 
used as a measure of pain interference. Participants completed this scale at 20:00 
hours on the first postoperative evening and circled numerical scores from 0-10 for 
the interference of pain on eight functional variables such as relationships, 
performance of social roles and physical function (Akyol et al., 2009; Zalon, 2006). 
The impact of pain on coughing, breathing and concentration have established 
validity and reliability against pain intensity as additions to the items in this study, 
while effects of pain on work or school were eliminated, making the modified BPI 
suitable for use in the context of postoperative pain (Akyol et al., 2009; Atkinson 
et al., 2010; Chen et al., 2010; Zalon, 2006). In a study on participants with 
osteoarthritis (Mendoza, Mayne, Rublee & Cleeland, 2006), increased pain 
intensity was consistent with higher scores for the impact of pain on activity and 
mood (Cronbach’s Alpha= 0.86-0.96). Prior to this research, the modified BPI was 
used to compare two interventions for CS pain (McDonnell, 2009). 
 
4.8.4 Pain Quality 
This is the first RCT to use the SF-MPQ-2 (Dworkin, Turk, Revicki et al., 2009; 
Katz & Melzack, 2011) to determine the quality and corresponding intensity of pain 
after CS. This research tool includes VAS scales for 22 items that state pain 
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qualities such as ‘throbbing’ or ‘piercing’.  It is sensitive to changes in treatment in 
a wide variety of situations, including neuropathic and acute postoperative pain, 
and validity and reliability has been well established (Fabbri et al., 2009; Katz & 
Melzack, 2011). The SF-MPQ-2 has been shown to be more discriminatory in 
regard to neuropathic and non-neuropathic pain descriptors which may make it 
useful in determining the nature of CPSP after CS (Katz & Melzack, 2011; 
Melzack, 1987). It was developed as an improvement on the first version through 
the addition of seven symptoms relevant to neuropathic pain and by adding a 0-10 
numerical scale to each item to increase responsiveness. The seven items included- 
dull, electric shock, cold-freezing, pain caused by light touch, itching, tingling or 
pins and needles, numbness, squeezing-pressure and piercing (Dworkin, Turk, 
Revicki et al., 2009; Katz & Melzack, 2011). The objective of the development of 
the SF-MPQ-2 was to provide a tool that would account for the symptoms of both 
neuropathic and non-neuropathic pain, rendering the instrument appropriate for the 
existence and measurement of chronic post-surgical pain (Breivik et al., 2008). 
When compared with the PGIC scale, less pain on the SF-MPQ-2 was strongly 
associated with improved global ratings after treatments for chronic pain (Dworkin, 
Turk, Revicki et al., 2009).  
 
4.8.5 Perception of Control over Pain Management 
Three 0-100mm visual analogue scales were used to assess personal control over 
pain management in childbirth. These were adapted from 0-10cm VAS items used 
in a study on the relationship between perceived control over pain management and 
satisfaction with the childbirth experience (McCrea & Wright, 1999). Participants 
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marked scales for their perception of who controlled pain management (either 
themselves or staff), the degree of perceived personal control and the degree of 
perceived staff control. As noted by McCrea and Wright, the items are single 
discrete scores on each scale and the direction of the degree of maternal control on 
some scales is different to others (McCrea & Wright, 1999). Similarly, the first and 
last questions on perceived control in this research (Appendix B) would reflect a 
higher degree of maternal control as participants marked toward the left of the scale, 
whereas the other scale assessing the degree of maternal control reflected greater 
control if they marked toward the right of the scale. Scales to measure perception 
of control in childbirth situations have been used in previous research (Ford & 
Ayres, 2008) but these have not been used to compare pain interventions for CS 
pain. 
 
4.8.6 Consumption of Opioid Analgesics and Adverse Effects 
Measuring consumption of opioids is standard in clinical trials in acute pain 
management and has been evaluated in many studies on treatment interventions. 
This research measured the doses of oral oxycodone and tramadol consumed by 
participants from 8:00 hours the day after CS until 12:00 hours on the second 
postoperative day. Opioid-induced nausea, pruritus and perceived drowsiness were 
evaluated using 0-100mm VAS scores with the anchors ‘none’ to ‘intolerable’. 
Similar VAS scales have been used in trials evaluating side effects after CS 
(McDonnell et al., 2010). Other data recorded included the use of anti-emetic and 
anti-pruritic medication during this period. Medical records were also 
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retrospectively screened for the incidence of decreased level of consciousness, 
increasing sedation and requirement for drugs to treat nausea or pruritus. 
 
4.9 Follow-up Study- The Graded Chronic Pain Scale (Version Two) 
In this research, the Graded Chronic Pain Scale (GCPS) - Version Two (Von Korff, 
2011) was used for the first time to determine pain intensity and disability three 
months after CS. Recall of pain over three months using this scale have 
demonstrated consistency with diary entries over the same period (r= 0.80) (Von 
Korff, 2011). Recall of the number of days in pain were not as highly correlated (r= 
0.67) (Von Korff, 2011). This eight-item scale allows for evaluation of pain 
intensity, pain interference and pain persistence by providing numerical rating 
scores from 0-10 (Von Korff, 2011). Three items for pain intensity give a score out 
of thirty and disability scores are also included to determine a score ranging from 
0-40. The end-point of the calculation provides a grade for chronic pain and 
disability ranging from Grade I (low intensity and interference) to Grade IV (severe 
pain interference). The tool has been used in diverse populations with tested validity 
and reliability and demonstrates that pain is associated with poor functional 
outcomes (Von Korff, 2011). Original development and testing of the scale 
demonstrated that pain intensity greater than 50mm on a 0-100mm VAS was 
required to be correlated with moderate disability but that scores greater than 70mm 
made little difference to the level of disability (Von Korff, Ormel, Keefe & 
Dworkin, 1992). The follow-up study also involved the collection of data with 
repeated measures using the EPNDS and the modified BPI. 
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4.10 Study Procedures 
4.10.1 Care given to all participants 
In the prenatal phase, participants attended a clinic one week prior to surgery. They 
were reviewed by the surgical team, midwives and anaesthesia medical staff who 
explained the benefits and risks of intrathecal analgesia. There was no standard 
material available for pain education and discussion of pain management was at the 
discretion of the various clinicians involved.  
 
When transferred to the operating suite for surgery following admission to hospital, 
the anaesthesiology director arranged for all participants to be administered 
intrathecal hyperbaric bupivacaine and opioids (morphine 100mcg and fentanyl 
20mcg) for anaesthesia prior to surgery. During the CS, one gram of paracetamol 
was administered by the intravenous route and 40 mg of intravenous parecoxib was 
also administered. In addition, oral paracetamol (one gram) was prescribed four 
times per day for three days commencing at 18:00 hours on the day of CS and oral 
ibuprofen (400 mg) three times per day for three days commencing at 08:00 hours 
on the first postoperative day. Adherence to this protocol was monitored by the NP 
and there were no breaches of protocol except for minor differences in the dose of 
intrathecal morphine for a few participants. These breaches are reported in the 
following chapter and occurred because some anaesthetists refused to comply with 
the protocol requested by their director. Some of these participants received a bigger 
dose of intrathecal morphine and some were not given morphine. These participants 
were included in the research because of the intention to treat principle as they had 
already consented and been admitted to the study. 
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On the morning after CS, all participants were seen by nurses and medical staff 
from the acute pain service. Throughout the research, the NP was not involved in 
this consultation. Routine acute pain service care consisted of: (1) focused 
neurological assessment in relation to recovery from intrathecal anaesthetic, (2) 
assessment of pain intensity at rest and on movement using a verbal rating scale 0-
10, (3) assessment of side effects related to intrathecal morphine such as nausea and 
itching, and (4) advice regarding the availability of IR oxycodone and tramadol for 
breakthrough pain.  
 
4.10.2 Intervention 
The intervention design was based on the BPS model of pain and the research 
literature. A NP approach to pain management was formulated to provide an 
integrated approach which recognises the uniqueness of each individual and that 
pain interventions have multiple components (Jensen et al., 2015; Mosely & Butler, 
2015; Turk & Okifugi, 2002). This approach also marks a shift in thought regarding 
the design of pain interventions for acute pain as multidimensional interventions 
are more likely to produce better outcomes than those based on a one-size-fits all 
approach (Bennell et al., 2012; Turk et al., 2010). The NP intervention for CS 
integrated treatment with oral oxycodone alongside supportive education about 
pain management and analgesic therapy for CS. The BPS model assumes that these 
integrative components can affect pain perception and are inseparable (Gatchel & 
Maddrey, 2004). 
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At 7:50 hours the day after CS, the NP attempted to create a supportive relationship 
by engaging participants in a general discussion relating to their CS experience. 
The session lasted for approximately 10 minutes and the content included an 
explanation of the schedule of IR oxycodone with prescribed doses at 8:00 hours 
(10mg), 14:00 hours (5mg) and 20:00 hours (5mg). The NP discussed participants’ 
beliefs about pain, preferences for pain management and analgesics used for CS 
pain. The discussion also aimed to identify any misconceptions participants had 
regarding the pharmacology and safety of analgesic therapy and to provide 
education to address any of these issues. It was conveyed that scheduled oxycodone 
doses could be refused and that participants could request oxycodone or tramadol 
at times decided by them. Additional doses of IR oxycodone and IR tramadol were 
prescribed separately to the scheduled doses and were always available to 
participants. 
 
Another key component of the intervention was to discuss the effectiveness of IR 
oxycodone and how it could lessen pain interference on sitting up, mobilising and 
caring for a newborn if participants waited approximately one hour for a dose to 
reach peak analgesic effect. It was explained that IR oxycodone achieves more rapid 
analgesia because it reaches highest plasma concentration in one hour (Aspen, 
2015). Hence, the NP suggested at the conclusion of this first interaction that pain 
and pain interference could be reduced because of the anticipated time to maximum 
concentration that would coincide with sitting or moving.  
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The final stages of the intervention involved follow-up of participants throughout 
the day at 11:00 and 14:00 hours.  The NP assessed participant reports of pain using 
a 0-10 verbal rating scale and, if analgesia was inadequate, options for pain relief 
were discussed. Each review lasted approximately 5-10 minutes. The intervention 
is summarised in Table 6. 
 
Table 6 
NP Intervention the day after CS 
Stage NP Intervention and Therapy Goals 
NP Review 
7:50-8:00 
The NP discussed pain management with the participant and the 
discussion included: 
▪ CS experience. 
▪ Beliefs about analgesics and pain. 
▪ Preferences for analgesics. 
▪ Explanation of scheduled doses of oxycodone and the right 
to refuse. 
▪ Availability of unscheduled IR oxycodone or IR tramadol on 
request. 
▪ Explanation of the pharmacology of IR opioids and how to 
reduce pain interference. 
Midwives administered 10mg of scheduled oral IR oxycodone at 
8:00 hours unless refused. 
Goals of stage one: 
1. Create a supportive relationship with the participant. 
2. Address concerns and misconceptions regarding analgesics. 
3. Enable greater control over pain management. 
4. Establish the link between analgesia & attainment of 
maternal functional goals. 
5. Reduce pain and pain interference. 
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NP Review 
11:00-11:10 
The NP followed up the intervention by: 
▪ Assessing pain intensity on a 0-10 verbal rating scale. 
▪ Discussing concerns about pain management. 
▪ Explaining options for pain relief. 
Goals of stage two: 
1. Determine the individual’s response to the pain management 
plan and enable modification through a discussion about 
access to analgesics or changes prescribed by the NP. 
2. Enable greater control over pain management. 
NP Review 
14:00-14:10 
 
The NP assessed the participant’s response to therapy by: 
▪ Assessing pain intensity on a 0-10 verbal rating scale. 
▪ Discussing concerns about pain management.  
▪ Explaining options for pain relief. 
Midwives administered 5mg of scheduled IR oxycodone unless 
refused. 
Goals of stage three: 
1. Determine the individual’s response to the pain management 
plan and enable modification through a discussion about 
access to analgesics or changes prescribed by the NP. 
2. Enable greater control over pain management. 
20:00 Midwives administered 5mg of IR oxycodone unless refused. 
 
4.10.3 Standard Conditions (Control Group) 
The control group was prescribed a standard postoperative dose of 10 mg of CR 
oxycodone commencing at 08:00 hours the day after surgery and continuing every 
12 hours for two days. This group did not receive follow-up care by the NP as this 
was not standard care. Participants did receive, however, routine review by the pain 
management service. During the course of the trial, a new formulation of CR 
oxycodone became available and was administered to the last 30 participants 
 130 
randomised to normal care.  However, the bioavailability data supplied by the 
manufacturers was close to the original formulation and so was not expected to 
influence the outcomes.  
 
4.11 Data Collection 
There were several phases to the collection of data for the study (Figure 2). 
Following consent, the NP collected baseline measures including demographic and 
clinical data from the medical record. Beginning at 8:00 hours the morning after 
CS, participants began completing the postoperative questionnaire. Midwives were 
trained prior to the research to assist participants with these tasks. The midwives 
were instructed by the researcher to explain to participants how to use all the scales 
in the postoperative questionnaires. Scores for pain intensity and PGIC were 
charted every hour until midday when participants also completed the SF-MPQ-2. 
On the same evening at 20:00 hours, participants charted numerical scores for pain 
interference and opioid-induced side effects. Finally, scores for pain on the second 
day were marked at 8:00 hours, followed by VAS scores of perceptions of control 
over pain management. One RA carried out retrospective chart audits of 
postoperative analgesic consumption measured by weight of drug. The RA also 
examined the observation charts for the incidence of decreased level of 
consciousness and requirement for drugs to treat opioid-induced side effects. Two 
RAs were employed to conduct telephone interviews with consented participants 
three months after the date of surgery. The RAs were blinded to treatment allocation 
and the questionnaire containing study measures was completed by the RAs who 
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circled participant answers. Each questionnaire was sequentially numbered to 
match the RCT allocation sequence. 
 
Figure 2. Data collection timeline for participant responses. 
 
4.12 Data Analysis 
Prior to analysis, a data cleaning process occurred to ensure the integrity of the data 
in relation to the original participant responses. The IBM SPSS Statistics version 
22 (IBM Corporation, Armonk, NY, USA) was used for data analysis. A statistician 
from the Institute of Health and Biomedical Innovation (Queensland University of 
Technology) was engaged in the process. 
 
4.12.1 Preparation and Verification of Data 
A RA obtained a random sample of 30 questionnaires from the postoperative and 
follow-up phases. The RA checked each questionnaire against the corresponding 
entries for the cases on the SPSS spreadsheet. Each VAS was measured with a 
metric ruler again by the RA to verify the scores entered. Tests were also conducted 
to identify outlier values and check them against the original questionnaires for 
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integrity. For missing cases in this study, a value of -1 was assigned and entered 
onto the SPSS spreadsheet. This was to ensure missing values were not included in 
statistical calculations. Patterns of missing data for the independent variables in the 
follow-up study were analysed by binary logistic regression to determine if data 
was missing completely at random. None of the variables predicted missing data. 
 
4.12.2 Analysis of Baseline Data 
Descriptive statistics were produced for all baseline data, either numerical, nominal 
or categorical. Numerical data was presented as means plus or minus standard 
deviations for the intervention and control groups and statistical differences were 
determined by independent samples t tests. Categorical data was analysed by Chi 
Square analysis. 
 
4.12.3 Primary Outcome Analysis 
Descriptive statistics for pain scores at rest and on sitting (8:00-12:00 hours) and 
for rest and moving (8:00 hours on the second morning) were tested for normality 
of distribution. There was a high degree of skewness and/or kurtosis in many 
instances and so pain scores at rest and on sitting/moving were tabulated as median 
values and interquartile ranges for all points in time. For more complex analysis, a 
mixed models method was applied because it is appropriate for determining 
associations between multiple variables, particularly for responses that display a 
wide pattern of variation (Demidenko, 2013; Shin, 2009). Mixed models analysis 
is also more suitable than repeated measures ANOVA as the analytical methods are 
more tolerant of missing data (Demidenko, 2013; Shin, 2009). This method was 
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important to this research because it retained the desired sample size as opposed to 
ANOVA which discarded a case if there was any missing data in a row 
(Demidenko, 2013; Shin, 2009). Mixed models analysis is an advanced form of 
ANOVA that is less influenced by missing data and large variations in outcome 
data (Cleophas, Zwinderman, Cleophas, & Cleophas, 2009).  
 
For this research, the following steps were undertaken in the mixed models 
analysis: (1) VAS scores were divided into three splines in order to address the non-
linearity of the mean response curves for pain at rest and on sitting and moving; (2) 
Random intercepts and random coefficients were calculated for each case; (3) 
Splines one, two and three were included in random effects models (see Appendix 
D) and only spline one showed little variance for pain at rest and on sitting or 
moving; (4) All independent variables (see Appendices E and F) were added by 
step-wise addition to the fixed regression models. Allocation plus the interaction of 
allocation and spline one were included in both fixed models; (5) For both resting 
pain and pain on sitting or moving, splines two and three displayed great variability 
in terms of participant response and were not included in the fixed effects models; 
(6) Independent variables were discarded from the models if their step-wise 
addition resulted in a p value greater than or equal to 0.2.  
 
4.12.4 Analysis of Patient Global Impression of Change 
The PGIC score was analysed by binary logistic regression. The PGIC score was 
originally a seven-point Likert Scale. It was collapsed to a binary categorical 
variable (responder/non-responder) due to low cell numbers in many cells of the 
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seven-point scale. Responders were those who rated pain relief as 'much improved' 
or 'very much improved' and every other response was classified as a non-
responder. The PGIC scores collected at 09:00, 10:00, 11:00 and 12:00 hours were 
analysed. Binary logistic regression controlled for confounders so all baseline 
variables were added initially to regression models by step-wise addition and 
discarded if the resulting p value was greater than or equal to 0.2.  
 
4.12.5 Analysis of Patient Global Assessment 
Descriptive values for each category of response were tabulated. Given low cell 
counts for some variables in the PGA, those who reported 'very good' or 'excellent' 
pain management were categorised into responders and others were categorised as 
non-responders. PGA was analysed using chi-square analysis. 
 
4.12.6 Analysis of Pain Interference 
Each item for the modified brief pain inventory was analysed for normality of 
distribution of 0-10 numerical scores. Due to many items not demonstrating normal 
distribution, the differences between the control and intervention groups were 
analysed by Mann Whitney U Tests. Numerical scores were thus presented as 
median values and interquartile ranges. A total score of all items was calculated for 
total pain interference and analysed in a similar fashion. 
 
4.12.7 Analysis of Quality of Pain 
Composite scores were calculated for qualities of pain as per the SF-MPQ-2. The 
four domains for pain quality are: (1) Continuous pain- throbbing pain, cramping, 
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gnawing, aching, heavy pain and tenderness; (2) Intermittent pain- shooting, 
stabbing, splitting, piercing, sharp and electrical pain; (3) Neuropathic pain- cold-
freezing, pain caused by light touch, pins and needles, hot-burning pain, tingling, 
itching and numbness; (4) Affective- sickening, punishing-cruel, fearful and tiring-
exhausting (Dworkin, Turk, Revicki et al., 2009). Due to many items and composite 
scores not demonstrating normal distribution, the differences between the control 
and intervention groups were analysed by Mann Whitney U Tests. Numerical 
scores were presented as median values and interquartile ranges. 
 
4.12.8 Analysis of Perception of Control over Pain Management 
VAS scores for three scales measuring perception of control over pain management 
met criteria for normal distribution. The control and intervention groups were 
compared using independent samples t tests. The group results were presented as 
means plus or minus standard deviations for the three discrete items. 
 
4.12.9 Analysis of Opioid consumption and side effects 
Consumption of oxycodone and tramadol were measured retrospectively by a RA 
and compared in terms of medians and interquartile ranges for each drug the day 
after CS and on the second postoperative day. Total opioid doses were also 
calculated for two postoperative days. The doses described in this research included 
scheduled plus additional doses of oxycodone and tramadol requested by 
participants. Along with opioid-induced side effects, Mann Whitney U tests were 
used to compare the distributions between the control and intervention groups. 
 
 136 
4.12.10 Follow-up Study Analysis 
There were 85 telephone interviews completed at three months out of the sample of 
122 participants. The 85 participants could have been representative of the complete 
sample because missing cases may have been missing completely at random. As a 
result, three-month follow-up data from the control and intervention groups were 
compared using Mann-Whitney U tests but the intent of the analyses were to also 
describe outcomes for the cohort and to create speculation on the basis of 
comparative statistics. 
 
Prior to analysing descriptive statistics and associations between variables for the 
cohort of 85 post-caesarean participants, normality of distribution for NRS scores 
were analysed. None of the 0-10 variables were normally distributed due to 
skewness or kurtosis scores outside the range of -2 to +2. Therefore, descriptive 
data was reported using median scores and interquartile ranges. Also, a grade for 
chronic pain was calculated for each participant as described in the Graded Chronic 
Pain Scale (Von Korff, 2011). Those with total pain scores less than 15 out of a 
total score of 30 and disability scores less than 17 out of 40 were categorised as 
having Grade I chronic pain. Grade II chronic pain required pain scores of 15-30 
and disability scores less than 17, while Grade III participants met criteria for 
moderate pain interference if they had total disability scores between 17-24. 
Regardless of pain intensity scores, a score greater than or equal to 25 was 
categorised as severe interference (Grade IV chronic pain and disability). 
According to Von Korff (2011), Grades II, III and IV denote clinically significant 
pain. 
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Multiple linear regression models were used to test for associations between 
perioperative variables and follow-up variables at three months. The dependent 
variables used were (1) number of days that participants experienced pain, (2) total 
pain reported using the SF-MPQ-2 and (3) total pain interference. All three 
dependent variables were log transformed because they were highly skewed. While 
these log transformations reduced skewness, scores remained outside the -2 to +2 
range. The three regression models only included independent variables with p 
values less than 0.2 (two-tailed) after bivariate analyses with each of the three 
dependent variables. In each model, remaining variables were added one at a time 
in order of increasing magnitude of p value. As each variable was added to the 
particular model, only those with p values less than 0.05 were retained in the final 
regression model. 
 
4.13 Ethical Considerations and Limitations 
The National Statement for the conduct of human research was used as a guide to 
the preparation of the submission for ethical approval (NHMRC, 2007). This study 
was a phase four clinical trial approved by the West Moreton Health Human 
Research Ethics Committee as well as the Queensland University of Technology 
Human Research Ethics Committee (Appendix C). The ethical approval process 
identified several key issues to decrease risk to participants in the study. For 
instance, there was potential for Aboriginal and Torres Strait Islander people to 
present for CS in this facility. If a participant of this origin was recruited into the 
sample, the hospital indigenous liaison officer would have been consulted prior to 
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consent being attempted. In this instance, the researcher would have applied the 
core values of indigenous beliefs about healthcare in all communication and 
treatment of participants. It was also possible that potential participants may have 
been staff members, family of staff members, friends or family related to the 
principal investigator. Participants who felt uncomfortable with the trial and the 
relationship were given full opportunity to not consent or withdraw consent at any 
time.  
 
There was a potential risk of fear of sub-standard treatment if a person did not 
consent to be a part of the study. It was stated in the participant information sheet 
that consent was voluntary and that the usual care provided by the NP and acute 
pain service would remain of a high standard and not be affected by a decision to 
participate or not to participate. The researcher discussed this with all potential 
participants. There were no financial or standard of care incentives on consenting 
or not consenting. The consent information sheet explained these concepts and also 
stated that it was totally voluntary and without reimbursement or withdrawal of 
standard pain management (see Appendix C). The following information was also 
inserted into the information sheet: ‘If the pain relief you receive is not enough, the 
acute pain team will intervene at any stage after your delivery and can respond 24 
hours per day. If you decide to withdraw from the research at any time, the hospital 
and acute pain team will ensure you receive the best pain relief possible and there 
will be no disadvantage to you’. This was to allay any fear that non-participation 
could result in inadequate care. 
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Confidentiality of participant information was a major priority for this research. 
Participants' details were kept alongside hardcopy data in a locked cabinet in the 
pain service office so that contact details were available for the follow-up study. 
Upon completion of the post-discharge interview, participants' information became 
de-identifiable on data entry. De-identified SPSS records were electronically stored 
on three backup devices which were password protected. It is intended that data be 
stored for five years as per QUT data management guidelines. Hard copy data 
sheets used during the data collection process remained locked at all times when 
not being used for analysis. Primary materials are stored under secure storage until 
approval is obtained for disposal. 
 
Staff training occurred in relation to the conduct of the trial. Formal presentations 
and information were provided to clinical staff in regard to the background and 
purpose of this research, as well as the recruitment and consent processes. 
Midwifery and acute pain nursing staff were briefed on the administration of drugs 
in the trial, especially in relation to the group of participants who were prescribed 
IR oxycodone on the front of the drug chart as three once only doses. Participants 
were reminded by midwifery staff to record data on the questionnaires during the 
trial. Thus, the research protocol may have resulted in an increased workload for 
some midwives, medical staff and pain management nursing staff.  
 
Approved amendments to the recruitment process were made during the trial. 
Initially, recruitment relied on consent being obtained in the anaesthetic 
preadmission clinic by the anaesthetists in the department. This led to a low rate of 
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recruitment despite directives from their line manager and reminders from the NP. 
As a result, the researcher (NP) made an application to amend the recruitment 
process by changing the initial contact to a telephone call to potential participants, 
followed by the information and consent form being mailed to them. This change 
was approved and the recruitment process was significantly improved. Both 
hospital and university HREC committees approved all responses and amendments 
to this trial and annual reports were sent to both committees describing the flow of 
participants and that there were no adverse events during the study. As requested, 
the researcher also forwarded an interim analysis of the trial to the hospital HREC 
after 60 participants were treated. 
 
The ethics application also contained stopping guidelines in the event that the 
conduct of the trial could potentially result in harm to participants. The criteria were 
medical emergency caused by the intervention, severe intractable pain, unexplained 
pain intensity, pain unable to be managed under the NP scope of practice, persistent 
opioid-induced side effects greater than 40mm despite treatment, withdrawal of 
consent by the participant or allergic drug reaction due to trial analgesics. Grounds 
for cessation of the trial were if greater than 30% of participants reported greater 
than 40mm for drowsiness, nausea or pruritus. Prospective analysis demonstrated 
no participant complaints, no increase in adverse drug effects and no increase in 
pain from the intervention when compared to the control group (standard care). 
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4.14 Conclusion 
This research compared standard treatment for CS with a NP approach to pain 
management based on the BPS model of pain. The theoretical framework informed 
the research design by demonstrating that many factors influence pain following 
CS and these factors have biological, psychological and social components. Hence, 
the BPS model of pain informed the NP intervention and multidimensional aspects 
of the research instrumentation. In addition, the follow-up study was also driven by 
the BPS model of pain because the assumption is that pain is experienced along a 
continuum rather than at static time-points.  
 
The postoperative phase of the research involved a two-group parallel RCT 
comparing two interventions. The sample of women who underwent elective CS 
was randomised into two groups in order to equalise their baseline characteristics 
to reduce bias. Due to the complex nature of CS pain described and supported by 
the literature, a linear mixed models design was used to analyse data and control 
for confounders such as the time of intrathecal morphine dose, surgical approach, 
BMI, number of previous CSs, depression, catastrophising and various 
sociocultural characteristics. The primary outcome was pain intensity at rest and on 
sitting and moving reported on 0-100mm VASs over 24 hours. A broad range of 
secondary outcomes added depth to the study in line with the BPS model and the 
evidence on the experience of CS pain. Therefore, patient global impression of 
change, pain interference, quality of pain and maternal control over pain 
management were added to the instrumentation for the study. 
 
 142 
The prospective design was extended to include a three-month follow-up study of 
participants. This aspect drew on the BPS model of pain which was originally 
designed to explain chronic pain. This phase of the study was not powered to 
demonstrate statistically significant differences between the treatment groups. 
Rather, it was intended to describe CS pain and determine the risk factors for the 
development of CPSP in this particular cohort. This was the community phase of 
the study and its exploratory nature could be used to develop further research 
questions about the nature and impact of CS pain three months after discharge from 
hospital. 
 
A standard anaesthetic was devised for all participants in collaboration with the 
medical team under the supervision of the Director of Anaesthesia. Both groups 
received the same schedule of non-opioid analgesics and access to extra IR 
oxycodone and tramadol if required. The only intended treatment difference was 
the schedule of IR oxycodone embedded within the NP intervention. The NP 
intervention was designed to support participants who received IR oxycodone by 
explaining the pain management plan and how they could use IR oxycodone to 
reduce pain interference. The intervention was also designed to shift more control 
to participants by discussing their beliefs about CS pain and what they saw as 
appropriate management. In contrast, the control group received a standard 
prescription of CR oxycodone.  
 
Participants completed postoperative questionnaires while in the hospital phase and 
participated in a telephone interview three months after surgery. All data for this 
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research was entered onto the statistical program by the NP who collaborated with 
the university research team regarding the analysis and report of findings. The study 
was approved by the hospital and university HRECs and was registered with the 
Australian and New Zealand Registry of Clinical Trials. 
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Chapter 5: Results 
5.1 Introduction 
Study results were presented in line with the CONSORT guidelines for reporting 
randomised controlled trials (Schulz, Altman & Moher, 2010). For the follow-up 
study, the two groups of trial participants were compared and a descriptive analysis 
generated based on the whole combined sample. Some of these results also explored 
associations between BPS factors and pain outcomes. The sequence of this chapter 
commences with a description of the flow of participants in the trial followed by 
baseline data for both groups. The primary outcomes are then described prior to 
secondary outcomes. The final section presents the results of the three-month 
follow-up study and a summary of the research findings as a whole.  
 
5.2 Sample 
Of 298 eligible participants, 132 declined to participate and 35 were excluded. 
Reasons for exclusion included a history of adverse drug reaction to agents used in 
the study, age less than 18 years, non-English speaking and active oral herpes 
simplex virus. The total sample included 131 women randomised to either the 
intervention (n=65) or control group (n=66). The final sample consisted of 61 
participants in each of the control and intervention groups as four participants from 
the intervention group and five from the control group left the hospital without 
completing any of the questionnaires (Figure 3). 
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Figure 3. Consort diagram of participant flow 
 
 
 
 
Assessed for eligibility (n= 298) 
Excluded: 
 Not meeting inclusion criteria (n= 35) 
ADR=8, Oral Herpes Simplex Virus=19, 
Age<18=2, No English=6 
 Declined to participate (n= 132) 
 
Analysed (n= 61) 
 Excluded from analysis (n= 0) 
Lost to follow-up (n= 4) 
 
Reason: Did not complete questionnaire 
 
Allocated to intervention (n= 65) 
 Received allocated intervention (n= 65) 
 
Lost to follow-up (n= 5) 
 
Reason: Did not complete questionnaire 
 
 
Allocated to Control (n= 66) 
 Received allocated intervention (n= 66) 
 
Analysed (n= 61) 
 Excluded from analysis (n= 0) 
 
Allocation 
Analysis 
Follow-Up 
Randomised (n= 131) 
Enrolment 
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5.3 Baseline Data 
Baseline data was collected from the medical record and Table 7 shows the 
demographic and antenatal characteristics of the control and intervention groups. 
Both groups were similar but there were differences in parity and ethnicity. The 
control and intervention groups differed in terms of the number of previous 
deliveries (parity) and there were no nulliparous participants in the final sample. 
Over half of all participants (50.8%) underwent their second CS and there were 
slight differences in Caucasian participants, 85.2% for the control group and 98.4% 
for participants receiving the intervention. A history of depression was noted for 
5.7% of all participants and the mean scores from the EPNDS were not indicative 
of depressive illness for most participants in the preadmission phase. 
 
Table 7 
Demographic and Antenatal Data 
Measure n Control Intervention p value 
Age M (SD) 119 29.9 (5.6) 30.2 (5.9) 0.822a 
BMI M (SD) 115 34.9 (7.8) 33.9 (7.2) 0.499a 
Ethnicity 
    Caucasian 
    Other 
122  
52 (85.2%) 
9 (14.8%) 
 
60 (98.4%) 
1 (1.6%) 
0.008b 
Education 
    <High School 
     High School 
     University 
122  
5 (8.2%) 
49 (80.3%) 
7 (11.5%) 
 
5 (8.2%) 
50 (82.0%) 
6 (9.8%) 
 
0.957b 
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Depression 122 3 (4.9%) 4 (6.6%) 1.000c 
EPNDS M (SD) 113 4.4 (4.3) 4.2 (3.3) 0.790a 
PCS M (SD) 97 14.1 (11.2) 11.3 (9.9) 0.189a 
Previous CS 
    First CS 
    Second CS 
    >2 CSs 
122  
13 (21.3%) 
29 (47.5%) 
19 (31.1%) 
 
13 (21.3%) 
33 (54.1%) 
15 (24.6%) 
0.695b 
Parity 
    Nulliparous 
    Primiparous 
    Multiparous 
122  
0 (0%) 
11 (18%) 
50 (82.0%) 
 
0 (0%) 
24 (39.3%) 
37 (60.7%) 
0.030b 
Gestation 
    36-37 weeks 
    38 weeks 
    >38 weeks 
122  
8 (13.1%) 
14 (23.0%) 
39 (63.9%) 
 
4 (6.6%) 
16 (26.2%) 
41 (67.2%) 
0.468b 
a Independent samples t-test, b Chi Square Test of Independence, c Fischer's Exact 
Test. 
 
The majority of participants underwent CS by Pfannenstiel incision while smaller 
proportions in both groups experienced either a Joel Cohen or a Modified Joel 
Cohen approach to the surgery. Five participants (4%) did not receive intrathecal 
morphine and another four received higher doses than the dose directed. This was 
because some anaesthetists did not comply with the directed protocol. For the 
majority of participants, the mean time from injection of intrathecal morphine to 
8:00 hours the day after CS was 20 hours. Table 8 shows that both groups differed 
in the total dose of oxycodone administered within six hours of the start of the 
intervention and control treatments. Fifteen participants in the control group (25%) 
 149 
received oxycodone compared to five participants (8.2%) in the intervention group, 
whereas 21 participants (34.4%) in the intervention group required tramadol 
compared to 10 (16.7%) in the control group. 
 
Table 8 
Perioperative Data 
Measure n Control Intervention p value 
Surgical Incision 
    Pfannenstiel 
    Modified Joel Cohen 
    Joel Cohen 
117  
42 (75.0%) 
9 (16.1%) 
5 (8.9%) 
 
41 (67.2%) 
10 (16.4%) 
10 (16.4%) 
0.468b 
Dose of intrathecal 
morphine 
    Nil 
    100 μg 
    150-200 μg 
122  
 
4 (6.6%) 
53 (86.9%) 
4 (6.5%) 
 
 
1 (1.6%) 
60 (98.4%) 
0 (0.0%) 
0.101b 
Minutes from 
intrathecal morphine to 
8:00 hours M (SD) 
119 1200.4 
(200.8) 
1213.5 
(179.2) 
0.710a 
Oxycodone dose prior 
to protocol 
    0 milligrams 
    5-10 milligrams 
    15-20 milligrams 
121  
 
45 (75%) 
12 (20%) 
3 (5%) 
 
 
56 (91.8%) 
5 (8.2%) 
0 (0.0%) 
 
 
0.032b 
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Tramadol dose prior to 
protocol 
    0 milligrams 
    50 milligrams 
    100 milligrams 
121  
 
50 (83.3%) 
1 (1.7%) 
9 (15%) 
 
 
40 (65.6%) 
2 (3.3%) 
19 (31.1%) 
0.073b 
a Independent samples t-test, b Chi Square Test of Independence, c Fischer's Exact 
Test. 
 
5.4 Primary Outcomes 
Repeated measures for pain intensity are described in Table 9 as median scores and 
interquartile ranges. Median pain scores at rest and on sitting and movement were 
under 47mm for all participants. Interquartile scores ranged from 3mm at rest for 
both groups to 66mm and 70mm for the control and intervention groups 
respectively. All differences in median pain scores at rest and sitting/moving were 
under 13mm on a 0-100 VAS.  
 
Table 9 
Participant reports of median pain intensity (and interquartile ranges) from 8:00 
hours on the first postoperative day to 8:00 hours on the second day 
Time 
Control 
n=61 
Intervention 
n=61 
 Resting Sitting/Moving Resting Sitting/Moving 
08:00 15 [5, 36] 43 [29, 64] 15 [5, 22] 45 [32, 62] 
09:00 14 [3, 31] 40 [22, 61] 10 [5, 20] 34 [21, 49] 
10:00 15 [5, 35] 42 [15, 55] 12 [4, 24] 30 [20, 51] 
11:00 19 [3, 35] 46 [18, 54] 13 [7, 29] 43 [21, 58] 
12:00 20 [5, 41] 39 [15, 57] 16 [7, 33] 42 [19, 70] 
08:00 19 [7, 43] 41 [18, 66] 12 [3, 29] 40 [22, 56] 
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Due to non-linear response curves for both pain at rest and moving (Figures 4 and 
5), random intercepts and random coefficients were calculated for each individual 
and data analysed by linear mixed models with spline regression. For resting pain, 
spline one covered the response from 8:00 to 9:00 hours, spline two the response 
from 9:00 to 12:00 hours and spline three the response from 12:00 to 8:00 hours the 
following morning. Spline one for pain on sitting covered the period from 8:00 to 
10:00, spline two 10:00 to 12:00 and spline three 12:00 to 8:00 hours the following 
morning. The difference in spline one for pain on sitting reflected the greater 
inflection in the mean curve for 10:00 hours compared to 9:00 hours for resting 
pain. 
 
Initial modelling for pain at rest and on sitting and moving specified random 
coefficients for all three spline segments as random effects, but the inclusion of 
spline one in these models caused computational difficulties because there was little 
or no variation in individual slopes for the spline segment.  Thus, spline one was 
specified as a fixed effect in all further models. Splines two and three showed large 
inter-individual variability in both intercept and slope so no further analysis was 
attempted in relation to treatment effects and these splines (see Appendix D).  
 
5.4.1 Pain at Rest 
An initial model incorporating spline one and treatment allocation showed no 
significance for the main effect of the intervention at 9:00 hours (p = 0.081, 95% 
CI -9.5, 0.6). Additional explanatory variables were tested in the model by stepwise 
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addition. The final most parsimonious model is shown in Table 10. The number of 
previous CSs, body mass index and total PCS were all statistically significant in the 
final model (p < 0.05). When adjusted for those independent variables, the 
significance of the intervention was strengthened with an adjusted mean decrease 
of 5.3 mm in pain intensity at 9:00 hours (p = 0.050, 95% CI -10.7, 0.0). For every 
one-point increase in BMI, mean pain at 9:00 hours decreased by 0.5 mm on a 0-
100 mm VAS (p = 0.036, 95% CI -1.0, 0.0). The number of previous CSs increased 
mean pain by 7.3 mm for every one previous delivery (p = 0.004, 95% CI 2.4, 12.0). 
For every one-point increase in PCS, mean pain was increased by 0.4 mm (p = 
0.023, 95% CI 0.1, 0.8). Overall, the model demonstrated no statistical significance 
in terms of the difference in pain scores between the control and intervention group 
over 24 hours (p= 0.40, 95% CI -4.8 mm, 11.9 mm). Mean pain scores at rest are 
presented in Figure 4. 
 
Table 10 
Fixed Effects Model for Resting Pain 
Variables 
Coefficient 
VAS mm 
Standard 
Error 
p value 
95% Confidence 
Interval VAS mm 
Intercept 22.5 9.2 0.017 4.1, 41.0 
Allocation 3.5 4.2 0.401 -4.9, 12.0 
Spline 1(0-1hr) 3.6 1.9 0.066 -0.2, 7.5 
Allocation * Spline 1 -5.3 2.7 0.050 -10.7, 0.0 
BMI -0.5 0.2 0.036 -1.0, 0.0 
Number of CS 7.3 2.4 0.004 2.4, 12.0 
Total PCS Score 0.4 0.1 0.023 0.1, 0.8 
Akaike's Information Criteria= 2993 (reduced by regression from 3298). 
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Figure 4. CS pain at rest (Means and Standard Errors) from 8:00 to 12:00 hours the 
day after CS and then at 8:00 hours on the second postoperative morning. 
 
5.4.2 Pain on Sitting and Moving 
The only significant parameters for the initial model were the oxycodone dose given 
within six hours of 08:00 hours the day after CS and the PCS score. However, 
experimentation with BMI and number of previous CSs (which had similar 
parameter estimates to those in the resting VAS model) showed that the Alkaike's 
Information Criteria (AIC) was improved by adding them to the model even though 
they failed of significance. 
 
The final sitting and moving pain model (Table 11) demonstrated no statistical 
significance in terms of the difference in pain scores between the control and 
intervention group over 24 hours (p= 0.561, 95% CI -15.2 mm, 8.3 mm). The 
groups differed in terms of pain on sitting between 08:00 and 10:00 on the first 
postoperative morning but the result was not statistically significant. Participants in 
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the intervention group had a greater reduction of pain by 6.1 mm on a 0-100 VAS 
when compared to the control group (p= 0.063, 95% CI: -12.6 mm, 0.3 mm). Mean 
pain scores on sitting and moving are shown in Figure 5 with the movement scores 
relating to 8:00 hours on the second postoperative morning, 24 hours after the 
treatments. 
 
Table 11 
Fixed Effects Model for Sitting and Moving Pain 
Variables 
Coefficient 
mm VAS 
Standard 
Error 
p value 
95% Confidence 
Interval mm VAS 
Intercept 38.2 13.01 0.005 12.2, 64.3 
Allocation -3.4 5.88 0.561 -15.2, 8.3 
Spline 1 (0-2hr) 4.8 2.35 0.040 0.2, 9.5 
 Allocation*Spline1 -6.1 3.28 0.063 -12.6, 0.3 
Total PCS Score 0.4 0.25 0.056 -0.0, 1.0 
BMI -0.4 0.33 0.231 -1.1, 0.3 
CS 6.2 3.41 0.073 -0.6, 13.0 
Oxycodone dose 
prior to treatment 
1.47 0.66 0.028 0.2, 2.8 
Akaike's Information Criteria= 3096 (reduced by regression from 3140). 
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Figure 5. Pain on sitting (means and standard errors) from 8:00 to 12:00 hours on 
the first postoperative day and then movement pain at 8:00 hours on the second 
postoperative morning. 
 
5.5 Secondary Outcomes 
5.5.1 Patient Global Impression of Change 
In the model of PGIC at 11:00 hours, participants in the intervention group reported 
improved or very much improved pain relief than those in the control group (p = 
0.014, Odds Ratio [OR] = 2.5, 95% CI 1.2, 5.3). This effect was not reported at 
9:00 hours (p = 0.172, OR = 1.7, 95% CI 0.8, 3.4), 10:00 hours (p = 0.134, OR = 
1.8 95% CI = 0.8, 3.8) or 12:00 hours (p = 0.135, OR = 1.7, 95% CI 0.8, 3.7). 
Additional predictor variables were tested as in the linear mixed model for VAS 
pain scores, but only the pre-intervention oxycodone dose was significant at 10:00 
hours (p = 0.040, OR = 1.2, 95% CI 1.0, 1.3). As noted, many participants in the 
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control group received more oxycodone prior to the schedule of CR oxycodone at 
8:00 hours.  
 
Table 12 
Patient Global Impression of Change in Pain 
Time Variable Odds Ratio 
95% CI of 
Odds Ratio 
p value 
09:00 Allocation 1.7 0.8, 3.4 0.172 
10:00 Allocation 1.8 0.8, 3.8 0.134 
10:00 Oxycodone 1.2 1.0, 1.3 0.040 
11:00 Allocation 2.5 1.2, 5.3 0.014 
12:00 Allocation 1.7 0.8, 3.7 0.135 
 
 
5.5.2 Quality of Pain 
Participants rated the intensity of various pain qualities on the SF-MPQ-2 at 12:00 
hours on the first postoperative day. There were no differences between the groups 
in terms of intermittent pain (U = 1196, p = 0.396), continuous pain (U = 1043, p = 
0.064), neuropathic pain (U = 1229, p = 0.534) or affective pain descriptors (U = 
1089, p = 0.115). The results are presented in Table 13. 
 
 
 
 
 
 
 
 157 
 
Table 13 
Quality of pain from 8:00 to 12:00 hours the day after CS  
Quality 
Control 
n=49 
Median [IQR] 
Intervention 
n=54 
Median [IQR] 
Mann 
Whitney 
U 
P value 
 
Continuous 
 
15.0 [7.5, 22.0] 
 
9.0 [5.0, 18.5] 
 
1043 
 
0.064 
Intermittent 5.5 [0.75, 13.25] 4.0 [0.0, 11.25] 1196 0.396 
Neuropathic 7.0 [3.0, 11.25] 6.0 [2.0, 10.0] 1229 0.534 
Affective 4.0 [0.0, 8.5] 1.0 [0.0, 5.0] 1089 0.115 
Total pain 33.0 [18.0, 52.75] 24.0 [11.0, 48.5] 1076 0.102 
 
5.5.3 Patient Global Assessment 
At 20:00 hours on the first postoperative evening, participants reported PGA scores 
for the quality of pain management (Figure 6). Chi-square analysis showed no 
significant difference between the control or intervention groups in terms of global 
assessment of pain management on the first postoperative day (χ² = 1.51, df = 1, p 
= 0.220). A detailed description of the number of responses for each category of 
the PGA scale is presented in Table 14. 
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Table 14 
Patient Global Assessment of Pain Management at 20:00 hours the day after CS 
Response Control Intervention Total 
Poor 1 (1.0%) 1 (1.0%) 2 (1.9%) 
Fair 8 (7.7%) 4 (3.8%) 12 (11.5%) 
Good 17 (16.3%) 20 (19.2%) 37 (35.6%) 
Very Good 15 (14.4%) 19 (18.3%) 34 (32.7%) 
Excellent 10 (9.6%) 9 (8.7%) 19 (18.3%) 
Total  51 (49%) 53 (51%) 104 (100%) 
 
 
 
Figure 6. Patient global assessment of pain management from 8:00 to 20:00 over 
the first postoperative day. 
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5.5.4 Pain Interference 
At 20:00 hours on the first postoperative day, pain interference scores were 
recorded on the modified BPI (Table 15). The intervention group experienced less 
overall pain interference than the control group (U = 992, p = 0.029).  This is 
presented graphically in Figure 7. The intervention group also experienced less pain 
interference on general activity (U = 1017, p = 0.042), walking (U = 925, p = 0.008) 
and coughing (U = 1011, p = 0.037).   
 
Table 15 
Pain interference recorded at 20:00 on the first postoperative day- medians and 
interquartile ranges 
Measure 
Control 
n=49 
Intervention 
n=54 
Mann 
Whitney U 
P value 
 
Activity 
 
5 [3, 7] 
 
4 [2, 7] 
 
1017 
 
0.042 
Mood 2 [1, 4] 1 [0, 3] 1069 0.087 
Walking 5 [3, 8] 3 [2, 7] 925 0.008 
Relationships 0 [0, 2] 0 [0, 1] 1208 0.379 
Coughing 7 [2, 10] 4 [1, 8] 1011 0.037 
Breathing 0 [0, 3] 0 [0, 1] 1195 0.329 
Concentration 1 [0, 4] 1 [0, 2] 1264 0.680 
Enjoyment 1 [0, 4] 1 [0, 3] 1173 0.295 
Total 25 [11, 39] 15 [8, 34] 992 0.029 
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Figure 7. Total Pain Interference recorded at 20:00 on the first postoperative day 
(p=0.029). 
 
5.5.5 Perception of Control over Pain Management 
Participants rated their perception of control over pain management at 8:00 hours 
on the second postoperative morning (Table 16). The results highlight that 
participants perceived they had approximately equal control over pain management 
with staff. No significant between-group differences were observed for perception 
of who controlled pain management (t = 0.37, p = 0.712), how much control 
participants felt they had (t = -1.10, p = 0.273), or how much control participants 
thought staff had over pain management (t = 0.56, p = 0.578). 
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Table 16 
Perception of Control over Pain Management from 8:00 hours the day after CS to 
8:00 hours on the second postoperative morning (0-100mm VAS) 
VAS Item 
Control 
n=47 
M (SD) 
Intervention 
n=46 
M (SD) 
Test 
Statistic 
p 
value 
Mean 
Difference 
(CI 95%) 
Perception of who 
controlled pain 
management 
(participants-staff). 
50.4 
(28.5) 
48.2 
 (31.2) 
0.37 0.712 -10 to 14.6 
Perception of the 
degree of control 
participants 
experienced (none-
complete). 
54.3 
(23.7) 
60.1 
(26.8) 
-1.10 0.273 -16.2 to 4.6 
Perception of the 
degree of control 
staff had (none-
complete). 
63.1 
(24.6) 
60.2 
 (24.1) 
0.56 0.578 -7.2 to 12.8 
 
5.5.6 Oral Opioid Consumption  
All doses of oxycodone and tramadol were calculated in terms of scheduled plus 
additional doses that were requested by participants for breakthrough pain (Table 
17). From 8:00 hours the day after CS to 12:00 hours on the second postoperative 
day, participants in the intervention group were administered less total oxycodone 
(median= 30, IQR = 20-25 mg) than the control group (median= 30, IQR = 30-40 
mg) (U = 989, p = 0.001). Also, the total dose of oxycodone consumed by the 
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intervention group was less at 1620mg compared to 2105mg by the control group 
(Table 18). On the day after CS, however, there was no statistically significant 
difference in oxycodone consumption (U= 1361, p= 0.193) but the total dose 
consumed by the intervention group was less at 1305mg compared to 1415mg by 
the control group. Data was not collected on the experience of breakthrough pain 
management or times that additional doses were requested. 
 
According to maternal preference stated at the NP review at 14:00 hours, the NP 
prescribed 10 mg of CR oxycodone for 21 participants from the intervention group 
(34.4%) to replace the scheduled IR oxycodone dose at 20:00 hours on the first 
postoperative night. Two of these participants refused the next scheduled dose at 
8:00 hours on the second postoperative morning. From the control group, seven 
participants (11.4%) refused the scheduled dose of CR oxycodone at 20:00 hours 
on the first postoperative night with an additional two participants refusing the 
scheduled dose at 8:00 hours on the second postoperative morning. There was no 
difference between groups in terms of postoperative tramadol consumption (U = 
1565, p = 0.989). However, the total tramadol dose consumed by the control group 
was 4250mg compared to 3150mg by those in the intervention group (Table 18). 
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Table 17 
Opioid Consumption (medians and interquartile ranges) 
 
Drug 
Control 
n=57 
Intervention 
n=55 
U Test 
p 
value 
Oxycodone Day 1 20.0 [20.0, 35.0] 20.0 [20.0, 25.0] 1361 0.193 
Oxycodone Day 2 10.0 [10.0, 12.5] 5.0 [0.0, 10.0] 772 0.001 
Total Oxycodone 30.0 [30.0, 40.0] 30.0 [20.0, 25.0] 989 0.001 
Tramadol Day 1 0.0 [0.0, 100.0] 0.0 [0.0, 100.0] 1448 0.402 
Tramadol Day 2 0.0 [0.0, 0.0] 0.0 [0.0, 0.0] 1515 0.662 
Total Tramadol 0.0 [0.0, 100.0] 0.0 [0.0, 100.0] 1565 0.989 
  
 
Table 18 
Opioid analgesic consumption (mg) 
Drug Day 1 Day 2 Total 
Control Intervention Control Intervention Control Intervention 
CR 
Oxycodone  
1130 240 530 170 1660 410 
IR 
Oxycodone  
285 1065 160 145 385 1310 
Total 
Oxycodone 
1415 1305 690 315 2105 1620 
Tramadol 
in mgs 
2800 1750 1450 1400 4250 3150 
 
 
5.5.7 Adverse Effects 
Participants in the study rated opioid-induced side effects on 0-100 mm visual 
analogue scales (Table 19). No statistically significant differences were found 
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between study groups in terms of subjective reports of nausea (U = 1333, p = 0.768), 
itching (U = 1367, p = 0.944) or drowsiness (U = 1326, p = 0.739) from 8:00 to 
20:00 hours, measured at 20:00 hours on the first postoperative day. Overall, 
participants reported very low ratings for nausea and mild to moderate scores for 
itching and drowsiness. One participant from the control group was observed as 
being conscious to voice and all other cases were observed as being alert on the 
general observation record. One participant from each group required medication 
to treat opioid-induced nausea from 0-12 hours. For pruritus, two participants in the 
control group and three from the intervention group were administered one dose of 
anti-histamine. 
 
Table 19 
Opioid-induced side effects reported on VAS 0-100 mm from 8:00 to 20:00 hours 
the day after CS (n=105) 
Adverse 
Effects 
Control Intervention 
Mann 
Whitney U 
p value 
 
Nausea 
 
4.0 [0.0, 17.0] 
 
3.0 [0.0, 11.0] 
 
1333 
 
0.768 
Itching 35.0 [5.5, 61.0] 23.0 [5.0, 62.25] 1367 0.944 
Drowsiness 28.0 [9.5, 63.5] 30.0 [5.0, 52.5] 1326 0.739 
 
5.6 Follow-up Study 
Although 50 participants (58.8%) said they had pain at the time of the telephone 
interview, the burden of pain was small for the majority of participants as all mean 
pain intensity scores for the entire cohort were less than four on a 0-10 NRS (Table 
20). Only five participants (5.9%) reported pain scores for 'pain right now' greater 
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than three out of 10. Thirty-eight participants (44.7%) reported their 'worst pain' as 
greater than three out of 10, while 21 (24.7%) reported 'average pain' as greater than 
three out of 10. 
 
When asked how many days they had pain for the three-month period following 
CS, participants reported a median score of only four days of pain. Only two 
participants (2.4%) reported daily persistent pain for greater than forty days. 
Participants from the intervention group had less pain intensity and duration of pain 
at three months following CS but the differences were not statistically significant 
(Table 20). In the final regression model, postnatal depression was associated with 
more days of pain. For every point increase in EPNDS, participants experienced 
another day of pain during the three months following CS (p<0.001, beta= 1.0, 95% 
CI 1.1, 1.8). 
 
Table 20 
Days in pain and pain intensity over three months following CS- medians and 
interquartile ranges 
Pain experience 
Total Sample 
n=80 
Control 
n=41 
Intervention 
n=39 
Mann 
Whitney 
U 
P 
value 
 
Days in Pain 
 
4 [2, 12] 
 
4 [2, 14] 
 
3 [1, 7] 
 
699 
 
0.330 
Pain Right Now 1 [0, 2] 1 [0, 2] 1 [0, 2] 719 0.414 
Worst Pain 3 [2, 6] 4 [2, 7] 3 [1, 4] 659 0.173 
Average Pain 2 [1, 4] 3 [1, 4] 2 [0, 3] 624 0.086 
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Women reported only mild pain interference on two scales at three months 
following CS. Single item pain interference scores for all participants were less than 
three out of 10 using the BPI and GCPS. Only seven participants (8.2%) reported 
total pain interference scores greater than 27 out of 90 (equivalent to scores greater 
than three out of 10 on a 0-10 NRS). 
 
When responding to another item on the GCPS asking the number of days that pain 
stopped them doing work, going to school or doing housework, four participants 
(4.7%) reported pain stopped them doing these usual activities for greater than 60 
days (Figure 8). This suggests that there were more than two participants who 
experienced pain for more than forty days. Median scores for pain interference were 
slightly lower for the intervention group (p<0.5) on the GCPS (Table 21) but the 
results were not different on the BPI (Table 22). Any group differences must be 
interpreted with caution as results demonstrated that pain did not impact greatly on 
most women for three months following surgery. 
 
Table 21 
Pain interference (Graded Chronic Pain Scale)- medians and interquartile ranges 
Aspect of 
Pain 
Interference 
Total 
Sample 
n=80 
Control 
n=41 
Intervention 
n=39 
Mann 
Whitney 
U 
P 
value 
 
Activity 
 
2 [1, 3] 
 
2.0[1.0, 3.0] 
 
1.0[0.0, 3.0] 
 
585 
 
0.034 
Recreation 1 [0, 2] 2.0[1.0, 3.0] 1.0[0.0, 2.0] 572 0.024 
Work 2 [0, 3] 2.0[1.0, 3.0] 1.0[0.0, 2.0] 596 0.045 
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Table 22 
Pain interference (medians and interquartile ranges) three months following CS on 
modified BPI  
Aspect of Pain 
Interference 
Total 
Sample 
n=85 
Control 
n=42 
Intervention 
n=43 
Mann 
Whitney 
U 
P 
value 
 
Activity 
 
1.0 [1, 3] 
 
1 [0, 3] 
 
1[0, 2] 
 
800 
 
0.344 
Mood 1 [0, 2] 2 [0, 3] 1 [0, 2] 780 0.265 
Walking 1 [0, 2] 1 [0, 2] 1 [0, 2] 835 0.531 
Relationships 0 [0, 1] 1 [0, 2] 1 [0, 1] 738 0.113 
Coughing 1.0 [1, 3] 1 [0, 3] 1 [0, 2] 878 0.821 
Breathing 0 [0, 1] 1 [0, 1] 1 [0, 1] 887 0.872 
Concentration 1.0 [1, 2] 0 [0, 2] 1 [0, 1] 857 0.666 
Enjoyment 0 [0, 1] 1 [0, 1] 0 [0, 1] 757 0.150 
Work 1 [0, 2] 1 [0, 2] 1 [0, 2] 857 0.678 
Total 1.0 [1, 2] 1 [0, 2] 1 [0, 2] 858 0.678 
 
 
Figure 8. Maternal reports of the number of days that pain stopped them doing usual 
activities (Intervals described by the Graded Chronic Pain Scale). 
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Increased total pain interference (sum of all scores on the modified BPI) was 
associated with postnatal depression and perceived degree of maternal control over 
postoperative pain management reported on the second postoperative morning. This 
needs to be interpreted with caution as pain interference was mild and only two 
women reported EPNDS scores greater than 13, indicative of postnatal depression 
(Cox et al., 1987). In the final regression model, every point increase in EPNDS 
was associated with an increase in total pain interference of approximately one 
point on a scale of 0 to 90 (p< 0.001, beta= 1.1, 95% CI 1.0, 1.1). As well, every 
millimetre of increase in perceived degree of control in the model (VAS 0-100mm) 
resulted in a decrease in total pain interference of approximately one point on a 
scale of 0 to 90 (p= 0.008, beta= 1.1, 95% CI 1.0, 1.0). Degree of perceived maternal 
control on the single item VAS was the only postoperative variable affecting pain 
interference at three months. 
 
As a cohort, reports of continuous, intermittent, neuropathic, affective pain and total 
scores for all these qualities were mild at three months with only three participants 
(1.2%) reporting greater than 72 points out of a total pain score of 240 (sum of all 
items on the MPQ). The results of the regression indicated that only change in 
EPNDS predicted total pain reported on the MPQ at three months. A one-point 
increase in EPNDS was associated with a mean increase in total pain score of 
approximately one point out of 240 (p= 0.025, beta= 1.1, 95% CI 1.0, 1.1). 
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Continuous pain scores (throbbing, cramping, gnawing, aching, heavy and tender) 
were also mild with only 10 participants (12.2%) reporting continuous pain greater 
than 18 out of 60 total points. Similarly, only eight participants (2.4%) reported 
intermittent pain (shooting, stabbing, sharp, splitting, electric shock and piercing) 
greater than 18 out of 60. Affective pain scores (tiring-exhausting, sickening, 
fearful and punishing-cruel) were also very mild with a median score of zero for 
the entire sample. Only one person (1.2%) rated these characteristics greater than 
29 out of a total possible score of 40. 
 
Often associated with chronic pain, only six participants (7.3%) out of the whole 
cohort reported a total score for neuropathic pain greater than 20 out of 60. In terms 
of neuropathic pain descriptors, the most common responses from all participants 
were pain sensitive to light touch (73.8%), itch (74.6%) and numbness (75.4%). 
Participants in the intervention group experienced less neuropathic pain than those 
in the control group (U=581, p= 0.016). The difference between groups may not be 
clinically significant as median scores were four and eight out of a total of 60 points 
(Table 23).  
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Table 23 
Quality of pain three months following CS (medians and interquartile ranges) 
Variable 
 
Sample 
n=82 
 
Control 
n=41 
 
Intervention 
n=41 
 
Mann 
Whitney 
U 
P 
value 
 
Continuous  
 
6 [2, 14] 
 
8 [5, 15] 
 
6 [2, 13] 
 
702 
 
0.198 
Intermittent  6 [2, 12] 6 [3, 12] 6 [0, 11] 729 0.296 
Neuropathic 6 [2, 11] 8 [4, 12] 4 [1, 7] 581 0.016 
Affective 0 [0, 4] 1 [0, 4] 0 [0, 4] 758 0.404 
Total pain 22 [8, 40] 30 [15, 44] 14 [4, 34] 659 0.092 
 
Despite zero participants being pain free (Grade 0), there was a low burden of 
chronic pain as graded by the GCPS three months following CS. This is because 
most participants (87.1%) experienced low pain intensity and low interference 
(Grade I). Three participants (3.5%) reported high pain intensity with little or no 
interference (Grade II). However, three participants (3.5%) experienced moderate 
interference (Grade III) and five participants (5.9%) reported severe interference 
(Grade IV). According to Von Korff (2011), this means that 11 participants (12.9%) 
experienced clinically significant pain for three months following CS (Grades II to 
IV). 
 
5.7 Conclusion 
This research has described two groups of participants with similar baseline 
characteristics. Surgery was performed for approximately equal proportions of 
women in both groups by either Pfannenstiel incision or the Joel Cohen approach. 
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Both groups of participants were mostly of Caucasian decent and most did not 
report scores for the EPNDS or the PCS scale that would have indicated either 
depressed mood or pain catastrophising. Of note, there were no nulliparous women 
in the sample and this may reflect a reluctance of first-time mothers to be involved 
in research.  
 
In line with the BPS model of pain, many prenatal factors were associated with 
more pain on 0-100mm VAS the day after surgery. While the baseline differences 
between groups in terms of EPDNS and pain catastrophising scores were not 
significant, higher scores reported on the PCS were associated with greater 
postoperative pain. Another significant factor that may not be directly related to 
catastrophising was the influence of previous CS surgery on postoperative pain 
intensity.  These results support the BPS model as a framework for the design of 
this research as the model assumes that these factors (including depression) work 
together to influence pain perception (Turk et al., 2010).  
 
For the primary outcome, the results of the study found no statistically significant 
or clinically meaningful differences in pain intensity at rest or on sitting/moving 
between groups. However, participants in the intervention group reported 
statistically significant improved global impression of pain relief over the first few 
hours following the intervention. Global assessment of pain management (a 
secondary outcome) was not significantly different when reported on the PGA scale 
later that evening. Overall, the study found that the NP intervention was more 
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effective than standard care when interpreting the results of the PGIC scale at 11:00 
hours the day after CS. 
 
The results did not differ between the groups in terms of the quality of pain reported 
at midday on the first postoperative day. The results from the SF-MPQ-2 
demonstrated that CS pain for most women has neuropathic components as well as 
nociceptive. While there was not a statistically significant difference between 
groups on the SF-MPQ-2, the trend in median results for intensity relating to many 
of these descriptors was slightly lower for those who received the NP intervention.  
 
A significant result of this research was that the intervention resulted in less pain 
interference measured by the modified BPI which measured the impact of 
postoperative pain for 12 hours. Of particular interest to postoperative pain 
management was the reduced impact of pain on coughing, activity and walking the 
day after CS (p<0.05). Participants in the intervention group also reported a 
statistically significant reduction in composite scores for pain interference.  
 
Measurements of perception of control over pain management demonstrated no 
differences between groups on three visual analogue scales. Participants in the 
intervention group, however, consumed slightly less oxycodone and less tramadol 
on the first postoperative day up until midnight that day. Importantly, there was a 
larger difference in opioid consumption on the second postoperative day when the 
scheduled doses of oxycodone had stopped for most women receiving the 
intervention. Overall consumption of oxycodone was less for the intervention group 
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over the two days and the difference was statistically significant. However, reports 
of opioid-induced side effects were similar in both groups. Most women in the 
sample reported mild to moderate levels of drowsiness and this is a new subjective 
finding not reported in previous research.  
 
At the time of the telephone interview three months after surgery, only five 
participants (5.9%) reported pain scores greater than three out of 10 on a numerical 
rating scale. However, only two participants (2.4%) reported daily persistent pain 
for greater than forty days and this was associated with postnatal depression. 
Women reported only mild pain interference but four participants (4.7%) reported 
that pain stopped them doing their usual activities for greater than 60 days. More 
pain interference was also associated with postnatal depression and perceived 
maternal control over postoperative pain management reported on the second 
postoperative morning. Postnatal depression was also associated with greater 
intensity of pain quality reported on the SF-MPQ-2. Most participants (87.1%) 
experienced low pain intensity and low interference but 12.9% experienced 
clinically significant pain for three months following CS. Often associated with 
chronic pain, only six participants (7.3%) out of the whole cohort reported a total 
score for neuropathic pain greater than 20 out of 60. In terms of neuropathic pain 
descriptors, the most common responses from all participants were pain sensitive 
to light touch (73.8%), itch (74.6%) and numbness (75.4%).  
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Chapter 6: Analysis and Discussion 
6.1 Introduction 
The research has demonstrated that the BPS model of pain is relevant to acute pain 
management. The results showed that CS pain is a complex experience because 
biological, psychological and social factors were associated with pain perception 
and other maternal outcomes at different points in time. Although the intervention 
did not result in statistically significant differences in pain intensity on 0-100mm 
VASs, other secondary outcomes were statistically significant and clinically 
meaningful in favour of the intervention. Of particular significance was that the NP 
intervention resulted in more participants reporting that they experienced greater 
pain relief over the first three hours than those in the control group. The results 
suggest that acute pain management is much more than prescribing an analgesic 
and evaluating the effectiveness of interventions based on pain intensity alone. A 
BPS approach to care led by a NP can also address some of the problems 
surrounding the variability in patient responses to pain and pain therapies by 
enabling control over opioid therapy. 
 
A BPS approach to acute pain is appropriate in terms of improving the use of 
analgesics to reduce pain interference after surgery. Interference with activity, 
coughing and walking were reduced for those who received the NP intervention 
and the differences were also statistically significant. Reducing pain interference is 
important to postoperative recovery because poor analgesia may lead to 
complications after surgery such as respiratory compromise and venous 
thromboembolism (Macintyre & Schug, 2014).  
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Without a BPS model to frame this research aspects of the CS experience, such as 
perceived control over pain management, would not have been considered and there 
are benefits associated with evaluating these outcomes even though the intervention 
in this study did not change perception of control in the two groups. It is still useful 
to interpret these results in a way that improves how CS pain management is 
delivered. Like many other studies, a biomedical approach to this subject would 
only produce an interpretation of the experience based on pain scores and opioid 
consumption, whereas this research has demonstrated that many BPS factors are 
associated with CS pain perception and behavioural response to pain. The results 
for control over pain management may reflect that complete control over pain 
management is not desirable for all patients and that the concept can be interpreted 
in many ways. 
 
The application of the BPS model has also underscored the importance of chronic 
pain in the CS experience and clinical outcomes after discharge from hospital. 
According to the assumptions of the BPS model of pain, the experience of pain is 
shaped along a continuum (Turk et al., 2010) and so this research included the 
community phase as an important component of the CS experience. Moreover, the 
International Association for the Study of Pain includes CS in a list of surgeries that 
pose a higher risk to patients in terms of CPSP (IASP, 2011). This research 
extended knowledge on the burden of pain after discharge from hospital and the 
association of CPSP with postnatal depression and other BPS factors. 
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The purpose of this chapter is to address the specific findings of this research in 
light of the BPS model of pain and what previous research has found in relation to 
CS pain. The discussion of results supports the application of a BPS model for CS 
pain management and it is argued that this model could be applied to other acute 
pain contexts. The proposed model views acute pain management along a 
continuum from preadmission and past discharge from hospital. 
 
6.2 Primary Outcomes 
Pain intensity on a 0-100mm VAS was reported by participants every hour for four 
hours following the start of the control treatment or the intervention and then at 24 
hours the next morning. Mean pain scores at rest and on sitting/movement were 
below 50mm for most participants in the study. Despite this, compared to 
participants in the control group, those who received the NP intervention reported 
less pain at all time-points other than at 11:00 and 12:00 hours for pain on sitting 
being less for the control group. This may have been due to the rise in plasma 
concentration of CR oxycodone. It is noted, however, that the differences in overall 
pain scores for both groups during the 24-hour period were not statistically 
significant in the final models. 
 
The only specific times VAS scores could be analysed by the general linear effects 
model were at 9:00 hours for pain at rest and at 10:00 hours for pain on sitting. This 
was due to the variability in reports of pain after these times which did not meet the 
computation requirements of the analytical model for spline segments two and 
three. Nonetheless, the larger reductions in pain occurred 1-2 hours after the first 
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dose of IR oxycodone. While not statistically significant, the changes at these times 
may have been partly due to the shorter time to maximum plasma concentration for 
IR oxycodone and the intent of the intervention to create a synergy between higher 
plasma levels and maternal mobilisation. Thus, it is likely that the knowledge of 
participants regarding the relationship between analgesia and pain interference may 
have led to slightly reduced pain intensity at these times. The discussion between 
the NP and participants prior to the first dose of oxycodone could also have 
increased participant expectations in relation to the benefits of the intervention. 
That is, the suggestion of less pain could have influenced pain perception 
(Jakovljevic, 2014; Sanderson, Hardy, Spruyt & Currow, 2013). Differences in pain 
intensity, while not statistically significant, occurred with statistically less 
consumption of oxycodone and tramadol for those in the intervention group, also 
suggesting that reports of pain intensity may also be influenced by many other 
biological and psychosocial factors. 
 
The interpretation of VAS pain scores is complex due to various associations 
between BPS factors and subjective pain perception. There is disparity in the 
literature regarding the meaning of pain intensity scores and the clinical meaning 
of pain reduction has undergone critique by leading researchers. For pain intensity 
on the VAS, most experts argue that a 30-33% reduction is a reasonable cut-off 
point for a treatment effect that is clinically meaningful (Farrar, 2010; Mason, 
Fauerbach & Haythorne, 2011; O’Connor & Dworkin, 2011). Hence, this study 
falls short of demonstrating a clinically meaningful change in pain intensity from 
the intervention because the larger mean reductions in pain intensity in the models 
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at 9:00 hours (resting pain) and at 10:00 hours (pain on sitting) were only 5.3mm 
and 6.1mm respectively. In terms of proportional reduction, a 5.3mm change would 
indicate a 31.4% change from a mean pain score at rest of 16.9mm for the sample 
at 9:00 hours, whereas pain on moving was reduced by only 16.8% based on a mean 
pain score of 36.4mm at 10:00 hours.  It has been argued, however, that small 
reductions in pain intensity like these may be clinically meaningful because mean 
pain scores overall were mild (Jensen et al., 2003). A further reason to show caution 
in the interpretation of VAS changes is that the use of the term ‘pain’ may have led 
participants to report greater pain than that experienced due to the suggestion of a 
negative experience rather than asking participants if they were ‘comfortable’ 
(Chooi, White, Tan, Dowling & Cyna, 2013).  
 
Despite the arguments for and against the relevance of pain intensity scores in 
clinical research, the NP intervention applied in this research did not result in a 
clinically meaningful or statistically significant reduction in pain compared to the 
control group. However, many other factors were associated with changes in pain 
intensity and these are addressed in subsequent sections in this chapter. A further 
explanation for a decreased response to treatment may be the high proportion of 
participants who had undergone a previous CS which may have predisposed those 
women to catastrophic thoughts and/or pre-existing scar hyperalgesia (Flor & Turk, 
2011; Loos et al., 2008; Ortner et al., 2013). Since the intervention also did not alter 
perceived control between groups, participants’ pain intensity scores could also 
have been negatively influenced by other emotional feelings (Flor & Turk, 2011). 
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The final sections in this chapter will revisit these concepts with a view to 
improving the intervention in a BPS model for acute pain management. 
 
6.3 Secondary Outcomes 
6.3.1 Global Measures 
As noted, there are limitations in the evaluation of pain based on VAS pain scores. 
This is why other measures such as PGIC have been suggested as alternative 
endpoints in clinical pain trials (Farrar et al., 2000). Participants reported subjective 
ratings of pain based on categorical effect and PGIC and these were useful measures 
of the effect of the intervention in this research alongside pain intensity (Farrar et 
al., 2000). Reports of PGIC were also useful here because the reports of lower pain 
intensity by most participants made it difficult to attribute clinically meaningful 
effect sizes to the intervention. Dworkin and others support the use of PGIC in such 
situations where VAS scores are on the lower end of the scale (Dworkin, Turk, 
McDermott et al., 2009). Furthermore, categorical responses can be divided into 
groups of responders and non-responders to a treatment and proportional evaluation 
cannot be achieved with analytical methods that rely on central tendency (Dworkin, 
Turk, McDermott et al., 2009).  
 
Global measures of the effect of the intervention were obtained in this research. Of 
note, PGIC was a secondary outcome but some have argued that it can be used as a 
primary endpoint in pain studies (Dworkin, Turk, McDermott et al., 2009; Jensen 
et al., 2005). Hence, it is important to note that participants in the intervention group 
were 2-3 times more likely to report ‘much improved’ or ‘very much improved’ 
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pain relief over three hours from the commencement of the intervention than the 
control participants. In addition to being statistically significant, the effect in 
relation to PGIC is equated to one of clinical importance (O’Connor & Dworkin, 
2011; Turk & Melzack, 2011). Reasons for a lack of effect at other measurement 
times are unclear, although the outcome of no difference between groups at 12:00 
hours may be partly explained by rising plasma concentrations of oxycodone in 
control group participants while the concentrations in those who received IR 
oxycodone would have been diminishing. Despite this, the effect reported at 11:00 
hours represented an aspect of pain that is distinct from pain intensity on a VAS 
because it evaluated pain relief over a three-hour period as opposed to pain intensity 
at one point in time.  
 
A global rating of analgesic pain management over 12 hours was reported by all 
participants at 20:00 hours on the first postoperative evening. The single item 
categorical scale ranged from poor to excellent pain management and most 
participants rated the analgesic plan, at least, as good. Although the PGA 
assessment tool has been validated in previous research involving analgesics (Farrar 
et al., 2010; Grond et al., 2007; Rothman et al., 2009), a large effect size that equates 
to a 50% reduction in pain intensity on a VAS is required to detect a meaningful 
difference between groups (Collins et al., 2001). The use of the PGA tool did not 
detect any differences between groups in this research because mean changes in 
VAS at rest and on moving were below 31.4%. Global measures of the benefit of 
an intervention over another are discrete outcomes to pain intensity and add another 
dimension to the pain experience (Farrar, 2010; Jensen et al., 2005). According to 
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the BPS view of pain perception, pain has multiple dimensions (Flor & Turk, 2011; 
Turk et al., 2010) and it was appropriate in this research to supplement 
measurements of pain intensity with global measures of pain relief in terms of the 
proportions of those who did and did not report good pain relief (Dworkin, Turk, 
McDermott et al., 2009).  
 
6.3.2 Postoperative Neuropathic Pain  
People describe pain in many ways and surgical pain is usually characterised by 
nociceptive pain. This type of pain is often described as sharp, stinging pain 
(somatic pain) or dull, cramping pain (visceral pain) (Macintyre & Schug, 2014). 
In this research, however, the results showed that nociceptive pain was 
accompanied by qualities that indicated neuropathic pain over 12 hours on the first 
postoperative day. Neuropathic pain is often characterised by feelings of burning, 
shooting or stabbing pain and is associated with a lesion of the nervous system 
(Macintyre & Schug, 2014). Patients may also report increased sensitivity to pain 
stimuli (hyperalgesia) and pain from stimuli that do not usually cause pain 
(allodynia) (Macintyre & Schug, 2014). Neuropathic pain may also not respond 
well to opioid analgesics (Macintyre & Schug, 2014) and this may partly explain 
the small effect sizes in terms of pain intensity on the first postoperative morning. 
Although there were no differences between the intervention and control groups in 
this research, mixed nociceptive and neuropathic pain has not been reported in 
previous RCTs involving CS patients. It is accepted that mixed nociceptive and 
neuropathic pain can be experienced in the context of acute pain (Macintyre & 
Schug, 2014), but these results further implicate CS as a risk factor for the 
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development of CPSP given that neuropathic pain has been associated with chronic 
pain (IASP, 2010; Loos et al., 2008; Schug & Pogatski-Zahn, 2011).  
 
6.3.3 Impact of CS Pain 
Reduced pain interference is an important clinical outcome for the NP intervention 
in this research because poor analgesia following CS makes it difficult to recover 
and care for a new born baby (Karlstrom et al., 2010; Marcus et al., 2015; Zanardo 
et al., 2010). The BPS approach to pain management suggested that a NP 
intervention may reduce pain interference by individualising maternal use of 
oxycodone through educational strategies on how to use oxycodone to cope with 
pain. A fundamental aspect of the BPS model of pain is how analgesics and other 
strategies can be used to reduce the impact of pain on physical and psychological 
rehabilitation (Flor & Turk, 2011; Turk et al., 2010). In applying these fundamental 
principles, the NP explained the actions of IR oxycodone and how it could be used 
to reduce pain interference. Mobilisation was a key aspect of the discussion which 
was designed to shift control of pain management to women so that they could 
control their doses of IR oxycodone effectively to reduce pain interference during 
the first postoperative day. By enabling more control, those who received the 
intervention could have anticipated periods of increased activity and requested IR 
oxycodone prior to undertaking the activity. This research demonstrated that 
participants who received the NP intervention experienced less pain interference on 
general activity, walking and coughing. According to expert opinion, the 
differences reported for coughing and walking were clinically meaningful as the 
median differences were 2-3 points on a 0-10 NRS (O’Connor & Dworkin, 2011). 
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Although other maternal functions such as breastfeeding and infant care were not 
measured in this research, it may be argued that improved mobility and the ability 
to better perform general activities might have the potential to improve these other 
functions in a positive manner. A key feature of the intervention was the supportive 
actions of the NP with education and counselling during the therapeutic plan 
(Nursing & Midwifery Board of Australia, 2014). Previous research in other 
surgical models has found that pain education about the pharmacology of analgesics 
can be used to reduce pain interference (Sayin & Aksoy, 2012; Wong et al., 2010). 
The supportive aspects of the NP intervention are also in line with the BPS model 
of pain as this support was given along a continuum of time during the first 
postoperative day. 
 
Of the psychological aspects of pain interference, participants in the sample 
reported that pain had little impact on enjoyment of life and mood. The relationship 
between pain, depression and anxiety therefore was not manifest in the 
postoperative phase of the study despite associations found by others (Anderssen et 
al., 2004; Hobson et al., 2005; Keogh et al., 2005; Lou & Kong, 2012; Saunders et 
al., 2006). Because depression is another major component of the BPS model of 
pain and made worse by cognitive errors regarding pain interference (Flor & Turk, 
2011; Turk et al., 2010), the association between CS pain and depression becomes 
manifest and is explored in the chronic phase of this discussion. 
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6.3.4 Participation and control over pain management 
The BPS model of pain views perceived control as important to effective pain 
management as it enables an individual to cope with pain using their own decision-
making ability and resources (Turk et al., 2010). The results of this research 
demonstrated that both groups of participants shared approximate equal control 
over pain management with clinical staff. This overall result for the cohort suggests 
that not all women experienced disempowerment (Malacrida & Boulton, 2012; 
McAra-couper et al., 2010). Lack of perceived control was not associated with 
postoperative pain as has been found by a previous study on CS pain (Keogh et al., 
2005). It has been noted in previous chapters that not all patients desire full control 
over pain management (McTier et al., 2014; Zoega et al., 2014). Hence, the results 
here suggest that the degree of control experienced by a high proportion of 
participants may be an acceptable position. Other researchers have noted that shared 
control over pain management between clinical staff and patients is what the 
majority perceive as desirable and that both have equal responsibility in relation to 
acute pain management (McTier et al., 2014). 
 
The meaning of control for women is difficult to interpret because individuals vary 
in the degree of control they require, or desire, over pain management (Etowa, 
2012). It has been suggested that some women may prefer to hand control over to 
clinical staff while others want to exercise a high degree of control over childbirth 
(Etowa, 2012). Nonetheless, women in Western societies generally defer to 
decisions made by medical staff in regard to childbirth pain management (Lowe, 
2002). The danger of this approach is that it encourages low self-efficacy (Turk et 
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al., 2010) and this may hinder the use of other coping strategies (Lowe, 2002). Thus, 
women have unique beliefs about how much control over pain management is 
appropriate for childbirth and this supports an alternative approach to pain 
management in childbirth. Although there are individual differences in the degree 
of control that is appropriate, the BPS model of pain proposes that a higher degree 
of control increases activity and prevents psychological trauma due to pain (Turk 
et al., 2010) and thus it is important to promote an acceptable degree of control to 
avoid depression and pain catastrophising (Talbot, 2012; Turk et al., 2010). 
Clinicians can improve pain outcomes such as maternal satisfaction by empowering 
women to make decisions regarding pain management (Arnold, Finnis & Kerridge, 
2014; McCrea & Wright, 1999).  
 
There are many possible reasons for the results of this research that pertain to 
differences in maternal control. These factors relate to the study design and how 
participants conceptualised control. The original intent of the design of this study 
was to abandon the standard practice of repeated scheduled doses of CR oxycodone 
after CS to be replaced with an approach that would enable women to have more 
control by commencing therapy with only one scheduled dose of IR oxycodone. 
Some medical staff were resistant to this method and expressed concern that 
participants in the intervention group may receive more scheduled oxycodone over 
the first postoperative day than those in the control group. It was also suggested that 
women may not receive the oxycodone required because midwives may not 
administer the requested treatment. Further to this, some anaesthetists suggested 
that the NP was not required to follow-up participants in the intervention group 
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despite this practice being a component of quality use of medicines described in 
national policy (Australian Pharmaceutical Advisory Council, 2005). As a result of 
these barriers, further scheduled doses of IR oxycodone were added to the 
intervention protocol so that approval for the study would occur. Hence, it may not 
have been possible for women in the intervention group to perceive more control 
as their decision regarding these repeated doses was removed prior to the study. An 
opportunity to control this situation, however, was provided by the NP who advised 
all participants on the first postoperative morning that they could refuse scheduled 
doses and request additional doses prescribed separately in the medication chart. 
Applying the BPS model to acute pain management was thus a challenge in terms 
of shifting the opinions of some medical staff regarding the nature and treatment of 
acute pain. Many have argued that the BPS model of pain is applicable to acute pain 
management (Edozien, 2015; Keefe, 2009) and the inability of some to view acute 
pain as multidimensional and complex is reminiscent of sensory-physiological 
models that drive research and clinical practice. This research, however, has 
supported the BPS approach to acute pain because there have been various BPS 
factors associated with the experience of CS pain.  
 
According to the BPS model, perceived control means having an opportunity to 
regulate how pain is managed (Flor & Turk, 2011). Other aspects of analgesic 
administration could have decreased perceived control for some participants 
because they could not regulate the types or doses of analgesics used. All 
participants were administered scheduled doses of non-opioid analgesics as part of 
the design of this study. They were not, however, given power over decision-
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making around control over other analgesic types such as paracetamol or non-
steroidal anti-inflammatory drugs. Other types of non-steroidal anti-inflammatory 
drugs, for example, could have been offered to participants as could control over 
oxycodone doses. Thus, opportunities to individualise other therapies were not 
considered and hence the women may have perceived that clinical staff had more 
control. Other researchers have suggested that promoting greater control over CS 
pain is extremely difficult due to this issue (McCrea & Wright, 1999). The 
intervention could be improved by offering participants more decision-making 
power over analgesics and by supporting the preferences of women.  
 
Some researchers have attempted to improve control over analgesics by enabling 
self-administration of oral medications. However, a French RCT found no 
difference in pain intensity between women who received patient-controlled oral 
analgesia compared to nurse controlled analgesia (Bonnal et al., 2016). The 
intervention in this French study instructed participants to self-administer non-
opioid analgesics contained in pill boxes but the only control they were given was 
to self-administer IR morphine tablets for breakthrough pain. The study did not 
measure maternal perceived control over pain management and nor did a UK 
midwife-led study on self-administration of analgesics (Snell & Hicks, 2006). 
However, in the UK study, participants had control over the administration of all 
tablets, including non-opioid analgesics. Participants from the self-administration 
group reported better pain relief and consumed less oral opioid analgesics than the 
nurse-controlled group (Snell & Hicks, 2006). This outcome suggests that greater 
control over the administration of all analgesics may increase perceptions of control 
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and improve outcomes for women who undergo CS. This approach may be a 
challenge in some hospitals because of poisons regulations and concerns about the 
security of opioid analgesics. Bonnal and others used pill boxes with only two 
tablets of IR morphine provided for a few hours rather than dispense a whole box 
of twenty tablets at one time (Bonnal et al., 2016). Patients can be discharged home 
on much more than this amount and so attitudes may need to change in healthcare 
facilities regarding medication administration and control. 
 
A BPS approach to pain management is designed to tailor treatment to the needs of 
the individual (Turk et al., 2010) and part of this is empowering the consumer 
regarding treatment choices (Jungyoun, 2015). However, enabling control over pain 
management may be difficult as control in childbirth may relate to many other 
factors such as where the birth will take place and who may be present (Meyer, 
2013). For most women who undergo CS, the protocol driven environment of the 
operating suite removes this broader sense of control from women and so the power 
of the institution outweighs individual beliefs, preferences and culture (Jungyoun, 
2015). Thus, the NP intervention used in this study may have been more effective 
if the relationship with participants commenced earlier prior to hospitalisation 
without the dominant forces that came into play on the day of surgery. Earlier 
commencement of the intervention could have promoted a supportive relationship 
prior to hospitalisation where discussion could have taken place regarding beliefs 
about analgesic therapy, options for pain management and the degree of support 
required in the perioperative period. This may be undertaken with supportive 
written material that explains the pharmacology of all the oral analgesics, risks to 
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neonatal health and how analgesics can be used in a way that satisfies maternal 
beliefs and goals for recovery (Sayin & Aksoy, 2012; Wong et al., 2010; Yates et 
al., 2004). These aspects of the intervention could have been reinforced again 
during the hospital phase and may have strengthened the results of the study. 
 
6.3.5 Oral Oxycodone 
For many women, additional pain relief is required to supplement the decline in 
analgesia from intrathecal morphine and it would be acceptable practice to give 
women access to additional oral doses of oxycodone for breakthrough pain. 
Supplemental opioid analgesia is mostly required the morning after CS when 
increased pain intensity may interfere with maternal function (Karlstrom et al., 
2010). This research supports access to oral oxycodone following intrathecal 
morphine as there was no association between pain intensity during the morning 
after surgery and intrathecal morphine administration. Furthermore, this research 
showed that 25% of all participants required oral oxycodone prior to the start of the 
intervention or control treatments. This may have occurred because levels of 
intrathecal morphine were declining well before 8:00 hours on the morning 
following surgery. Access to supplemental oral opioid analgesia is, therefore, an 
appropriate position because a BPS approach to pain supports the uniqueness of 
individual perceptions of pain and response to analgesic therapy (Albin & Buskila, 
2012; Leo & Quinton, 2010; Sadhasivam & Chidambaran, 2012). Individualised 
therapy is better provided with IR oxycodone rather than CR oxycodone as it is 
shorter acting and response to therapy can be evaluated regularly to adjust the pain 
management plan if required (Baber et al., 2015; Candiotti et al., 2013; Rang, 2016). 
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The BPS model of pain supports individualised assessment and adjustments to 
therapy over several points in time (Turk et al., 2010). This was a key feature of the 
NP approach to pain management in this research. 
 
Individual variance in relation to acute pain can be explained by the BPS model of 
pain. While biological differences can influence responses to opioid therapy and 
how pain is processed (Flor & Turk, 2011), an individual’s psychosocial 
characteristics also interact with biological factors to shape beliefs about pain and 
how to manage pain (Turk et al., 2010). Hence, other strategies can be used 
alongside analgesics to improve acute pain management and address the problem 
of individual variance (Keefe, 2009). Inherent in this approach is the view that 
analgesics will work better if there exists shared decision-making and a positive 
relationship between patients and clinical staff (Australian Pharmaceutical 
Advisory Council, 2005; McTier et al., 2014). Thus, the use of analgesics in a pain 
management plan is a process where patients are the central point of pain 
management (Department of health & Ageing, 1999). The BPS model of pain also 
reflects these principles and recognises the complexity and unique experience of 
pain (Turk et al., 2010).  
 
This research supports the BPS approach by demonstrating that the requirement for 
oral oxycodone and the intensity of pain was highly variable. The results also 
showed that consumption of oral opioids was not the central factor involved with 
the perception of postoperative pain. This is because slightly less pain intensity and 
improved secondary outcomes were found for the intervention group despite 
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consuming less opioids than those in the control group. Many BPS factors, thus, 
acted synergistically to influence pain perception (Gatchel & Maddrey, 2004) and 
behavioural responses such as less pain interference for those in the intervention 
group did not come at the expense of greater analgesic consumption. The NP 
intervention in this research was surrounded by a conceptual view of pain that 
involves analgesic therapy, educational strategies and follow-up support to enhance 
the individual’s ability to manage postoperative pain (Flor & Turk, 2011; Turk et 
al., 2010). This approach to pain management was derived from the BPS model of 
pain that can be applied to the acute pain setting because pain is a multidimensional 
experience (Jensen et al., 2015; Mosely & Butler, 2015; Turk & Okifugi, 2002) and 
childbirth is a complex acute pain situation (Mander & Murphy-Lawless, 2013; 
McNeill & Jomeen, 2010).  
 
In Chapter two, it was noted that the biomedical approach is the predominant view 
that guides acute pain management. For women who undergo CS, this means that 
the focus is often on drug therapy to alleviate pain with a one-size-fits all approach. 
Of major concern is that acute pain management interventions may end with a drug 
prescription without adequate follow-up management. Thus, women could be 
administered scheduled doses of oral opioids over several days (Niklasson, Arnelo 
et al., 2015; Seaton & Reeves, 2009; Zhong et al., 2014) which poses a risk of 
respiratory depression in babies (Lam et al., 2012).  
 
No adverse events were reported during this research but many women reported 
feeling drowsy from oxycodone. This finding differs with the observations of 
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clinical staff that participants were alert as reported on observation charts. Thus, 
there is disparity between objective data for maternal level of consciousness and 
subjective perceptions of drowsiness which may have been due to the side effects 
of oxycodone (Aspen, 2015). In clinical practice, objective levels of consciousness 
are a priority as falling levels are associated with impending respiratory depression 
(Analgesic Expert group, 2012). The implication of the findings of this research is 
that maternal drowsiness may also interfere with the ability of women to function 
following CS in terms of mobilising and performing infant care. Without an 
approach to acute pain management that recognises the uniqueness of every 
individual and the multidimensional nature of the CS experience, women may also 
suffer from the adverse effects of opioids such as respiratory depression, 
drowsiness, nausea, itching and constipation (Analgesic Expert Group, 2012). 
 
A BPS approach to oxycodone administration for CS also has implications for 
clinical practice in terms of feasibility and acceptance by other team members. A 
new model for acute pain management would require a NP with the skills and 
resources to provide the service and this may present further resource issues as one 
NP cannot be available for all women who undergo CS. Another barrier to this type 
of intervention for CS is that other prescribers may resist changes to standard 
practice. Furthermore, the BPS model of pain may not reflect the opinions of some 
clinical staff or patients who view pain as a sensory-physiological concept (Flor & 
Turk, 2011). Nonetheless, this research has demonstrated that drugs are not the only 
factors involved in acute pain management. 
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6.4 Factors associated with CS Pain 
Application of the BPS model of pain to this research was appropriate given the 
broad range of factors that were identified as being associated with CS pain. Some 
findings were unexpected such as the association between previous CS and 
postoperative pain. Pain catastrophising was a strong predictor of postoperative 
pain and this was an expected result based on previous research and the emphasis 
given to catastrophising in the BPS model of pain (Flor & Turk, 2011; Keefe, 2009; 
Turk et al., 2010). Depression, however, was not associated with postoperative CS 
pain despite being a component of the BPS model. Without the BPS model of pain 
as a framework for this research, unexpected results may not have been identified 
and propositions about how all these factors interacted to contribute to the pain 
experience after CS not articulated.  
 
In this research, a strong association was found between previous CS history and 
postoperative pain intensity. This has not been addressed in previous CS research 
because most studies have not used appropriate analytical models to determine 
associations between pain and multiple factors. Nonetheless, the causation of more 
pain intensity for every previous CS may be explained by the BPS approach in that 
biological and psychosocial factors may have influenced this outcome. It is 
plausible that some participants may have suffered from pre-existing neuropathic 
pain from previous surgery and this could have enabled a perioperative 
hyperalgesic state where these women were more sensitive to pain than others. This 
may have been possible due to nerve injury from previous Pfannenstiel incision 
which can also predispose individuals to experience CPSP (Loos e al., 2008; Ortner 
 195 
et al., 2013). The association is also made complex because many women in this 
research reported symptoms of neuropathic pain and it is unknown whether this was 
related to previous surgery. From a BPS perspective, however, psychosocial factors 
could also have contributed to the connection between previous CS surgery and 
postoperative pain intensity. Pain catastrophising, for example, may have been a 
result of a previous CS experience that was marked by poor analgesia and fear of 
movement alongside pain (Flor & Turk, 2011; Keefe, 2009). The BPS model of 
pain supports a view that a previous negative pain experience may predispose 
patients to expect severe pain in a subsequent pain experience (Turk et al., 2010). 
Hence, a range of BPS factors form reciprocal relationships that shape pain 
perceptions and behavioural responses in the acute pain setting (Keefe, 2009; Turk 
et al., 2010).  
 
As noted above and explained by the BPS model of pain, fear of pain and 
catastrophising are potent mediators of pain (Turk et al., 2010). In this study, pain 
catastrophising was a potent factor that resulted in greater reports of postoperative 
pain and this was an expected result in concordance with the BPS model of pain 
(Turk et al., 2010). Intense fear of CS pain was also a factor that contributed to pain 
intensity in a previous study (Keogh et al., 2005). Similarly, the statistically 
significant association between maternal catastrophising and pain in this study are 
consistent with previous research (Flink et al., 2009; Strulov et al., 2007). Pain 
catastrophising may be related to an unexpected degree of fear in women where 
both factors interact to worsen catastrophic thoughts (Hobson et al., 2005; Keogh 
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et al., 2005; Saunders et al., 2006). Maternal catastrophising might also interact 
with depression to increase pain following CS (Dehghani et al., 2014). 
 
Perioperative depression has been associated with greater postoperative CS pain 
(Lou & Kong, 2012) but it was not associated with postoperative pain in this 
research. Despite being a major component of the BPS model of pain, depression 
might be weighted more as an influence in a transition to the chronic phase of CS 
(Grosu & de Kock, 2011; Leo & Quinton, 2010). Furthermore, depression may have 
reciprocal relationships with catastrophising and fear of childbirth (Dehghani et al., 
2014; Keefe, 2009; Keogh et al., 2005; Turk et al., 2010). Thus, the combined 
effects of many other factors may have obscured the influence of depressive 
symptoms on postoperative pain. This research further demonstrated that there was 
a low incidence of depression prior to CS and so depression alone may not have 
been a key factor associated with postoperative pain. 
 
This research supports the use of the pain catastrophising scale alongside 
assessment of maternal depression in the perioperative setting. Both the pain 
catastrophising scale and the EPNDS scales could be easily administered by a NP 
prior to surgery where a therapeutic relationship could begin. A BPS approach to 
CS pain management strengthens the importance of a transitional pain management 
intervention that supports women from the prenatal phase through to the 
community phase.  
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Therapeutic support provided by clinicians can alleviate catastrophic thoughts and 
thus help patients to cope with pain using other strategies (Van der Gucht & Lewis, 
2015). As a known mediator between various BPS factors and pain, catastrophising 
is amenable to interventions such as education, relaxation, problem solving, 
communication and mindfulness meditation (Flor & Turk, 2011; Turk et al., 2010). 
The components of the BPS model of pain can enable the design of interventions 
that promote mutual discussion between the women and clinicians in relation to 
beliefs about pain, analgesic therapy in childbirth, previous experience, catastrophic 
thoughts and what factors are driving these thoughts (Turk, 1983). This approach 
may allow a NP to get to know the patient, identify the patient’s unique needs and 
discuss a pain management plan that can enable greater control and participation in 
CS birth (Jungyoun, 2015). This relationship, commenced prior to hospitalisation, 
could be strengthened on the day of surgery when the woman is admitted to 
hospital. 
 
6.5 Transition to CPSP 
Originally developed for the chronic pain setting (Turk et al., 2010), the BPS model 
of pain is an appropriate framework to explore the transition to CPSP following 
caesarean delivery. Studies on CPSP across different surgical contexts make it clear 
that biological, psychological and social factors are involved in the development of 
CPSP (Masselin-Dubois et al., 2013). The results of this research support the BPS 
model but there were expected and unexpected findings relating to the transition to 
chronic pain.   
 
 198 
The follow-up study to this research found that perioperative catastrophising was 
not associated with pain or pain interference during the three months after CS. 
While this differs with a study demonstrating that catastrophising was predictive of 
CPSP in various surgical models (Masselin-Dubois et al., 2013), the result for this 
research may have been because measurements of catastrophising were reported 
prior to hospitalisation, three months prior to the follow-up study. Thus, 
catastrophising measures for participants at three months may have differed to that 
in the prenatal phase. Moreover, maternal catastrophising prior to admission to 
hospital may have been influenced by anxiety and fear of the impending surgery.  
 
While some studies have shown an association between the intensity of 
postoperative pain and CPSP (Kainu et al., 2010; Niklasson, Ohman et al., 2015), 
no association was found in this research. As noted, average pain scores in the 
postoperative period were mild suggesting participant pain management was 
appropriate for most women in the study. Thus, postoperative pain intensity for this 
cohort would not have been high enough to demonstrate a connection between these 
factors because significant postoperative pain is required to create the biological 
changes necessary to cause peripheral sensitisation where pain transmission is 
amplified via the NMDA receptor in the dorsal horn of the spinal cord (Gupta et 
al., 2011; Kehlet et al., 2006; Voscopoulos & Lema, 2010). However, if pain 
persists for some individuals past the normal healing time, biological changes in 
the central nervous system may mark a transition to chronic pain (Navratilova & 
Porreca, 2014). 
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Emotional components of the BPS model such as depression contribute to the 
developing pain experience in the chronic phase (Gatchel, 2010). The transition to 
CPSP following CS involves biological changes but the impact of depression 
during this phase compounds the situation (Lavand’homme, 2013). This research 
demonstrated that the development of PND (measured by changes in EPNDS scores 
from baseline) predicted higher scores for pain quality, more days of pain and 
greater pain interference, three months following CS. Whether pain precedes 
depression or depression develops before CPSP is unclear (Gaudet et al., 2013). 
However, a large cohort study (n= 5614) found that the odds of developing PND 
were greater if women reported higher pain intensity after delivery and that PND 
was associated with caesarean delivery (Gaudet et al., 2013). This research found 
no association between changes in EPDNS scores and perioperative pain. Hence, 
there is a complex association between PND and CPSP and the accepted position 
is that no causal direction can be ascertained (Gaudet et al., 2013). Furthermore, it 
is also argued that many biological, psychological and social factors are involved 
in the development of PND (Chang et al., 2016). According to the BPS model, the 
transition to chronic pain after surgery is underscored by the interaction between 
pain and depression (Leo & Quinton, 2010) and the results of this research add 
increased knowledge to the impact of depression on pain outcomes as EPNDS 
changes predicted more pain across three dimensions. 
 
Perception of control in childbirth reflects the BPS model which supports self-
regulation and the use of personal resources to cope with pain (Turk et al., 2010). 
Control is an important issue because it has been linked to improved outcomes after 
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childbirth (Fenwick et al., 2003; McNeill & Jomeen, 2010) but any relationship 
between control and CPSP is unknown. In this research, however, increased 
perception of control reported in the postoperative period was associated with less 
pain interference three months after surgery. The meaning of this association is also 
difficult to interpret because there may exist a reciprocal association between 
control and PND that could also have influenced pain and pain behaviour following 
CS. A cohort study (n= 353), for example, found that women who perceived a lack 
of control were at higher risk for developing PND 6-8 weeks after delivery 
(Mohammed et al., 2011). While the causal relationships are complex and 
interrelated (Chang et al., 2016; Gaudet et al., 2013), despite the complexity of these 
relationships, the results of this research could indicate that women who had a 
higher perception of control and self-efficacy coped better with pain and were not 
bothered as much by pain and pain interference. Since PND has been associated 
with CPSP in this study, complex reciprocal relationships between PND, perceived 
control, pain interference and duration of pain need to be explored further and this 
research has provided an impetus to do so. 
 
This research and the BPS model recognise the role of biological factors in pain 
perception. Some have argued that obesity may lead to a pro-inflammatory state 
that contributes to persistent neuropathic pain (Ianitti et al., 2012; Lavand’homme, 
2013). In this study, maternal obesity was not linked to pain or pain interference 
during three months following CS despite a theoretical association between obesity 
and the development of chronic pain (Ianitti et al., 2012). Over 40% of participants 
in this study were classified as obese prior to CS, yet BMI still did not increase the 
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risk of CPSP in this cohort. It is argued here, therefore, that the transition to chronic 
pain is much more complex and that attempts to attribute causality based on single 
factors does not fit with the research literature on CS pain or the BPS model of pain. 
 
Acute pain may present as mixed subjective reports of nociceptive and neuropathic 
pain (Macintyre & Schug, 2014). Neuropathic pain, however, is not necessary to 
label pain as CPSP (IASP, 2010) but it has been implicated in the development of 
chronic pain, possibly due to the biological impact of surgery on nerves near the 
surgical site (Grosu & de Kock, 2011; Loos et al., 2008; Ortner et al., 2013). The 
quality of pain described by participants at three months suggested the presence of 
neuropathic pain with over 70% of all participants reporting numbness, itch and 
sensitivity of the scar to light touch. The high proportion of participants reporting 
neuropathic pain in this study therefore needs to be taken seriously and the use of 
research tools such as the SF-MPQ-2 is supported by these results because it can 
differentiate neuropathic and nociceptive pain (Breivik et al., 2008). Thus, the BPS 
approach to pain requires a comprehensive assessment of pain after discharge from 
hospital to identify potential factors that may drive the persistence of pain and 
deconditioning (Kerns & Ebert, 2010).  
 
Some women reported pain at the time of the telephone interview and the 
International Association for the Study of Pain notes that the incidence of CPSP 
after CS is approximately 10 per cent (IASP, 2011). This study found that pain was 
mild for most women at the time of the telephone interview with a point prevalence 
of approximately 6%, similar to the findings reported by Bonnal and others after 
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their study on patient controlled oral analgesia after CS (Bonnal et al., 2016). 
Therefore, the prospective design of this study may have yielded a more accurate 
prevalence for pain three months following CS and this approach has been 
supported as a more reliable design to evaluate CPSP (Lavand’homme, 2013). The 
prospective design of this research also enabled control of confounding variables 
and a more accurate recall of pain at the three-month time point, rather than some 
cohort studies with a high variability in recall periods from months to years after 
the surgery (Declerq et al., 2008).  
 
Serious disability may result from chronic pain and pain interference after surgery 
and the incidence of CPSP after CS is about 4 per cent (IASP, 2011). For most 
women in this study, pain and pain interference had decreased significantly from 
what was reported the day after surgery. This is also supported by the decreasing 
impact of pain for most participants in this study in relation to the number of days 
that pain stopped them doing their usual activities. If pain stopped maternal activity 
rather than make it more difficult, some women (4.7%) experienced serious pain 
interference, closer to the proportion of women who may develop disability after 
CS (IASP, 2011).  Moreover, this proportion of women said pain had stopped them 
for over 60 days and this suggests CPSP had a significant impact for these women. 
According to the methods of grading chronic pain and disability, nearly 6% of 
women in this study had a grading of severe disability, a little higher than 4% as 
described by the IASP (2011). From a BPS perspective, chronic pain is marked by 
complex relationships between pain, depression, pain interference and disability 
(Joshi & Ogunnaike, 2005). For some women, surrendering to pain also involves 
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significant depression and physical deconditioning may worsen maternal health and 
quality of life (Gatchel & Maddrey, 2004). Disability is also promoted by a 
perception that pain has taken over all aspects of an individual’s life (Gatchel & 
Maddrey, 2004). 
 
6.6 Limitations 
The sample size for this study limits the application of the findings to the general 
population and many factors involved are particular to the childbirth experience. 
For example, postoperative studies following other surgeries may not be influenced 
by previous childbirth experiences or postnatal depression. The size of the sample 
in the community phase of this study does not have the power to make statistical 
assumptions about CPSP after CS or the differences between groups in terms of 
neuropathic pain. However, the results may stimulate further research in this area.  
 
There could also be differences between the demographic characteristics of the 
sample and that of other birthing mothers in Australia. An example is where there 
was a lower proportion of participants in this study (10.6%) educated beyond high 
school compared with a proportion of almost 50% for the health district (Australian 
Bureau of Statistics, 2016). As well, only 8.2% of the sample were non-Caucasian 
and this may not reflect the makeup of the general population. As noted previously, 
there were no Aboriginal or Torres Strait Islander women in the study while the 
proportion of these persons in the district is 3.6% (Australian Bureau of Statistics, 
2016). The average age of participants in the sample is similar to women birthing 
in the Australian population (Australian Bureau of Statistics, 2016). One of the 
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strengths of this research, however, is that demographic factors were controlled for 
in the statistical methods applied to the primary outcome as well as the PGIC scale. 
 
This study is limited by the degree of blinding to treatment allocation. However, 
the integrative design of the study made it difficult in terms of blinding participants 
to the formulation of oxycodone because the intent of the intervention was to take 
advantage of the pharmacokinetics of IR oxycodone, whether administered in 
scheduled doses or as requested by participants. This concept also formed part of 
the content discussed with participants prior to the intervention.  This means that 
the use of a double dummy approach by administering the same number and type 
of tablets to both groups in real and placebo forms would have impacted on the 
intent of the IR oxycodone used as part of the NP intervention. As stated previously, 
this study did not set out to compare IR oxycodone with CR oxycodone. Rather, the 
intent was to compare an integrated NP intervention to one based on CR oxycodone 
which is prescribed in many settings. Despite this, it is acknowledged that more 
aspects to an intervention and less blinding is associated with confounding placebo 
or nocebo effects (Jakovljevic, 2014).  
 
Many factors have the potential to interact with the belief system of participants 
and confound research outcomes (Jakovljevic, 2014). It is unknown if participants 
in this study could have been in the same vicinity at some stage of the trial. The 
influence of other participants on trial outcomes was possible. If any participants 
observed benefits or no pain relief from the effects of treatments in other 
participants, the reported outcomes may have been confounded (Colloca & Grillon, 
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2014). These effects are difficult to control and participants may have also been 
influenced by staff members in a negative or a positive way. Verbal suggestions 
and attitudes of attending staff can also influence how participants may have 
perceived their treatment (Sanderson et al., 2013).  
 
The impact of CS pain and the difference in treatment effects on breastfeeding and 
maternal satisfaction were not included in this research. During the preparation 
phase of the research, these issues were considered because they have been 
measured in cohort studies on CS pain. However, many factors were excluded from 
this research due to a fear that more outcome measures would increase the burden 
placed on participants. 
 
6.7 A Biopsychosocial Model of Pain for CS 
From the origin of the BPS model in the setting of chronic pain, the model has 
become the overarching framework to guide research and clinical practice in pain 
management (Mosely & Butler, 2015). It was necessary, however, to modify the 
BPS model of pain due to its focus on psychosocial aspects of the pain experience 
(Leo & Quinton, 2010). While this research has shown that the BPS model is 
appropriate in the setting of acute pain management, some of its key components 
required refinement in order to articulate a perioperative framework for acute pain 
management. 
 
An approach to acute pain management that encompassed psychosocial 
components was proposed by Keefe (2009) but this approach left biological 
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influences on acute pain to the side. More recently, Edozien (2015) argued that a 
BPS model for childbirth pain should remain focused on all parts of the BPS model 
of pain. In keeping with a broad approach to acute pain management, a BPS 
approach considers all factors that influence the pain experience (Edozien, 2015). 
This includes analgesic therapy and other perioperative interventions. Biological 
factors also form a major aspect of a BPS approach to acute pain because they are 
usually more predominant influences on pain perception in this phase (Flor & Turk, 
2011). The original BPS model of pain supports this proposition because one of the 
basic assumptions of the model is that the weighting of factors can differ according 
to the situation or phase of care (Turk et al., 2010). This research focused on the 
acute phase of the CS experience which led to a refinement of the BPS model of 
pain. The purpose of the following sections is to present a revised BPS model of 
pain that can be used in the acute pain setting and, in particular, pain management 
for CS from preadmission to the community phase.  
 
6.7.1 Preadmission 
It was proposed earlier in this chapter that the NP intervention could be 
strengthened by commencing therapy prior to hospitalisation. This proposition is 
supported by the underlying assumption of the BPS model that the pain experience 
can be influenced by factors that exist prior to the pain stimulus or that anticipation 
of poor analgesia may increase catastrophic thoughts (Flor & Turk, 2011; Turk et 
al., 2010).  A clinic or telephone consultation by a NP could thus determine a 
catastrophising score and implement strategies to attenuate anxiety, fear and 
catastrophising. The discussion with women could incorporate educational 
elements and include previous childbirth experiences, beliefs about pain 
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management and control, preferences for pain management and options available 
in terms of generic analgesics. The BPS model of pain is not just a theoretical model 
but an interventional model that also includes relaxation and cognitive strategies to 
modify anxiety and catastrophising about pain (Flor & Turk, 2011; Turk et al., 
2010). Table 24 below sets out an intervention that could be carried out in the 
preadmission phase of the CS experience.  
 
Table 24 
Preadmission Intervention for CS Pain Management 
Strategy Content, Process and Rationale 
Introduction: 
Develop rapport & 
explain the NP role. 
Discuss the role of the NP: analgesic management, supportive 
role in hospital, ability to prescribe & individualise pain 
management. Rationale: A supportive relationship can decrease 
anxiety and enhance coping with pain (Flor & Turk, 2011; 
Jungyoun, 2015). 
Assessment: Gather 
information about 
the individual, 
assess pain 
catastrophising and 
desired degree of 
control or 
participation. 
Discuss previous experiences, beliefs, preferences for pain 
management and options available. Following this, assess degree 
of catastrophising with the PCS. Rationale: Perioperative 
catastrophising about pain is associated with greater 
postoperative pain (Darnal, 2016) and this has been 
demonstrated by this research. Patients express varying degrees 
of desire for control or participation over pain management 
(McTier et al., 2014; Zoega et al., 2014). 
Education on the 
ABC model, deep 
breathing and 
relaxation. 
Use the ABC model to modify catastrophic thoughts by getting 
the woman think about: 
A: What is the situation? 
B: How does she evaluate the situation? 
C: Describe feelings get the woman to dispute B & C and 
formulate a new evaluation. 
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Discuss how to identify cues or thoughts that increase stress and 
teach deep breathing exercises to reduce tension and think about 
pleasant situations. Rationale: Strategies can be used to reduce 
catastrophic thoughts and promote effective postoperative pain 
management (Darnal, 2016). The ABC model enables the 
individual to clarify a situation and evaluate negative feelings 
(Flor & Turk, 2011). Diaphragmatic breathing leads to relaxation 
and reduces tension leading to better pain control (Flor & Turk, 
2011). 
Construct an 
individualised 
analgesic plan. 
Explain the role of non-opioid analgesics and encourage IR 
opioids to reduce pain interference. Provide choice around type 
of non-steroidal analgesics and opioid therapy. Offer self-
administration if allowed in the facility and if appropriate to the 
individual’s desire for control. Rationale: Enable a degree of 
control over pain management that is appropriate for the 
individual woman (Flor & Turk, 2011; Snell & Hicks, 2006; 
Turk et al., 2010). 
 
The preadmission consultation can also involve a discussion about strategies to 
increase perceived control to a degree that is acceptable to women and to share 
specific information about the pharmacology of analgesics and how they can be 
used to decrease pain interference with maternal functional goals. Discussions 
about using analgesics to reduce pain interference can lead to less pain and better 
mobility following surgery (Sayin et al., 2012). This strategy might also promote 
maternal confidence to communicate about pain management to clinical staff in 
terms of additional pain relief (Yates et al., 2004). The content of this section needs 
to also address how opioid analgesics will be administered or made available. The 
options would include oral IR oxycodone on request only (midwife administered) 
or self-administration as required by the woman. Procedures would have to be in 
place for self-administration within the postnatal care unit to comply with 
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government poisons legislation and medication safety guidelines for the particular 
hospital. The end of this discussion may include content on the use of oral opioids 
and breast feeding. This is an area of significant maternal concern and it needs to 
be conveyed that there is a small risk to neonatal health, especially when the woman 
produces increased volumes of milk (Seaton, Reeves & McLean, 2009).  
 
As noted previously, more decision-making power could be shifted to a woman 
undergoing CS if various classes of non-steroidal anti-inflammatory drugs are made 
available such as ibuprofen, diclofenac and celecoxib. In terms of opioid analgesia, 
there are other classes of oral opioids available as well. Oral morphine or tramadol 
may be preferred by some women as the primary opioid for postoperative pain 
management. A BPS approach to pain management might offer women more 
choice about what therapies will be used so that the treatment plan meets individual 
requirements (Jungyoun, 2015). In collaboration with the woman, a pain 
management plan comprising drug and non-drug strategies needs to be documented 
and the information shared with the healthcare team. The effectiveness of 
interventions involves collaboration with the patient and other team members 
(Jungyoun, 2015).  
 
In summary, the modified BPS model for acute pain commences a NP intervention 
prior to CS rather than on the day of surgery as in this study. The goals of an NP 
intervention in this phase are to: (1) develop a supportive relationship by getting to 
know the woman; (2) identify the unique beliefs and preferences of the woman in 
terms of pain management therapies and childbirth; (3) assess maternal 
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catastrophising so that early intervention can alleviate these symptoms; (4) teach 
selected women strategies to reduce catastrophising and unhelpful thoughts and; (5) 
share information about pain interventions for childbirth and develop an 
individualised pain management plan that meets the needs of the woman and 
promotes an appropriate degree of control and participation in care. 
 
6.7.2 Hospitalisation 
The BPS model of pain assumes that pain is experienced over time and that, as such, 
pain interventions should be delivered at different points in time (Turk et al., 2010). 
A NP can enhance the supportive relationship formed in the preadmission phase by 
meeting the woman prior to surgery and discussing any concerns about CS and what 
was discussed during the preadmission consultation. The aim here is to 
communicate support for the woman and clarify the plan formulated prior to 
surgery. 
 
On the morning following CS, the NP could assess pain and pain interference, 
implement the pain management plan and suggest other strategies to help the 
woman cope with pain such as distraction, deep breathing and relaxation (Flor & 
Turk, 2011). These supportive strategies can reduce stress and tension that may lead 
to greater pain perception and interference (Flor & Turk, 2011). The discussion 
would also include using IR oral opioids to decrease pain interference and promote 
mobility and infant care. It would be important to discuss concerns about 
breastfeeding and infant safety by describing how little milk infants receive in the 
first few days and thus how little opioid would be ingested by the baby over this 
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period (Seaton et al., 2009). The analgesic plan also needs to be implemented 
according to maternal preference and degree of control required. Analgesic options 
and other strategies are described in Table 25. Importantly, follow-up of the woman 
should repeat assessment of pain, degree of interference and modifications could 
be made according to response. This is a fundamental element of NP practice and 
quality use of medicines (Australian Pharmaceutical Advisory Council, 2005; 
Nursing & Midwifery Board of Australia, 2014).  
 
Table 25 
NP Intervention for Postoperative CS Pain 
Strategy Content, Process and Rationale 
Develop 
supportive 
relationship. 
 
 
Greet the woman and reinforce the supportive role of the NP. 
Explain that no two people will experience pain the same way and 
that pain depends on analgesics and other factors such as mood and 
stress. Reinforce deep breathing and other strategies discussed in 
the preadmission phase. Rationale: A supportive relationship can 
decrease anxiety and enhance coping with pain (Flor & Turk, 2011; 
Jungyoun, 2015). The intervention uses multiple interventions to 
cope with pain and stress (Flor & Turk, 2011). 
Assess pain and 
discuss analgesic 
plan. 
 
 
Assess subjective pain intensity on a 0-10 verbal rating scale at rest 
and on movement. Explain the use of analgesics and the 
relationship with pain interference.  Discuss the analgesic plan 
considered in the preadmission phase. Rationale: Individuals 
respond to pain and analgesics in unique ways (Turk et al., 2010). 
The strategy reinforces that IR opioids have a faster onset and can 
reduce pain interference. Discussing the plan made in preadmission 
ensures the desired degree of control over pain management (Flor 
& Turk, 2011; Snell & Hicks, 2006; Turk et al., 2010). 
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Assess response 
to the pain 
management plan. 
Time: anytime as 
discussed with the 
woman or on 
request. 
Re-assess pain and assess pain interference using 0-10 verbal rating 
scales. Assess pain interference on activity, walking and coughing. 
Provide opportunities to alter the plan in regard to:  type of 
analgesic, scheduled or unscheduled doses. Adjust opioid 
analgesics according to the woman’s needs. Rationale: Pain 
interference on walking, coughing and activity was reduced by the 
NP intervention in this research. Follow-up assessment allows 
modification to the pain management plan and is a Quality use of 
Medicines guideline. 
Discharge Pain 
Management. 
Determine opioid requirements over the previous 24 hours and 
discuss preferred discharge analgesics with the woman. Prescribe 
only IR opioids if necessary and limit quantities dispensed. Provide 
education on monitoring baby for sedation, opioid side effects, 
storage & disposal of opioids. Rationale: Promote safety by 
reducing the diversion of opioids into the community (Macintyre & 
Schug, 2014). Acute pain will decrease over time and opioid 
requirement will decrease (Macintyre & Schug, 2014). 
 
6.7.3 Community Phase 
The focus and intensity of this phase in terms of the intervention will depend on the 
individual situation. From the analysis in this study and other prospective studies 
three months after CS, it appears that most women recover quickly from CS with 
little pain, low depression scores and mild disability for a short time. However, 
around 5-6% of women continue to suffer from pain past the normal healing time 
of 1-2 months and their problems may only be known to the NP and other team 
members if a telephone follow-up is conducted.  
 
A thorough pain assessment with a BPS approach needs to be undertaken to 
ascertain if there are problems with pain, function and mood after CS. The GCPS 
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can be used to determine the burden of pain after CS by evaluating the number of 
days that women experienced pain, pain intensity and pain interference (Von Korff, 
2011). The NP can then assign a grading to the woman and base treatment options 
on the grade of chronic pain and disability (Von Korff, 2011). Because Grade I 
indicates low intensity and disability, no intervention may be required. Suggested 
interventions, however, for Grades II to IV are described in Table 26. The quality 
of pain can be assessed by asking the woman to describe her pain to determine the 
presence of neuropathic pain so that appropriate treatment can be implemented such 
as BPS approaches to CPSP.  
 
Increased EPNDS score for the woman is a sign of PND developing and scores 
greater than 13 can trigger referral for specialist treatment.  The score is of 
importance due to the strong link between CPSP and PND found in this study and 
the argument of others that psychosocial factors are the drivers of CPSP (Masselin-
Dubois et al., 2013). Adequate social support at this time may also be crucial for 
the woman’s return to healthy functioning in relation to pain and depressive 
symptoms (Chang et al., 2016; Gaudet et al., 2013). Whether pain is a causal factor 
in PND or not, services have a responsibility to monitor for both as they are 
associated with disability and healthcare burden. In this sense, an integrated model 
of care would be more widely accepted because of the established links the BPS 
model has with chronic pain. A multidisciplinary approach to care can be 
encouraged by the NP if a woman continues to experience pain and disability in the 
community. There are resources available to assist women and these include 
community midwives, child health nurses, psychologists, general practitioners and 
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community pharmacists. This current research challenges existing models that 
separate acute pain from chronic pain because the results of the study in the prenatal 
and hospital phases also fit within the BPS model of pain. Moreover, the BPS model 
of pain assumes that pain has a longitudinal nature rather than an experience at one 
point in time. 
 
Table 26 
Postoperative telephone consultation by NP at three months  
Strategy Content, Process and Rationale 
Graded Chronic 
Pain & Disability 
Scale. 
Assess pain intensity on a 0-10 verbal rating scale at the time of 
interview, average over three months and worst over the last three 
months. Determine the number of days that pain was experienced in 
three months. Assess pain interference using 0-10 verbal rating 
scales with: usual activities, daily activities and recreational, social 
and family activities. Also, determine the number of days that pain 
stopped the woman doing usual activities. Rationale: The scale can 
be used to grade chronic pain and disability (Von Korff, 2011) and 
there is evidence for CPSP in this research and confirmed by the 
IASP (2011). 
Assess pain 
quality. 
Ask the woman to describe her pain quality and note symptoms of 
neuropathic pain such as burning, shooting, stabbing, numbness, 
allodynia and hyperalgesia (Macintyre & Schug, 2014). Rationale: 
Neuropathic pain has been implicated in CPSP following CS (Loos 
et al., 2008; Ortner et al., 2013). 
Assess EPNDS. Assess for postnatal depression (Cox et al., 1987). Rationale: There 
was an association between depression and CPSP in this research 
and in BPS model of pain (Turk et al., 2010). 
Intervention & 
referral 
processes. 
Chronic pain and disability grading: 
Grade I: Discuss options if no resolution or pain gets worse. 
Grade II: suggest review of wound by local medical officer 
and offer analgesic advice. 
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Grade III to IV: Collaborate with hospital team for urgent 
follow-up appointment- surgical and NP pain consultation. 
EPNDS >13: refer the woman to GP for treatment of depression. 
Rationale: Pain related disability may be around 4% following CS 
(IASP, 2011). EPNDS>13 can indicate significant depression (Cox 
et al., 1987). 
 
6.7.4 Financial cost  
From the perspective of this research, a NP pain specialist would be required to 
deliver comprehensive care to women in order to transition them through the phases 
of the CS experience. This is because of the need to use extended practice 
assessment skills, advanced communication skills and prescribing rights to initiate 
and adjust analgesic therapy along the continuum of care (Nursing & Midwifery 
Board of Australia, 2014). Yet, few pain services in the acute pain setting have a 
NP as part of a team with medical staff in the provision of childbirth pain 
management. For those without this team structure led by a NP, this new model of 
care would come at a cost with some NPs in Australia receiving higher annual 
earnings than anaesthetic trainees or medical registrars (Queensland Health, 2016, 
2015a). Some have criticised the BPS model of pain for encouraging innovative 
pain services that may be costly in terms of human resources, space and time to 
implement integrated care along a continuum (Kerns & Ebert, 2010). Nonetheless 
and while many acute pain services in Australia are led by Advanced Practice 
Nurses who do not have prescribing rights the cost to convert these roles to a NP 
level would be a wage increase of approximately seven thousand dollars annually 
(Queensland Health, 2015a). The benefits of a collaborative and autonomous NP 
led service might offset this cost in terms of increased access to healthcare for 
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women, early discharge from hospital and the prevention of chronic pain and 
disability. For existing NP led models of pain management, the capacity already 
exists for NPs to extend their practice into this area and work autonomously, rather 
than participate on collaborative pain rounds with medical staff. Moreover, the 
domains of NP practice support a BPS approach that can be delivered in an 
autonomous fashion and promote the individualised care that is required (Nursing 
& Midwifery Board of Australia, 2014). While the collaborative model has benefits 
that may fill gaps in pain service provision when NPs work autonomously 
(Schoenwald, 2011), NP roles have the capacity to develop in new directions that 
enable NPs to function according to their full scope of practice so that innovative 
models of care can address complex health problems such as childbirth pain 
management. 
 
6.8 Conclusion 
The overarching theme and outcome of this research is that the BPS model of pain 
is relevant to acute pain management and has deserved further development so it 
can be applied to further research and clinical practice. As a framework for pain 
management nursing, the BPS model of pain complements the domains of NP 
practice. The application of the model integrates well with the BPS approach 
because NP professional standards support biological and psychosocial aspects of 
healthcare delivery (Nursing & Midwifery Board of Australia, 2014). This research 
has also shown that CS is a complex BPS experience that requires consideration of 
many factors other than analgesic therapy to meet the individual needs of women. 
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The NP led intervention was an attempt to improve pain management so that the 
unique needs of women might have been met. While the NP intervention 
demonstrated no significance of effect on the primary outcome, standard treatment 
with CR oxycodone had no benefit across most outcome measures when compared 
to the intervention. Furthermore, many secondary outcomes favoured the NP 
intervention such as a reduction in pain interference the day after CS and the 
perception of improved pain relief over three hours following commencement. 
These results were also clinically meaningful and support a new model of care for 
acute pain management in this setting as women could have better attained their 
functional goals as a result of less pain interference with mobilisation and infant 
care. Moreover, less pain interference in the acute pain setting may prevent severe 
postoperative complications (Macintyre & Schug, 2014).  
 
One of the main psychological factors that underscores the childbirth pain 
experience is that of perceived control and this is also a major component of the 
BPS model of pain. The NP led intervention did not alter perceptions compared to 
standard treatment and it was argued that women could have been given more 
decision-making power over the type and doses of analgesics used and how they 
could be administered. Moreover, this could have been enhanced by developing a 
pain management plan prior to hospitalisation for CS where a NP could address the 
degree of control required by the women and how beliefs about pain management 
could direct maternal preferences for analgesic use in childbirth. 
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This research also supports the need for women to request additional opioid 
analgesia even though they received intrathecal morphine during the anaesthetic. 
Many women requested additional analgesia well before eighteen hours following 
administration and this coincides with the decline in intrathecal morphine analgesia 
after 12 hours (Hindle, 2008) and the potential for some women to have mobilised, 
necessitating the requirement for additional analgesia. Not all women required 
additional analgesia and like previous research on CS pain (McDonnell et al., 
2010), this research has also demonstrated that maternal requirements for oral 
opioids are highly variable. Hence, a new approach to pain management is required 
to manage the supplemental use of oral oxycodone with a supportive intervention 
that enables follow-up assessment and individualised opioid titration. This method 
is supported by clinical guidelines on acute pain management (Analgesic Expert 
group, 2012) and national guidelines on the quality use of medicines (Australian 
Pharmaceutical Advisory Council, 2005). Thus, the continuous support of a NP 
within a BPS approach to acute pain management addresses the pitfalls of a one-
size-fits all approach that cannot provide appropriate pain management for all 
women because it is based on a sensory-physiological conceptualisation of pain. 
 
This research concludes that there are a range of BPS factors that shape perceptions 
of and responses to the CS experience. As described across various surgical models 
(Masselin-Dubois et al., 2013), the association between catastrophising and 
postoperative pain was an expected result and this points to assessment and 
treatment of pain catastrophising prior to hospitalisation. At this time, a woman’s 
experience of childbirth can also be explored as this research also found previous 
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CS to be associated with more postoperative pain. These results underscore a BPS 
approach to understanding CS pain because these factors may also be connected 
with neuropathic pain from previous surgery. Intense fear of pain prior to a 
subsequent delivery may compound into catastrophising and more pain. 
Furthermore, the implication of PND in the transition to chronic pain has added 
new knowledge to the complexity of pain management following CS and supports 
an approach that continues after discharge from hospital. 
 
A BPS model of acute pain management is not complete without an exploration of 
CPSP following caesarean delivery. For many women, the burden of pain was low 
but this research also demonstrated that a small proportion of women experienced 
significant pain and disability three months after surgery. According to the chronic 
pain and disability scale (Von Korff, 2011), 6% of women in this research were 
categorised as having Grade IV chronic pain and disability, a little higher than 4% 
proposed by the International Association for the Study of Pain (IASP, 2011). This 
means that between four and six women out of 100 may experience significant 
healthcare problems following CS surgery. This is a serious issue given the rising 
number of CS deliveries across the world. Hence, service models can be re-
developed to address these complex issues and so this research proposed a revised 
BPS model of pain that can be applied to acute pain management for CS. 
 
The main implication of this research is the development of the BPS model for 
acute pain. The refined model expands on the work of Keefe (2009) and includes 
biological factors as equally important components of the model. While the BPS 
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model of pain has been a comprehensive model for application to the chronic pain 
setting (Leo & Quinton, 2010), the model as a framework for acute pain 
management needed to address biological factors as these are weighted as having 
an important influence on acute pain (Flor & Turk, 2011).  
 
Implementation of a NP led BPS model of care for CS has cost implications. 
However, for existing models led by nurses who are not NPs, the cost of conversion 
to an NP role may be under $10,000 per annum once training is completed. Pain 
service models led by nurses who are already NPs can modify the scope of practice 
and enable more autonomous pain management within this area. Role re-
development and expansion has the potential to narrow this gap in health service 
and promote shorter hospital stay, appropriate use of analgesics and the prevention 
of chronic pain after surgery.
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Chapter 7: Conclusion 
The research reported upon here was conceived during an extensive lead-up period 
of clinical practice, service innovation and critique of existing practices.  The NP 
who led the research and delivered the intervention explored the problem of CS 
over a decade prior to formalising a research strategy and was directly involved 
with pain management following CS on a daily basis as part of a multidisciplinary 
team. Endorsement as a NP enabled further exploration with analgesic prescription 
and evaluation of alternative methods of pain management compared to standard 
practice in the research setting. As noted earlier in this thesis, it is common for NPs 
to question existing practices as they become more experienced and confident in 
challenging the views of other health professionals (Cashin et al., 2014). In 
particular, the art of challenging entrenched practice is not easy and was met with 
strong opposition from some clinical staff. This reflected dichotomous views of 
childbirth pain management that result in favouritism given to biological or 
psychosocial interventions. Nonetheless, the process was worthwhile and the 
findings of this research support the use of the theoretical model by showing that a 
broader approach to pain management can be effective in improving pain outcomes 
after CS. 
 
New knowledge in the area of acute pain management was developed from this 
research. The specific purpose was to compare an integrated NP intervention to a 
standard regimen of CR oxycodone. While the primary outcome of pain intensity 
at rest and on sitting/movement was not changed in a meaningful way, or maternal 
perceptions of control altered, other outcomes favoured the NP intervention where 
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there was less pain interference during the day after surgery and less consumption 
of opioid analgesics over two postoperative days. Furthermore, catastrophising in 
the preadmission period and previous history of CS were associated with more 
postoperative pain. In terms of chronic pain after discharge from hospital, this 
research also adds knowledge in this area because it not only reported the point 
prevalence of significant pain at three months (5.9%) but also reported that women 
experienced pain for a median of four days in three months after discharge. More 
importantly, for the 5.9% of women who were categorised as having severe 
interference from pain over three months (Grade IV chronic pain and disability), 
pain stopped most of them undertaking normal activities for more than 60 days.  
With greater than 70% of the cohort reporting symptoms of neuropathic pain, it is 
speculated here that neuropathic pain may also contribute to chronic pain following 
CS. A major finding was that postnatal depression was associated with pain 
interference, more days in pain and total pain intensity over three months. The 
research results have addressed the original objectives of this research which were 
to test the effectiveness of a NP intervention, explore the experience of chronic pain 
following CS, and to support the use of the BPS model of pain in the context of 
acute pain management. 
 
This research provides the justification for the BPS model of pain to be accepted as 
a valid framework in the acute pain setting. As a model to guide theory, research 
and practice, the BPS model of pain has traditionally been viewed as a model for 
chronic pain (Leo & Kern, 2010).  Nonetheless and as argued elsewhere (Edozien, 
2015), the model has not been utilised to its full potential for acute pain treatment 
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or research (Edozien, 2015). The lack of recognition might be due to the dominant, 
disciplinary based philosophical views on the nature and experience of pain that 
have led to some components of the model attributed greater credibility than others. 
Hence and arguably, the potential for the model to serve as a comprehensive 
platform for research and pain intervention has not been fully realised because of 
the prevailing concept of mind-body dualism. Psychologists, for example, may 
direct more attention to psychosocial factors that influence pain and anaesthetists 
may view pain as proportional to the biological stimulus and adequacy of drug 
treatments. As a broad model of pain management for this research, the BPS model 
has enabled an interpretation of the treatment and experience of pain following CS 
that fits with much research on the nature of this experience and the domains of NP 
practice. 
 
The fundamental assumptions of the BPS model have derived from a long history 
of thought regarding the nature of pain and observational data on the effectiveness 
of both psychosocial and biological interventions to reduce pain. Despite the 
acceptability of the model by the scientific community (Mosely & Butler, 2015), 
acute pain interventions remain focused on analgesic administration which reflects 
the prevailing philosophy of mind-body dualism. There are many research 
examples of this philosophical approach where various drugs and invasive therapies 
have been compared in order to improve pain management after CS. Examples are 
procedures such as local anaesthetic infusions (Kainu et al., 2012; Larsen et al., 
2015), oral gabapentinoids (Short et al., 2012) and transversus abdominal plane 
blocks (Loane et al., 2012; Mishriky et al., 2012). These procedures are attempts 
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by anaesthetists to combat postoperative CS pain with biological interventions but 
the effects are short-lived. This may reflect a general view that other strategies are 
not a priority for acute pain management and so little consideration has been given 
to supportive strategies that enhance pain management beyond the acute 
perioperative period. The current research challenges the assumptions of the 
biomedical approach to acute pain management in taking an integrative approach 
that considers biological, psychological and social aspects of pain and pain 
intervention. A challenge to the biomedical position appeared over 50 years ago 
with the gate control theory (Melzack & Wall, 1965) and has continued with the 
development of psychological interventions in the treatment of pain. Many theorists 
and practitioners, including Ronald Melzack (1999), John Loeser (1982) and 
Dennis Turk (1996), led the evolution of the BPS model of pain which asserts that 
biological aspects of pain management are important but these factors are not able 
to treat pain effectively without integrating other strategies. Despite what is known 
about the nature of pain, the biomedical approach appears to prevail in acute pain 
contexts as a one-size-fits all approach to pain management. The approach negates 
the need for additional resources such as new roles with clinical expertise and 
flexibility in terms of multidimensional approaches to pain management.   
 
This research has demonstrated that CS pain is a complex experience and the 
methodology employed followed a call for the BPS model to be applied in acute 
pain (Edozien, 2015). The model led to the design of a NP intervention that 
contributes new evidence for the treatment of acute pain in integrating drug and 
non-drug strategies. The aim was to individualise treatment with a NP approach to 
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pain management as an alternative to a standard fixed dose of oxycodone which is 
not an effective solution to a complex childbirth problem that has been described 
as an intensely painful experience (Marcus et al., 2015). It appears as though nurses 
are the best prepared clinicians to transform acute pain management. Nurses assess 
patients using a broad range of perspectives and use critical reasoning to meet the 
individual needs of patients (Cashin & Harding, 2015). Furthermore, nurses are the 
primary pain management providers along a continuum of care that seeks to meet 
patient needs when they need it (Cashin & Harding, 2015; Kindler, Polomano & 
Douglas, 2015). Nursing practice has evolved from many scientific views about 
human health and many NPs have autonomous prescribing rights in relation to 
opioid analgesics. The NP intervention in this research was designed to create a 
supportive relationship with women, increase their knowledge and confidence 
regarding the use of IR oxycodone and promote control over pain management with 
particular emphasis on oral oxycodone and its relationship with reduced pain 
interference. To deliver a BPS approach to pain management, the NP can consider 
the unique characteristics of women to customise an appropriate pain management 
plan that accounts for biological, psychological and social perspectives of the pain 
experience (Jungyoun, 2015; Schoenwald & Douglas, 2016). The BPS model 
informs this approach and supports the integration of analgesic medication and 
other strategies to optimise pain management (Turk et al., 2010). This includes 
strategies to address anxiety, catastrophising and supportive relationships 
(Schoenwald & Douglas, 2016). In contrast to the biomedical model, nurses and 
NPs give high priority to non-drug interventions (Schoenwald & Douglas, 2016) 
and bring together all that is relevant to acute pain management. 
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In this research, the NP intervention did not affect pain intensity scores enough to 
result in a statistically significant difference between groups or one that reduced 
pain by a proportion that would indicate clinically meaningful pain reduction.  A 
suggestion was made that VAS pain scores are not the only indicators of the 
effectiveness of pain interventions and global impression of change in pain can be 
also useful in determining the effectiveness of an intervention. Although these were 
secondary outcomes, the NP intervention improved outcomes for women by 
demonstrating better pain relief on a categorical scale and more reduction of pain 
interference with clinically meaningful effect sizes for both. Thus, while reduced 
pain intensity for the intervention group was not clinically meaningful, the overall 
trend across many other dimensions favoured the NP approach and suggests a 
potential for future research to evaluate interventions based on a BPS framework. 
Significant results such as reduced pain interference, less opioid consumption and 
greater odds of experiencing clinically meaningful pain relief warrant further 
attention by the research and clinical community.  
 
The research results also support multidimensional pain assessment as a 
fundamental concept of the BPS model as it allows exploration of the various BPS 
factors involved. Failure to address pain in this way would mean continued reliance 
on pain intensity scores without consideration of the psychological and social 
impact of pain on patients. This study has shown that CS pain can be measured in 
terms of its intensity, impact and quality and that an integrated intervention can 
target these components. The BPI, for example, considers biological, psychological 
 227 
and social factors with questions to measure the impact of pain on mobility, mood 
and relationships. The NP approach to acute pain management drew on these 
concepts and on the BPS model as the platform for evaluation of the CS experience. 
 
This research speculated that the NP intervention in this study would increase 
maternal perceptions of control but there were no differences between the 
intervention and control groups. Various reasons were suggested for this outcome 
such as women having little control over analgesic administration and the 
disempowerment of women as the result of an overwhelmingly biomedical 
experience on the day of surgery and in the immediate postoperative period. As 
noted previously in the theoretical framework and analysis, biological intervention 
is necessary but may marginalise attempts to individualise care where that care is 
commenced during these periods.  Thus, a recommendation of this study is to 
commence a BPS approach to pain management prior to admission to hospital. 
Strategies to improve self-efficacy and control may be better commenced in the 
preadmission phase as part of an intervention for pain that needs to be part of a 
collaborative team approach. This is because control in childbirth may also relate 
to decisions regarding the birth environment, who will be present and what happens 
around the delivery of the baby (Meyer, 2013). A team approach to control in 
childbirth may enhance self-efficacy and reduce catastrophising, anxiety, 
depression and pain surrounding the CS experience. This is supported by the 
conceptualisation of this approach to care as a collaborative exercise and a 
therapeutic and personal endeavour (Jungyoun, 2015). The approach also 
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recognises that patients have different levels of desire for control over pain 
management (McTier et al., 2014). 
 
Since the BPS model assumes that the pain experience is not relative to one point 
in time, this study viewed the subject from a longitudinal perspective and 
recognised that biological, psychological and social factors influence pain 
perception over time. Many factors affect pain perception and behaviour prior to 
the pain stimulus itself and throughout the journey. The results of this study 
substantiate this basic assumption by finding that catastrophic thoughts were 
associated with greater postoperative pain intensity. The degree of catastrophising 
is a potent predictor of pain and this research has highlighted the importance of 
preadmission assessment. The research results confirm that biological factors are 
not the only influences on pain perception and that a biomedical approach to CS is 
limited. Thus, new evidence from this and existing research supports a BPS 
approach to CS pain that may commence prior to hospital admission and continue 
after discharge from hospital. 
 
An exploratory follow-up study into pain outcomes three months after CS was one 
of the main purposes for the research because of the evidence for CPSP after CS 
and the assumptions of the BPS model of pain that pain is not an experience at a 
single point in time. Thus, the results of this research and the research literature 
strongly support the extension of the NP intervention to the community phase of 
the CS experience. While a small proportion of women were found to have 
experienced chronic pain and disability over three months, it is appropriate to 
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address this problem because of ethical considerations and the long-term 
implications this may have for many women. Assessment of pain and mental health 
following discharge from hospital is an important implication of this research 
because CPSP and disability were associated with postnatal depression. While there 
is no established causal relationship between pain and depression (Gaudet et al., 
2013) these factors are interrelated and influence pain perception and rehabilitation 
(Gatchel & Maddrey, 2004) as reflected in the BPS model of pain. In this study, the 
development of postnatal depression was a strong predictor of pain interference and 
the number of days that women experienced pain. Hence, this new finding in the 
context of postoperative pain supports the application of the BPS model in acute 
pain management given the broad and longitudinal aspects of the model. 
 
Without the BPS model of pain as a framework for this research, it may not have 
been realised that previous CS surgery can predispose women to greater 
postoperative pain that displays neuropathic pain qualities. Many women reported 
pain descriptors signifying that pain after CS has mixed nociceptive and 
neuropathic components. Neuropathic pain has been associated with nerve injury 
from Pfannenstiel incision (Loos et al., 2008) and is associated with chronic pain 
(IASP, 2011). Thus, routine assessment of postoperative pain quality is another 
implication of this research. It would be appropriate to include this in a 
multidimensional assessment of outcomes after CS because of the psychosocial 
drivers of CPSP such as depression. The potential transition from acute to chronic 
pain after CS and the complex interactions between many factors leaves little doubt 
about the credibility of the BPS model as a platform for exploration and service 
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delivery following the CS experience. A failure to recognise this may lead to 
significant disability for some women and a burden on health services. Given that 
CS may account for over 25% of births in some countries (Betran et al., 2016), an 
incidence of chronic pain and disability of 4-6% represents a serious healthcare 
problem and economic cost.  
 
There are many drivers of CPSP and psychosocial factors are predominant in 
various surgical models (Masselin-Dubois et al., 2013). Perceived control and self-
efficacy are related psychosocial concepts that feature in the BPS model of pain 
with its focus on chronic pain (Turk et al., 2010). The application of the BPS model 
of pain to this research resulted in an unexpected finding that maternal perception 
of control over pain management in the postoperative phase was associated with 
less pain interference three months after surgery. The reason for this relationship is 
unclear but the two concepts may be linked because women who perceive 
themselves to be in control or self-efficacious could have better coped with pain 
using their own skills and resources (Turk et al., 2010). The implication may be that 
perceived control needs to be explored in the community phase of CS so that 
individual perceptions can be evaluated and suitable interventions designed to use 
perceived control to promote recovery from CS in terms of pain and its emotional 
and social impact. 
 
When looking more specifically at the pain management plan, maternal control and 
participation in pain management may be promoted by commencing therapy in the 
preadmission phase where time could be devoted to the formation of an appropriate 
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analgesic plan. There are many types of opioid and non-opioid analgesics to choose 
from and choices about doses and administration times. In the appropriate hospital 
environment, self-administration of analgesics may also enhance analgesia without 
greater opioid consumption (Snell & Hicks, 2006). The one-size-fits all approach 
reflects the narrow assumptions of the biomedical model. The concept of 
individualised care refutes the Cartesian view that there is little variance in 
individual responses to pain and analgesic therapies. The approach used in this 
research drew on the premise that individuals respond differently to pain and have 
unique beliefs and preferences for pain management. A tailor-made pain 
management plan can avoid some of the problems created by the biomedical 
approach such as opioid-induced side effects and inadequate analgesia.  
 
A major limitation of this research is that the treatment effect of the intervention 
could only be applied across all time-points and at only two specific points in time, 
at 9:00 hours for pain at rest and at 10:00 hours for pain on sitting the day following 
surgery. This is because the second and third splines of the response curves for pain 
intensity were too varied to include them in the regression models. Analysis of these 
other time points would also not have been appropriate due to the issue of 
multiplicity in statistical interpretation. This means that, for every statistical test, 
the likelihood of a statistically significant result increases and so the results become 
less reliable (Turk et al., 2008). The results for pain scores on a 0-100mm VAS, 
however, are relevant to this research because the BPS model of pain assumes the 
unique response of individuals to pain and analgesic therapy. It may not be a 
surprise, therefore, that the primary outcome displayed high variability at many 
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time-points. Hence, while this variability in results limited the study, it confirms 
the assumptions of the BPS model of pain and why it is important to individualise 
pain management using multiple strategies. 
 
In terms of research design, a further limitation is the degree of participant and 
researcher blinding. This can be partly attributed to funding restrictions and the cost 
that would have been incurred by having to manufacture dummy tablets of 
oxycodone. The design of the intervention and funding also made it difficult to 
reduce the potential for the NP to influence the outcomes of the study due to direct 
involvement as part of the intervention. The NP researcher also entered the data 
onto the statistical software program. However, data management and statistical 
analysis are part of developing as a researcher.  Nonetheless, the NP intervention 
was an innovation for acute pain management as it challenged the biomedical 
approach to analgesic therapy by viewing acute pain and CS as complex BPS 
experiences. The method of analysis with spline regression within a linear mixed 
model overcame some of the shortfalls of this research because many other 
confounding variables were controlled for in the model, whereas previous studies 
have not included psychosocial variables in the interpretation of acute pain trials, 
nor controlled for their association with pain outcomes. 
 
Overall and when comparing multiple outcome measures, this research 
demonstrated that a NP approach to pain management with oxycodone resulted in 
more effective pain management with less consumption of opioids. From this 
perspective, the results and discussion integrated with the purpose of the research 
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as it generated new evidence for a NP approach to acute pain management and for 
measuring multiple BPS factors in acute pain research.  The NP approach to pain 
management was underpinned by the assumptions of the BPS model of pain and 
supported by guidelines on analgesic therapy for acute pain and quality use of 
medicines (Analgesic Expert Group, 2012; Australian Pharmaceutical Advisory 
Council, 2005; Department of Health & Ageing, 1999). This study gives support to 
these guidelines and critiques the practice of prescribing CR oxycodone to 
supplement intrathecal morphine analgesia the morning following CS. In the 
context of CS, the practice of prescribing CR oxycodone is unnecessary for most 
women and risks poor analgesia, maternal drowsiness and neonatal respiratory 
depression. The continued prescription of oxycodone for use in the community also 
risks diversion of oxycodone and mismanagement of opioid medication to people 
for which it was not prescribed. The potential for misuse can be reduced by 
individualised assessment of pain and opioid requirements prior to discharge from 
hospital as not all women require opioids at this stage as evidenced by this research 
and in clinical practice. 
 
One of the main purposes for this research was to show that the BPS model of pain 
is relevant to acute pain management. In this context, a new BPS model for CS was 
proposed and it has the potential to be applied across many surgical models of care. 
The new model has drawn on the BPS model of pain as the overarching framework 
but specific parts of the acute model were a synthesis of the results of this study and 
research that explored some of the components of the BPS model in acute and 
chronic pain environments. The study began as an expansion on previous research 
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for the effectiveness of IR oxycodone following CS (Davis et al., 2006; McDonnell 
et al., 2010) and its randomised design was based on these earlier trials. However, 
review of the literature revealed that CS pain is a complex experience and many 
BPS factors needed to be considered in terms of control over baseline data and 
baseline maternal characteristics in addition to the methodology with 
multidimensional pain outcomes. As PI, the NP developed the intervention based 
on the literature and the BPS model of pain. Hence, the intervention in this study 
has supported the notion that pain management is more than drug therapy (Douglas, 
2014). Also inherent in the acute BPS model is a longitudinal approach to service 
delivery and intervention. A model that commences prior to admission to hospital 
would help transition patients through the stages of the perioperative experience 
and beyond into the community. Derived from the BPS model, all phases of the 
experience are inseparable as well as the biological, psychological and social 
factors that intertwine to produce individual outcomes. A failure to recognise this 
upholds the biomedical model and perpetuates the dichotomous views that pervade 
the acute pain community, despite general acceptance of the BPS model as the 
preferred model for pain science (Moseley & Butler, 2015).  
 
It is may appear that one of the most common major surgeries is underrated when 
it comes to pain and how pain can impact on maternal recovery. Similar surgery 
without the outcome of childbirth is often met with significant intervention for pain 
over a few days such as intravenous patient controlled analgesia. However, CS pain 
is often managed with an expectation that the day after a woman will not require 
such intervention. This may be informed by social views on childbirth and an 
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expectation that women will endure some pain. Some have argued that women 
themselves expect to endure this pain so they can feel a sense of control by 
accessing their own maternal resources and coping skills to manage the situation. 
These factors add more complexity to CS which some have argued is a BPS 
experience. 
 
Despite contemporary views on pain that reject the concept of mind-body dualism, 
most women would have an expectation of an approach to postoperative pain 
management that aims to minimise pain for the first 24 hours. In the clinical context 
of intrathecal morphine and multimodal oral analgesics, this way of treating acute 
pain has considerable benefit over a short time. However, women are often 
expected to mobilise at a time when the analgesia from intrathecal morphine has 
decayed significantly from its peak effect hours earlier. The preferred clinical 
practice has been to supplement this decline in analgesia with oral CR oxycodone 
with an initial dose 18-24 hours following surgery. The key problem with CR 
oxycodone for acute pain management is that the time to peak analgesic effect is 
approximately three hours which is unsuitable for oral supplementation after CS 
when a faster onset is required for the first dose. The entrenchment of this practice 
among anaesthetists may have resulted from research promoting CR oxycodone 
following major orthopaedic surgery. This study attempted to individualise the 
experience by providing a BPS approach to pain management using IR oxycodone 
which has a faster onset of analgesia than CR oxycodone.  
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The research has addressed some other gaps in the literature because this 
intervention specifically targeted CS pain from the first postoperative morning 
when most women are expected to mobilise.  In addition, no CS studies have 
compared treatments using PGIC and only one RCT has evaluated pain interference 
with the modified BPI (McDonnell, 2009). Few studies have evaluated CS 
outcomes in terms of CPSP or discovered a strong association between PND and 
poor outcomes three months after CS (Gatchel & Maddrey, 2004). Furthermore, no 
studies comparing pain interventions after CS have explored the concept of 
maternal control over pain management or demonstrated that increased perceived 
control in some women may result in less disability three months after surgery. This 
was the first RCT comparing pain interventions for CS using a mixed effects model 
that controlled for many potential confounding variables such as depression, pain 
catastrophising and intrathecal morphine analgesia. The results of this study 
confirm that a BPS approach is required to enable acceptable analgesia for women. 
CS is a complex BPS experience and if women are expected to do without more 
invasive analgesic techniques the day after surgery, they deserve an approach that 
uses multiple strategies to ensure the outcomes they desire and to prevent chronic 
pain, depression and disability. 
 
Translation to practice is the next challenge for the NP researcher because there are 
barriers to the acceptance of the BPS model in the acute pain setting as well as 
obstacles to changing prescribing practices. For example, a BPS view of acute pain 
management would require a major shift in thought away from the biomedical 
model. It has been argued that this would have to commence with major changes to 
how medical practitioners are educated (Edozien, 2015). In terms of service 
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delivery, existing NPs who work in acute pain services could expand their scope of 
practice by establishing a supportive relationship with women in the preadmission 
phase and after discharge. In contrast to the medical approach of daily postoperative 
review, NPs could develop nursing models of care to drive service innovation rather 
than medical guidelines such as those proposed by the Australian and New Zealand 
College of Anaesthetists which appear to shape acute pain service delivery in a 
broad sense (ANZCA, 2013), but do not offer a comprehensive approach to pain 
management based on the BPS model of pain. The NP can influence practice at a 
grass roots level by promoting and employing a pain management approach as 
suggested by this research and auditing practice outcomes to communicate the 
benefits of change. Finally, the BPS model for acute pain can be tested by further 
research into the effectiveness of the model in various surgical contexts. 
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Appendix B: Questionnaires 
Preoperative Questionnaire 
What is your highest level of education? 
Less than high school 
graduate☐ 
  High school 
graduate☐ 
College, trade or 
technical education☐ 
         University degree☐ 
Thoughts about pain 
We are interested in the types of thoughts and feelings that you have when you are in pain. 
Listed below are statements describing different thoughts and feelings that may be associated 
with pain. Using the 0-4 scale below, indicate the degree to which you have these thoughts and 
feelings when you are experiencing pain.  
0                             1                            2                                3                        4 
Not at all       To a slight degree        To a moderate degree          To a great degree      All of the time 
 
When I’m in pain … 
☐ I worry all of the time about whether the pain will end. 
☐ I feel I can’t go on. 
☐ It’s terrible and I think it’s never going to get any better. 
☐ It’s awful and I feel that it overwhelms me. 
☐ I feel I can’t stand it anymore. 
☐ I become afraid that the pain will get worse. 
☐ I keep thinking of other painful events. 
☐ I anxiously want the pain to go away. 
☐ I can’t seem to get it out of my mind. 
☐ I keep thinking about how much it hurts. 
☐ I keep thinking about how badly I want the pain to stop. 
☐ There’s nothing I can do to reduce the intensity of the pain. 
☐ I wonder whether something serious will happen. 
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Postoperative Questionnaire 
Please complete the following questions at 8 am in the morning on the day 
after surgery 
Q1. Mark the line below to indicate how much pain you have at rest: 
 
      
no pain                                                                                   worst pain imaginable 
 
Q2. Mark the line below to indicate how much pain you have on moving to a 
sitting position: 
 
      
no pain                                                                                   worst pain imaginable 
 
 
Please complete the following questions at 9 am in the morning on the day 
after surgery 
Q1. Mark the line below to indicate how much pain you have at rest: 
 
      
no pain                                                                                   worst pain imaginable 
 
 
Q2. Mark the line below to indicate how much pain you have on moving to a 
sitting position: 
 
      
no pain                                                                                   worst pain imaginable 
 
 
 
Q3. Since 8 am, my pain relief is:  
 Very much improved 
  
 Much improved 
  
 Minimally improved 
  
 No change 
  
 Minimally worse 
  
 Much worse 
  
 Very much worse 
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Please complete the following questions at 10 am in the morning on the day 
after surgery 
Q1. Mark the line below to indicate how much pain you have at rest: 
 
      
no pain                                                                                   worst pain imaginable 
 
 
Q2. Mark the line below to indicate how much pain you have on moving to a 
sitting position: 
 
      
no pain                                                                                   worst pain imaginable 
 
 
 
Q3. Since 8 am, my pain relief is:  
 Very much improved 
  
 Much improved 
  
 Minimally improved 
  
 No change 
  
 Minimally worse 
  
 Much worse 
  
 Very much worse 
 
 
 
Please complete the following questions at 11 am in the morning on the day 
after surgery 
Q1. Mark the line below to indicate how much pain you have at rest: 
 
      
no pain                                                                                   worst pain imaginable 
 
 
Q2. Mark the line below to indicate how much pain you have on moving to a 
sitting position: 
 
      
no pain                                                                                   worst pain imaginable 
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Q3. Since 8 am, my pain relief is:  
 
 Very much improved 
  
 Much improved 
  
 Minimally improved 
  
 No change 
  
 Minimally worse 
  
 Much worse 
  
 Very much worse 
 
Please complete the following questions at 12 midday on the day after 
surgery 
Q1. Mark the line below to indicate how much pain you have at rest: 
 
      
no pain                                                                                   worst pain imaginable 
 
 
Q2. Mark the line below to indicate how much pain you have on moving to a 
sitting position: 
 
      
no pain                                                                                   worst pain imaginable 
 
Q3. Since 8 am, my pain relief is:  
 
 Very much improved 
  
 Much improved 
  
 Minimally improved 
  
 No change 
  
 Minimally worse 
  
 Much worse 
  
 Very much worse 
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The questionnaire now provides you with a list of words that describe some of the 
qualities of pain and related symptoms. Please put an X through the numbers that 
best describe the intensity of each of the pain and related symptoms you are feeling. 
Use 0 if the word does not describe your pain or related symptoms. 
 
 
 
 
Throbbing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Shooting pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Stabbing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Sharp pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Cramping pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Gnawing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Hot-burning pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Aching pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Heavy pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Tender none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Splitting pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Tiring-exhausting none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Sickening none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Fearful none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Punishing-cruel none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Electric-shock pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Cold-freezing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Piercing none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Pain caused by light touch none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Itching none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Tingling or pins and needles none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Numbness none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
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Please complete the following questions prior to 8 pm at night on the day 
after surgery 
 
Q1. Overall, how would you rate your oral or tablet pain management over the 
last 12 hours? 
Poor Fair    Good      Very Good                Excellent 
 
           
                   
Q2. Circle the number that describes how much, during the last 12 hours, pain has 
interfered with your: 
 Does not  
interfere 
Completely  
interferes 
General activity 0 1 2 3 4 5 6 7 8 9 10 
 
  
Mood 0 1 2 3 4 5 6 7 8 9 10 
   
Walking ability 0 1 2 3 4 5 6 7 8 9 10 
   
Relationships with 
other people 
0 1 2 3 4 5 6 7 8 9 10 
   
Coughing 0 1 2 3 4 5 6 7 8 9 10 
   
Breathing 0 1 2 3 4 5 6 7 8 9 10 
   
Concentration 0 1 2 3 4 5 6 7 8 9 10 
   
Enjoyment of life 0 1 2 3 4 5 6 7 8 9 10 
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For the next questions, please mark the line to indicate how much you 
experienced any of these symptoms:  
 
Q3. In terms of feeling drowsy during the last 12 hours, how would you rate this 
feeling on the scale below? 
 
   
None                                                                                    Intolerable 
 
Q4. In terms of feeling itchy during the last 12 hours, how would you rate this 
feeling on the scale below? 
 
         
None                                                                                    Intolerable 
 
Q5. In terms of nausea and vomiting during the last 12 hours, how would you rate 
this feeling on the scale below? 
 
     
None                                                                                    Intolerable 
 
 
 
 
Please complete the following questions at 8 am in the morning on the second 
day after surgery 
Q1. Mark the line below to indicate how much pain you have at rest: 
 
      
no pain                                                                                   worst pain imaginable 
 
 
Q2. Mark the line below to indicate how much pain you have on movement: 
 
      
no pain                                                                                   worst pain imaginable 
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For questions 3-5, please mark the line that best indicates how much control 
you had over your pain management over the last 2 days: 
 
Q3. Who was in control of the way your pain was managed? 
 
 
you                                                                                   hospital staff 
 
 
 
Q4. How much control did you have over your pain management? 
 
 
none                                                                                  complete 
 
 
Q5. How much control did hospital staff have over your pain management? 
 
 
none                                                                                  complete 
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Follow-up Study by Telephone Interview 
Q1. On how many days in the last 3 months have you had caesarean scar pain?  
Days________  
Q2. How would you rate your caesarean scar pain RIGHT NOW? Using a scale 
from 0 to 10, where 0 is “no pain” and 10 is “pain as bad as could be.” 
0      1       2       3       4       5       6       7       8       9       10 
 
Q3. In the last 3 months, how would you rate your WORST caesarean scar pain? 
Use the same scale, where 0 is “no pain” and 10 is “pain as bad as could be.” 
0      1       2       3       4       5       6       7       8       9       10 
 
 Q4. In the last 3 months, ON AVERAGE, how would you rate your CS pain? 
Use the same scale, where 0 is “no pain” and 10 is “pain as bad as could be.” 
[That is, your usual pain at times you were in pain.] 
0      1       2       3       4       5       6       7       8       9       10 
 
 Q5. In the last 3 months, how many days did your caesarean scar pain keep you 
from doing your USUAL ACTIVITIES like work, school or housework? 
Days:   0    1     2   3–4   5–6    7–10   11–15   16–24   25–60   61–75   76–90 
Score: (0) (1)   (2)  (3)    (4)      (5)        (6)        (7)         (8)        (9)       (10) 
 
Q6. In the last 3 months, how much has caesarean scar pain interfered with your 
DAILY ACTIVITIES? Use a 0 to 10 scale, where 0 is “no interference” and 10 is 
“unable to carry on any activities.” 
0      1       2       3       4       5       6       7       8       9       10  
 
Q7. In the last 3 months, how much has caesarean scar pain interfered with your 
RECREATIONAL, SOCIAL AND FAMILY ACTIVITIES? Use the same scale, 
where 0 is “no interference” and 10 is “unable to carry on any activities.” 
0      1       2       3       4       5       6       7       8       9       10  
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Q8. In the last 3 months, how much has caesarean scar pain interfered with your 
ABILITY TO WORK, including housework? Use the same scale, where 0 is “no 
interference” and 10 is “unable to carry on any activities.” 
0      1       2       3       4       5       6       7       8       9       10 
 
Q9.  On a scale of 0 to10, where 0 mean no interference and 10 means completely 
interferes, in the last 3 months what number describes how pain has interfered 
with: 
 
 Does not  
interfere 
Completely  
interferes 
General activity 0 1 2 3 4 5 6 7 8 9 10 
   
Mood 0 1 2 3 4 5 6 7 8 9 10 
   
Walking ability 0 1 2 3 4 5 6 7 8 9 10 
   
Relationships with 
other people 
0 1 2 3 4 5 6 7 8 9 10 
   
Coughing 0 1 2 3 4 5 6 7 8 9 10 
   
Breathing 0 1 2 3 4 5 6 7 8 9 10 
   
Concentration 0 1 2 3 4 5 6 7 8 9 10 
   
Enjoyment of life 0 1 2 3 4 5 6 7 8 9 10 
   
Normal work 0 1 2 3 4 5 6 7 8 9 10 
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Q10.  This questionnaire provides you with a list of words that describe some of 
the qualities of pain and related symptoms. Using a scale of 0 to 10, where 0 
means none and 10 means worst possible, indicate the number that best describes 
the intensity of your pain and related symptoms. 
 
 
 
Throbbing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Shooting pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Stabbing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Sharp pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Cramping pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Gnawing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Hot-burning pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Aching pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Heavy pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Tender none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Splitting pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Tiring-exhausting none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Sickening none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Fearful none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Punishing-cruel none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Electric-shock pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Cold-freezing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Piercing none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Pain caused by light touch none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Itching none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
Tingling or pins and 
needles 
none 
0 1 2 3 4 5 6 7 8 9 10 
worst possible 
Numbness none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
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Q11. Finally, we would like to ask some questions about your mood over the past 
week. I will read you some statements and possible responses. Please indicate 
which answer best represents how you have felt in the past 7 days, not just how you 
feel today. 
 
I have been able to laugh and see the funny side of things. 
 ☐As much as I always could 
 ☐Not quite so much now 
 ☐Definitely not so much now 
 ☐Not at all 
 
I have looked forward with enjoyment to things. 
☐As much as I ever did 
☐Rather less than I used to 
☐Definitely less than I used to 
☐Hardly at all 
 
I have blamed myself unnecessarily when things went wrong. 
 ☐Yes, most of the time 
 ☐Yes, some of the time 
 ☐Not very often 
 ☐No, never 
 
I have been anxious or worried for no good reason. 
 ☐No, not at all 
 ☐Hardly ever 
 ☐Yes, sometimes 
 ☐Yes, very often 
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I have felt scared or panicky for not very good reason. 
 ☐Yes, quite a lot 
 ☐Yes, sometimes 
 ☐No, not much 
 ☐No, not at all 
 
Things have been getting on top of me. 
☐Yes, most of the time I haven’t been able to cope at all 
☐Yes, sometimes I haven’t been coping as well as usual 
☐No, most of the time I have coped quite well 
☐No, I have been coping as well as ever 
 
I have been so unhappy that I have had difficulty sleeping. 
 ☐Yes, most of the time 
 ☐Yes, sometimes 
 ☐Not very often 
 ☐No, not at all 
I have felt sad or miserable. 
 ☐Yes, most of the time 
 ☐Yes, quite often 
 ☐Not very often 
 ☐No, not at all 
 
 I have been so unhappy that I have been crying. 
 ☐Yes, most of the time 
 ☐Yes, quite often 
 ☐Only occasionally 
 ☐No, never 
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The thought of harming myself has occurred to me. 
 ☐Yes, quite often 
 ☐Sometimes 
 ☐Hardly ever 
 ☐Never 
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Thank you for submitting your research to the West Moreton Hospital and 
Health Service (WMHHS).  I am pleased to inform you that the Executive 
Director and/or delegate has now given formal approval for your study to 
commence at our site following your compliance with the NHMRC 
guidelines and Queensland Health’s ethical and governance research 
review process.   
 
The WMHHS Research Ethics & Governance Office operates and 
complies with the NHMRC National Statement on Ethical Conduct in 
Research Involving Humans, 2007 and is conducted according to the ICH 
Harmonised Tripartite, Good Clinical Practice Guidelines and the World 
Medical Association Declaration of Helsinki 2000  
 
CONDITION OF COMMENCEMENT 
 
As a condition of approval, the investigators & research staff must abide 
by the:  
1. National Statement on the Ethical Conduct in Human Research 2007 
2.  Australian Code for the Responsible Conduct of Research 2007 
3. Public Health Act 2005 - Access to confidential health information for 
researchers 
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According to QHealth’s Good Clinical Practice (GCP) based Standard 
Operating Procedures (SOPs) a research study folder must be maintained 
and should contain the following documents depending on the state of 
progress of your research: 
• Approved Research Protocol 
• Application for HREC ethical review 
• Checklist for research HREC study submissions 
• Approved NEAF   
• All approved versions of consent/assent forms 
• Approved recruiting advertisement/ brochures/flyers 
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• If applicable, CTN / CTX forms 
• If applicable, indemnity forms 
• Study staff curriculum vitas. 
• Originals of the signed Participant Information and Consent Forms,  
• Letters of Support or agreement from participating sites, if applicable 
• HREC approval Letters from collaborative institutions, if applicable  
• All signed HREC approval letters and other HREC correspondence 
• All progress and safety reports /continuing review. 
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• Amendments to protocol etc (letter of submission to HREC for review 
and approval received 
• Current and superseded Participant Information and Consent Forms, 
with appropriate version numbers and dates 
• Final report 
IMMEDIATE NOTIFICATION 
As a condition of approval, the investigators must promptly report anything 
which might affect ethical acceptance of the study, including: 
 
• Proposed amendments to the research protocol or conduct of the 
research which only affects the ongoing acceptability of the project at this 
site; 
• Any other proposed amendments to the research protocol, conduct of 
the research, unforeseen events that might affect continued ethical 
acceptability of the study e.g. adverse effects on participants, any 
complaints or expressions of concern made in relation to the study, and 
notification of the completion or cessation of the study are to be 
submitted firstly to the approving HREC for review and then to the 
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WMHHS research ethics/ governance office after a HREC decision is 
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Appendix D: Random Effects Models of VAS for pain at rest and on moving 
or sitting 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Random Effects: Resting Pain 
Factor 
Variance 
Estimate 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Intercept 
 [subject = id] 
111.29 42.94 0.010 52.24 237.09 
Spline 2 (1-4hr) 100.54 27.60 <0.0005 58.70 172.19 
Spline 3(4-24hr) 52.07 20.56 0.011 24.01 112.90 
Random Effects: Pain on Sitting or Moving 
Parameter 
Variance 
Estimate Std. Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Residual 158.12 17.04 <0.0005 128.02 195.30 
Intercept  
[subject = id] 
325.03 81.25 <0.0005 199.13 530.52 
Spline 2 (2-4hr) 54.35 21.13 0.010 25.37 116.43 
Spline 3(4-24hr) 78.52 27.16 0.004 39.86 154.65 
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Appendix E: Testing the effect of additional predictors on the basic model for 
pain at rest. 
 
Factor Parameter 
Estimate 
Sig. AIC 
Basic Model   3298  
Ethnicity 0.053 0.818 3293 
Education 0.334 0.801 3282 
Technique  2.81 0.879 3288 
BMI 0.612 0.009* 3292 
Age 0.253 0.452 3298 
History of 
Depression 
7.57 0.357 3291 
Parity 0.94 0.3467 3296 
No. of previous 
Caesarean  
6.49 0.003* 3268 
Spinal morphine 
dose 
0.018 0.790 3302 
Time intrathecal 
morphine 
administered 
0.296 0.651 3297 
Total Oxycodone 
dose given in the 
six hours before 
intervention 
0.709 0.160 3296 
Total Tramadol 
dose given in the 
six hours before 
intervention 
0.0075 0.873 3303 
Gestational age 
(duration in 
weeks) 
0.720 0.739 3295 
Pre-op 
Edinburgh 
(EPNSD)score 
0.234 0.618 3298 
Total PCS Score 0.458 0.019* 3209 
Effect of adding individual factors to the basic model. (*= p<0.05) 
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Appendix F: Testing the effect of additional predictors on the basic model for 
pain on sitting and moving. 
 
 
Factor Parameter 
estimate 
p value AIC 
Basic Model   3406 
Ethnicity -9.06 0.345 3398 
Education -12 0.321 3385 
Technique -2.9 0.929 3394 
BMI -0.584 0.068 3403 
Age 0.813 0.072 3402 
History of 
Depression 
14.45 0.193 3397 
Parity 0.437 0.803 3403 
No. of previous 
Caesarean 
sections 
5.70 0.094 3398 
Spinal morphine 
dose 
-0.026 0.774 3408 
Time intrathecal 
morphine 
administered 
1.02 0.246 3403 
Oxycodone dose 
given in the six 
hours before 
intervention 
1.609 0.017* 3399 
Tramadol dose 
given in the six 
hours before 
intervention 
0.0402  3409 
Gestational age 
(duration in 
weeks) 
1.16 0.691 3401 
Pre-op Edinburgh 
(EPNDS) score 
0.297 0.641 3404 
Total PCS Score 0.557 0.035* 3140 
Effect of adding individual factors to the basic model. (*= p<0.05) 
 
 
 
 
